KOL | Rikard HolmdahlNational and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China | Medical ... |
Kol melanjutkan untuk Rikard Holmdahl
| Year | |
|---|---|
| 2022 | National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China Medical Inflammation Research, MediCity Research Laboratory, University of Turku, Turku, Finland |
| 2021 | The Second Affiliated Hospital of Xi’an Jiaotong University (Xibei Hospital), Xi’an, China Department Medical Biochemistry and Biophysics, Division Medical Inflammation Research, Karolinska Institute, 171 77 Stockholm, Sweden;, (M.A.);, (X.C.);, (B.X.);, (G.F.L.);, (M.Y.B.);, (Y.H.);, (L.B.) Division of Medical Inflammation Research, Dept. of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden |
| 2020 | Dept. of Medical Inflammation Research, Section of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm Section for Medical Inflammation Research, BMCI11, Lund University, Lund, Sweden National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, 710004 Xi’an, China Karolinska Institutet |
| 2019 | Section for Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solnavägen 9, 171 65, Solna, Sweden Center for Medical Inflammation Research, Southern Medical University, Guangzhou, China R. Holmdahl and C.I. Svensson contributed equally to this paper. |
| 2018 | School of Pharmaceutical Science, Southern Medical University, Guangzhou, China Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden Medicity Research Laboratory, University of Turku, Turku, Finland |
| 2017 | Karolinska Institutet Division of Medical Inflammation Research Stockholm Sweden Center for Medical Immunopharmacology Research, Southern Medical University, 510515 Guangzhou, China. Medicity Research Laboratory, University of Turku, Turku, Finland, . |
Rikard Holmdahl: Statistik pengaruh
Jalankan laporan
| Concept | World rank |
|---|---|
| paamcryogel | #1 |
| cells cb11 | #1 |
| model rheumatoid arthritis | #1 |
| mumt mice oestrogen | #1 |
| inflammation living mice | #1 |
| macrophage ros | #1 |
| cii arthritis | #1 |
| insulitis strains | #1 |
| mutant p47phox | #1 |
| c57bl strains loci | #1 |
| ethylene isostere | #1 |
| tnfα tlr3 expression | #1 |
| arthritis monoclonal arthritis | #1 |
| tolerance arthritis susceptibility | #1 |
| idiotype‐specific binding | #1 |
| mab ciif4 ciic1 | #1 |
| cb11 sequence cii | #1 |
| b10q b10riii | #1 |
| rats hfdmets | #1 |
| arthritis intraperitoneal injection | #1 |
| lower capacity ros | #1 |
| oestrogen cia | #1 |
| hladrbound peptides | #1 |
| ul1 ciif4 | #1 |
| macrophages hladr1transgenic mice | #1 |
| hiit nox2 activity | #1 |
| inconsistent susceptibility | #1 |
| proteins gay | #1 |
| extraarticular cartilage | #1 |
| autoantibodies collagen | #1 |
| ciid3 | #1 |
| socalled collagen antibody | #1 |
| ifn signature mice | #1 |
| genetic crossbreeding | #1 |
| immunologic animals arthritis | #1 |
| lys264 | #1 |
| liver histone deacetylase | #1 |
| autoimmune response cii | #1 |
| cii u1 | #1 |
| collagen dendritic cells | #1 |
| clec4b | #1 |
| b10qnfr | #1 |
| ltabncr3 | #1 |
| therapeutic c4bp | #1 |
| cia13 | #1 |
| bcell activities | #1 |
| mice burkholderia cepacia | #1 |
| cia induced | #1 |
| ros continental ancestry | #1 |
| pepsin immunization | #1 |
| transgenic nadph oxidase | #1 |
| antibody induced | #1 |
| cells rat cii | #1 |
| suppression collagen arthritis | #1 |
| autoimmune arthritis activation | #1 |
| cii cix | #1 |
| position ros production | #1 |
| heterologous peptide response | #1 |
| arthritis darkness | #1 |
| cartilagespecific protein | #1 |
| inbred dba prolactin | #1 |
| induced arthritis | #1 |
| major locus cia | #1 |
| pia5 | #1 |
| immunisation cells | #1 |
| fecq4 | #1 |
| human α‐enolase | #1 |
| polymer adjuvant activity | #1 |
| rats pia9 alleles | #1 |
| caia induced | #1 |
| obs electrophoresis | #1 |
| β1helix | #1 |
| mucosal tolerance cii | #1 |
| development aureus arthritis | #1 |
| mbq mouse macrophages | #1 |
| arthritis estrogen | #1 |
| arthritis aim | #1 |
| deficient neonatal | #1 |
| rp autoimmune disease | #1 |
| oxoethyl6h | #1 |
| cii heterologous cii | #1 |
| inflammation caia | #1 |
| pia rats tlr3 | #1 |
| pia cii | #1 |
| arthritis rat strains | #1 |
| oxidative burst disease | #1 |
| induce arthritis | #1 |
| disease collagen | #1 |
| major antigenic epitope | #1 |
| cia oestrogen | #1 |
| cells mouse cii | #1 |
| severity cia | #1 |
| mice l012 | #1 |
| enhanced autoimmunity arthritis | #1 |
| position ciilysdnp | #1 |
| immune priming events | #1 |
| animal genes cia | #1 |
| h2r h2q | #1 |
| caia gene segments | #1 |
| peptide characterisation | #1 |
| nephritis nodq | #1 |
| cii immunization | #1 |
| humans animals arthritis | #1 |
| thps cii | #1 |
| cii experimental arthritis | #1 |
| immunization heterologous | #1 |
| concentrations mouse cii | #1 |
| biodegradation cryogels | #1 |
| cxi pia | #1 |
| sterically privileged | #1 |
| cii epitope | #1 |
| rats ncf1 allele | #1 |
| autoantibody responses cii | #1 |
| presence mhv | #1 |
| suggestive locus chromosome | #1 |
| glycosylated epitope | #1 |
| cii comp | #1 |
| h2q mice | #1 |
| antibody responses cii | #1 |
| avridine arthritis | #1 |
| ciif4 ciic1 | #1 |
| vivo experimental arthritis | #1 |
| ciipeptide | #1 |
| streptococcal endo | #1 |
| genetic background rats | #1 |
| mice developed | #1 |
| arthritis mcaia | #1 |
| rheumatoid collagen | #1 |
| melatonin release pinealectomy | #1 |
| mice cryogels | #1 |
| ncf1 | #1 |
| specific antibody protection | #1 |
| immune cartilage | #1 |
| collagen 256 | #1 |
| myeloid effector functions | #1 |
| susceptible strain cross | #1 |
| ciilysdnp mice | #1 |
| dominant traits | #1 |
| increased salt exposure | #1 |
| ros mip | #1 |
| compdeficient mice | #1 |
| genome b10riii | #1 |
| fecq4 locus | #1 |
| tcell congenic arthritis | #1 |
| disease affinity | #1 |
| c57bl 10q | #1 |
| hg6pi | #1 |
| cell tolerance cii | #1 |
| qa2 ncf1 | #1 |
| nzw parental | #1 |
| rabeximod treatment | #1 |
| rats rt1f mhc | #1 |
| w33t | #1 |
| arthritis toe stiffness | #1 |
| genetic association ncf1 | #1 |
| peripheral cells alphachains | #1 |
| anticlever1 antibody treatment | #1 |
| arthritismodulating | #1 |
| peptide agonist fmlf | #1 |
| selfcii | #1 |
| cia induced arthritis | #1 |
| relapsing arthritis | #1 |
| caia mab | #1 |
| antibodies cii | #1 |
| cia caia model | #1 |
| cii response | #1 |
| respiratory burst severity | #1 |
| comp cii | #1 |
| polychondritis autoimmune disease | #1 |
| cd4 treatment | #1 |
| cii256−270 | #1 |
| ciiinduced arthritis | #1 |
| mbp c5a | #1 |
| cia swr mouse | #1 |
| rats congenic arthritis | #1 |
| epitope cartilage | #1 |
| ncf1 sle | #1 |
| ncf4 mip | #1 |
| cia b10q | #1 |
| cii dendritic cells | #1 |
| b10qc5δ | #1 |
| cii mhc | #1 |
| polychondritis mice | #1 |
| pathogenesisis | #1 |
| mir144 tlr2 | #1 |
| function single | #1 |
| fumia | #1 |
| ncf1 mutated | #1 |
| experimental autoantibodies | #1 |
| valphachain | #1 |
| endos hydrolyzed igg | #1 |
| joint inflammatory phase | #1 |
| genes arthritis | #1 |
| mediate pulmonary inflammation | #1 |
| induction oia | #1 |
| acpas specificity | #1 |
| cii mab | #1 |
| cia rat cii | #1 |
| pia experimental arthritis | #1 |
| adjuvant oils | #1 |
| cii peptides | #1 |
| native comp | #1 |
| cii vivo | #1 |
| specific cii | #1 |
| cxiia | #1 |
| autoimmunogenic hydrocarbon oils | #1 |
| rats ncf1 | #1 |
| arthritogenic antibody | #1 |
| promoter regions antigens | #1 |
| rt1u lew1w | #1 |
| cii cartilage explants | #1 |
| formation arthritis | #1 |
| tlr3 synovium | #1 |
| h‐2q | #1 |
| dimethyl6n | #1 |
| collagen type cii | #1 |
| igg1 igg2b isotypes | #1 |
| disease arthritis | #1 |
| cia rheumatoid autoantibodies | #1 |
| phytol molecular pathways | #1 |
| differential susceptibility cia | #1 |
| confers arthritis susceptibility | #1 |
| f1 males influence | #1 |
| arthritis ncf1 | #1 |
| targeted deletion ncf1 | #1 |
| ftirm mice | #1 |
| tracheolaryngeal | #1 |
| etoposide topoisomerase antagonist | #1 |
| arthritis animal | #1 |
| 2 months beta | #1 |
| cii lewis rats | #1 |
| cia11 | #1 |
| estrogen immune responses | #1 |
| adaptive immunity fcγrs | #1 |
| ncf1 mice | #1 |
| tumor colonization | #1 |
| pia blocking arthritis | #1 |
| ncf1m1j m1j mice | #1 |
| hufcgammariia | #1 |
| citrullinated collagen | #1 |
| mice mutated type | #1 |
| antiidiotypic antibodies cd4 | #1 |
| cia antibody response | #1 |
| animal models polychondritis | #1 |
| f1 hybrids disease | #1 |
| effects fab2 | #1 |
| controlling collagen | #1 |
| transgenic tolerance tlymphocytes | #1 |
| lathyritic cii | #1 |
| alpha type collagen | #1 |
| pia rats arthritis | #1 |
| cii259 | #1 |
| hydrocarbon oil structure | #1 |
| mice cii epitopes | #1 |
| eae2 | #1 |
| minimal glycopeptide core | #1 |
| wo2012127214 | #1 |
| phase cia | #1 |
| arthritis anticii abs | #1 |
| psich2nh2 | #1 |
| anticii antibodies | #1 |
| arthritis incidence severity | #1 |
| experimental chromosomes | #1 |
| cia locus | #1 |
| ncf1339 allele | #1 |
| partial advanced intercross | #1 |
| dba 1jpfp | #1 |
| data act389949 | #1 |
| cii severity | #1 |
| collagen type‐ii epitope | #1 |
| mutated ncf1 | #1 |
| autoantibodies cii | #1 |
| cii256270 | #1 |
| cells arthritogenicity | #1 |
| nzb mice trait | #1 |
| chromosomes eae loci | #1 |
| existence periodontitis | #1 |
| dapia6 | #1 |
| rats rheumatoid | #1 |
| immunization rat cii | #1 |
| developed severe | #1 |
| beta 812 | #1 |
| cii matrix protein | #1 |
| citrulline collagen | #1 |
| antitlr3 antibody | #1 |
| genetic variants ncf1 | #1 |
| antibody response cii | #1 |
| collagen induced | #1 |
| cia2 arthritis | #1 |
| ncf1 ros | #1 |
| act389949 agonist | #1 |
| arthritis genetics | #1 |
| peritonitis transgenic | #1 |
| chronic arthritis development | #1 |
| immunization mouse | #1 |
| arthritis development cross | #1 |
| ncf1 mutant mice | #1 |
| lnchc cholesterol metabolism | #1 |
| immunization autologous peptide | #1 |
| therapeutic cleavage | #1 |
| autoimmune diseases cnvs | #1 |
| mabs cii | #1 |
| hla–dr1 | #1 |
| representative swedish | #1 |
| effects ciif4 | #1 |
| arthritis pepsin | #1 |
| type disease | #1 |
| eae chromosomes | #1 |
| arthritis monoclonal | #1 |
| rats mhc genes | #1 |
| homologous type collagen | #1 |
| b10dr4ncf1 mice cii | #1 |
| multiple sclerosis rabeximod | #1 |
| pia11 | #1 |
| dba 1 mouse | #1 |
| hfdmets | #1 |
| male mice arthritis | #1 |
| autologous peptide cells | #1 |
| ncf1 deficient | #1 |
| chronic active arthritis | #1 |
| cia eae39 | #1 |
| fibroblasts ifnbetadeficient mice | #1 |
| phase arthritis | #1 |
| rat cb11 immunization | #1 |
| ciif4 cartilage damage | #1 |
| b10q h2q | #1 |
| increased incidence cia | #1 |
| new arthritis therapy | #1 |
| injection lewis rat | #1 |
| rats established pia | #1 |
| fpr1 agonist neutrophils | #1 |
| cia5 qtl | #1 |
| strong response epitopes | #1 |
| b10qbalb | #1 |
| rheumatoid arthritis immunization | #1 |
| comp cxi | #1 |
| arthritis locus | #1 |
| chromosome 17 mhc | #1 |
| ncf1 339 | #1 |
| b10dr4ncf1 | #1 |
| phenotypes ncf1m1j mice | #1 |
| nox2 complex addition | #1 |
| ncf1 m1j | #1 |
| autologous type collagen | #1 |
| psicoch2 | #1 |
| cii h2q | #1 |
| b10dr4ncf1 mice | #1 |
| caia experimental arthritis | #1 |
| csfspecific | #1 |
| rats chronic disease | #1 |
| ppt medium | #1 |
| arthritis estrus cycle | #1 |
| resistance collageninduced arthritis | #1 |
| glycosylated epitope structures | #1 |
| pia eae | #1 |
| cii development | #1 |
| nod loci genes | #1 |
| synovial cells macrophages | #1 |
| eae2 chromosome | #1 |
| ncf1 knockout | #1 |
| mediating arthritis | #1 |
| ncf1 ncf1m1j mutation | #1 |
| hg6pi325 | #1 |
| suppressive development | #1 |
| emerging glyco‐based strategies | #1 |
| blocking arthritis | #1 |
| tumor models ncf1 | #1 |
| citrullinated cii | #1 |
| cia ul1 mab | #1 |
| comp mabs | #1 |
| ncf1 nos2 | #1 |
| established sialadenitis | #1 |
| c4bp alternative pathway | #1 |
| periodontitis rats pia | #1 |
| collagen ii‐induced | #1 |
| models rheumatoid | #1 |
| p47phoxv232 | #1 |
| phosphatase 22 | #1 |
| cii monoclonal arthritis | #1 |
| animal genetic predisposition | #1 |
| 4 histone deacetylases | #1 |
| inflammatory arthritis assessment | #1 |
| signaling characterization | #1 |
| heterologous cii cells | #1 |
| sialadenitis congenic mice | #1 |
| caia effects | #1 |
| collagen iiinduced arthritis | #1 |
| dancf1da rats | #1 |
| ncf1deficient mice | #1 |
| presence arthritogenic mabs | #1 |
| cia compdeficient mice | #1 |
| pristaneprimed cells | #1 |
| collagen reactive | #1 |
| cia opportunities | #1 |
| ccp positive patients | #1 |
| col2259 | #1 |
| dth nzb | #1 |
| glut4dependent glucose transport | #1 |
| strains developed | #1 |
| rat cii arthritis | #1 |
| cuiiidaligands | #1 |
| ftirm cii | #1 |
| sensitive wkymvm | #1 |
| mem lglutamine | #1 |
| tolerance immunodominant | #1 |
| cii immunization treatment | #1 |
| rheumatoid disease models | #1 |
| tlr3 flss | #1 |
| disease development effects | #1 |
| chromosome cia | #1 |
| satellite encephalomyelitis | #1 |
| cii sera | #1 |
| cii major epitope | #1 |
| macrophages cii degradation | #1 |
| bqncf1m1j | #1 |
| tlr3 expression tnfα | #1 |
| isolated fragment chromosome | #1 |
| gia expansion | #1 |
| glycosylation cell recognition | #1 |
| mouse chromosome eae39 | #1 |
| transgenic mice mhcii | #1 |
| polyi arthritis | #1 |
| experimental arthritis articular | #1 |
| vivo treatment | #1 |
| 22 variant r620w | #1 |
| inbred strains cia | #1 |
| toxin‐1‐producing staphylococci | #1 |
| cii260 | #1 |
| mouse cii | #1 |
| saline arthritis | #1 |
| glycosylated cii259 | #1 |
| tolerance cia | #1 |
| nadph activation | #1 |
| mcaia | #1 |
| collagen immunization | #1 |
| prevents arthritis | #1 |
| cii pia | #1 |
| collagen cxi | #1 |
| citrullinated variants | #1 |
| susceptibility collageninduced arthritis | #1 |
| type collagen cxi | #1 |
| cii ros | #1 |
| congenic fragments | #1 |
| inflammatory phase cia | #1 |
| arthritis development immunisation | #1 |
| rats synthetic peptide | #1 |
| development collagen | #1 |
| phytol arthritis | #1 |
| animal epitopes injections | #1 |
| cii cells | #1 |
| acpa general population | #1 |
| new therapy arthritis | #1 |
| pc117 extracellular structures | #1 |
| mir144 tlr2 expression | #1 |
| gene ncf1 | #1 |
| celldependent disease | #1 |
| arthritis autoantibody | #1 |
| cii 6 | #1 |
| ros antigens | #1 |
| arthritis multiple | #1 |
| rats arthritis | #1 |
| lewis rats pepsin | #1 |
| tolerance collagen | #1 |
| ciic1 mabs | #1 |
| arthritis adjuvants | #1 |
| complex cia | #1 |
| anticardiolipin antibodies p005 | #1 |
| mice darkness | #1 |
| mcaia ncf1 | #1 |
| mcia1 | #1 |
| genetic regions | #1 |
| defined polymeric adjuvant | #1 |
| oestrogen induced | #1 |
| loci sialadenitis | #1 |
| glycosylation hla | #1 |
| ncf1 polymorphisms | #1 |
| cholera toxin study | #1 |
| bb2bb3 regulation | #1 |
| placental mhc class | #1 |
| cii cross reactivity | #1 |
| development collageninduced arthritis | #1 |
| 15a11 | #1 |
| cii rat cii | #1 |
| collagen antibody arthritis | #1 |
| c3bireceptors | #1 |
| rat cii cii | #1 |
| cells caia | #1 |
| epitopes cii | #1 |
| new arthritis | #1 |
| sle‐prone mrl | #1 |
| nodq×b10q | #1 |
| ides treatment severity | #1 |
| autoimmune priming | #1 |
| function ncf1 gene | #1 |
| disease th1 immunity | #1 |
| ftirm ciic1 | #1 |
| greater osteoclasts | #1 |
| features arthritis | #1 |
| immunization rat | #1 |
| encephalomyelitis arthritis | #1 |
| pia4 | #1 |
| oestradiol exacerbation | #1 |
| function p47phox | #1 |
| collagen‐induced | #1 |
| arthritis ides | #1 |
| tlr3 pristane | #1 |
| transgenic nadph | #1 |
| disease glycoproteins | #1 |
| qtl chip | #1 |
| siliac | #1 |
| estrogen physiological doses | #1 |
| dth mice trait | #1 |
| mice anticd4 treatment | #1 |
| m2139 ciic1 | #1 |
| nzw parental strain | #1 |
| arthritis induced | #1 |
| arthritis animal mice | #1 |
| rheumatoid arthritis cia | #1 |
| cii mouse | #1 |
| cii rheumatoid autoantibodies | #1 |
| eae3 chromosome | #1 |
| cia vivo priming | #1 |
| lew ztm ncf1 | #1 |
| rats comp | #1 |
| stromal cells osteoclasts | #1 |
| ciif4 mab | #1 |
| restricted role fcγr | #1 |
| dba 1 | #1 |
| role ncf1 | #1 |
| collagen epitope expression | #1 |
| insulitis nodq | #1 |
| cii human | #1 |
| therapeutic cleavage igg | #1 |
| congenic mice genes | #1 |
| cii induced arthritis | #1 |
| collagen reactivity cxi | #1 |
| cia ul1 | #1 |
| cix disease | #1 |
| administration antibodies hyaluronanreceptor | #1 |
| selected anti‐t‐cell | #1 |
| arthritis rheumatoid arthritis | #1 |
| epitopes vivo | #1 |
| c3hq mice | #1 |
| findings new therapy | #1 |
| cia pia | #1 |
| oxa nzb mice | #1 |
| experimental arthritis autoimmune | #1 |
| genistein collagen | #1 |
| locus cia development | #1 |
| anticii autoantibodies | #1 |
| double deficiency qa2 | #1 |
| arthritis‐susceptibility loci | #1 |
| arthritis severity rats | #1 |
| lew1w rt1u | #1 |
| nox2complex | #1 |
| milk titers | #1 |
| riiis segment chromosome | #1 |
| mice interferon gamma | #1 |
| ncf4 gene | #1 |
| cii cartilage | #1 |
| myelomonocytic arthritis interleukin2 | #1 |
| cii cell | #1 |
| cxi cii | #1 |
| caia kgf | #1 |
| oestrogen lupus disease | #1 |
| pristaneinduced arthritis | #1 |
| abetachains | #1 |
| animal immunosuppressive agents | #1 |
| cii acpa | #1 |
| 339 polymorphism | #1 |
| arthritogenic mab ciic1 | #1 |
| treatment physiological doses | #1 |
| ifnbeta deficiency | #1 |
| mab ecm | #1 |
| epitopes arthritis | #1 |
| impact etoposide | #1 |
| drb10401 col2259 | #1 |
| cxi arthritis | #1 |
| disease genotype immunoglobulin | #1 |
| loci controlling diabetes | #1 |
| rat cii | #1 |
| daiu | #1 |
| arthritis tlr3 upregulation | #1 |
| eae39 study | #1 |
| skg mutation | #1 |
| u1 epitope | #1 |
| oestrogen treated | #1 |
| rat cii response | #1 |
| congenic arthritis rats | #1 |
| chromosome arthritis severity | #1 |
| cii specific | #1 |
| inflammatory phase arthritis | #1 |
| beta 10b beta | #1 |
| targeted mutation ncf4 | #1 |
| ox8 antibodies | #1 |
| keratinocytes dth reaction | #1 |
| ym1deficient mice | #1 |
| elimination carbohydrates | #1 |
| sod3 peritonitis | #1 |
| rat pristaneinduced arthritis | #1 |
| beta 10b mrl | #1 |
| disease dba 1jpfp | #1 |
| maintenance arthritis | #1 |
| plasminogendeficient mice arthritis | #1 |
| rats pristaneinduced arthritis | #1 |
| induced relapsing | #1 |
| b10qacb | #1 |
| emulsions induction | #1 |
| ym1 alternative activation | #1 |
| major epitopes patients | #1 |
| b10b | #1 |
| caia acute arthritis | #1 |
| nodp nod | #1 |
| pia8 | #1 |
| model rheumatoid | #1 |
| suppression collagen | #1 |
| protein expression genes | #1 |
| cia cii | #1 |
| leukosialin rats | #1 |
| hladr1transgenic mice | #1 |
| comp experimental autoantibodies | #1 |
| ncf1 p47phox | #1 |
| ncf1 copy variation | #1 |
| citrullination cii | #1 |
| nodq nod | #1 |
| chronic stage arthritis | #1 |
| g6pi peptide | #1 |
| acute phase arthritis | #1 |
| surface redox levels | #1 |
| rats phytol | #1 |
| mab cb268 | #1 |
| congenic fragment | #1 |
| rabeximod | #1 |
| induced arthritis cia | #1 |
| dnp epitopes lysine | #1 |
| cii 256270 peptide | #1 |
| cii treatment | #1 |
| cii chronic | #1 |
| pparγ cbrh7919 cells | #1 |
| adjuvanticity autoimmunity | #1 |
| ciiderived | #1 |
| patients china cohort | #1 |
| ability gut protection | #1 |
| immunization lathyritic cii | #1 |
| upregulation tlr3 | #1 |
| disease transgenic models | #1 |
| b10q | #1 |
| chick cii cii | #1 |
| bb2bb3 | #1 |
| cii saline | #1 |
| l012 vivo imaging | #1 |
| argltgrpgda | #1 |
| immunological transmitter | #1 |
| frequency chronic arthritis | #1 |
| collagen arthritis progesterone | #1 |
| tolerance arthritis | #1 |
| genes antibodies | #1 |
| dba mouse epitopes | #1 |
| comp arthritis models | #1 |
| concentrations cii | #1 |
| estrogen differential outcome | #1 |
| ncf1 mice wt | #1 |
| qtl animal genes | #1 |
| chronicity arthritis | #1 |
| ros experimental arthritis | #1 |
| da1f | #1 |
| kupffer cells mir144 | #1 |
| substrains ztmrhd | #1 |
| animals arthritis | #1 |
| ncf1m1j mice ncf1 | #1 |
| fcγr3 | #1 |
| lymphocytes cartilage | #1 |
| 6 cii | #1 |
| act389949 fpr | #1 |
| single monoclonal | #1 |
| psoriasis spread | #1 |
| ox8 monoclonal | #1 |
| cii severe arthritis | #1 |
| satellite encephalomyelitis autoimmune | #1 |
| chemiluminescent probe l012 | #1 |
| arthritis epitopes | #1 |
| ncf1 spread | #1 |
| macrophages cii | #1 |
| position 264 | #1 |
| ncf1m1j mice function | #1 |
| eae2 resistant locus | #1 |
| mhc genetic region | #1 |
| homologous cii | #1 |
| cii cia | #1 |
| 1 ncf1 | #1 |
| cia12 pia4 | #1 |
| anticii antibody response | #1 |
| arthritis collagen arthritis | #1 |
| caia model | #1 |
| pc4 pc117 | #1 |
| m2139 arthritogenic mab | #1 |
| phemagelatin | #1 |
| response cii | #1 |
| severe arthritis | #1 |
| autoantibodies cartilage | #1 |
| arthritis immunisation | #1 |
| snat proteins | #1 |
| c1iii type collagen | #1 |
| immunization type | #1 |
| mice b10q | #1 |
| dominant susceptibility loci | #1 |
| pristane macrophages | #1 |
| alphachains cell surface | #1 |
| cells autologous cii | #1 |
| nucleotide reactive | #1 |
| arthritis transfer | #1 |
| re04001activatedfpr1 | #1 |
| serum chromosome | #1 |
| cii ncf1 | #1 |
| mhc influence | #1 |
| ncf4 | #1 |
| mice mutated cii | #1 |
| rat comp arthritis | #1 |
| antibodies consensus motif | #1 |
| mmc transgene | #1 |
| tissue attack | #1 |
| molecule aq | #1 |
| rats cxi | #1 |
| epitopes cb11 fragment | #1 |
| nox2 complex–derived ros | #1 |
| chondrocytes kgf | #1 |
| cia9 | #1 |
| arthritis caia | #1 |
| nfr origin | #1 |
| cia oia | #1 |
| cii caia | #1 |
| cii olive oil | #1 |
| tracheolaryngeal cartilage | #1 |
| immunospecific reactions | #1 |
| cia antigens haplotypes | #1 |
| receptor γ pparγ | #1 |
| spleen pristane injection | #1 |
| vivo monoclonal mouse | #1 |
| ala261gly262 | #1 |
| cb268 | #1 |
| arthritis promoting | #1 |
| joint proteins | #1 |
| ncf1 genes | #1 |
| mhc cia | #1 |
| oxidative burst inducers | #1 |
| ztmrhd | #1 |
| mip ncf4 | #1 |
| genetic encephalomyelitis autoimmune | #1 |
| pathogenesis cia | #1 |
| cia molecular basis | #1 |
| ncf1 mutation mice | #1 |
| cia tsc transgenic | #1 |
| cia h2p | #1 |
| mice cii immunization | #1 |
| effector phase arthritis | #1 |
| autoimmunity mineral oils | #1 |
| nodq locus | #1 |
| collageninduced arthritis loci | #1 |
| cd68‐expressing cells | #1 |
| murine psoriasis model | #1 |
| cia7 chromosome | #1 |
| cartilage explants m2139 | #1 |
| cells chronic arthritis | #1 |
| pepsin arthritis | #1 |
| 256 270 | #1 |
| human gpi protein | #1 |
| pia3 pia4 | #1 |
| ncf1 gene | #1 |
| e3xda | #1 |
| spread induced psoriasis | #1 |
| arthritis congenic | #1 |
| chronic arthritis rats | #1 |
| δ228 | #1 |
| regulates severity | #1 |
| polymorphism mitochondrial genome | #1 |
| melatonin cia | #1 |
| chronic relapsing arthritis | #1 |
| copy variation ncf1 | #1 |
| fpr act389949 | #1 |
| g6pi chronic arthritis | #1 |
| backcrosses nzb mice | #1 |
| recombinant vaccine inflammation | #1 |
| haplotype ltab | #1 |
| swr mice immunization | #1 |
| congenic cia40 | #1 |
| frequency igaproducing cells | #1 |
| cathelicidin expression blood | #1 |
| antibody ciic1 | #1 |
| incidence arthritis | #1 |
| normal cartilage arthritis | #1 |
| oestrogen‐induced | #1 |
| nzb dth | #1 |
| susceptibility collagen | #1 |
| monoclonal arthritis arthritis | #1 |
| act389949 | #1 |
| day cii immunisation | #1 |
| 2 nox2 | #1 |
| oia induction | #1 |
| established pia disease | #1 |
| ncf1 lyme arthritis | #1 |
| rats severity | #1 |
| salivary glands antigen | #1 |
| arthritis rabeximod | #1 |
| 17βestradiolregulation | #1 |
| loci cia2 | #1 |
| spleen cluster | #1 |
| cia dominant epitope | #1 |
| h2q c3hnb | #1 |
| cia recognition | #1 |
| phytol rna | #1 |
| arthritis qtl pia7 | #1 |
| ros immunohistochemistry implants | #1 |
| macrophages mannans | #1 |
| arthritis arthritis loci | #1 |
| transient joint inflammation | #1 |
| dth dba 1 | #1 |
| cii immunodominant | #1 |
| riiis alleles eae2 | #1 |
| rat recombinants | #1 |
| antibody cartilage blymphocyte | #1 |
| glycoprotein alpha1microglobulin | #1 |
| single bout hiit | #1 |
| cartilage antibody | #1 |
| genes animal models | #1 |
| human cii cartilage | #1 |
| ncf4 mice | #1 |
| cd200 btla | #1 |
| autoimmune diseases identification | #1 |
| mice salt intake | #1 |
| pristane stimulation | #1 |
| cageeffects | #1 |
| ciispecific | #1 |
| dba 1j | #1 |
| citc1iiip | #1 |
| mice functional ncf1 | #1 |
| ii‐induced arthritis | #1 |
| arthritis susceptibility rats | #1 |
| ncf1 mutant | #1 |
| type cii | #1 |
| rns type collagen | #1 |
| new loci controlling | #1 |
| h2p susceptibility | #1 |
| cxi rats | #1 |
| epitope type | #1 |
| severe arthritis immunization | #1 |
| cell recognition carbohydrates | #1 |
| nox2derived ros mice | #1 |
| genes congenic | #1 |
| tlr2 tlr2 regulation | #1 |
| arthritis driven | #1 |
| arthritis synovial tlr3 | #1 |
| serum interferon activity | #1 |
| pia cia13 pia7 | #1 |
| presentation arthritis | #1 |
| manifestations lupus disease | #1 |
| rats rt1 | #1 |
| urokinase enzyme | #1 |
| identification genetic regions | #1 |
| nox2 complex | #1 |
| arthritis antibody | #1 |
| lew avridineinduced arthritis | #1 |
| plasminogen deficiency cia | #1 |
| collagen chains antibody | #1 |
| cia olive oil | #1 |
| models rheumatoid arthritis | #1 |
| specificity arthritis | #1 |
| diabetes sialadenitis | #1 |
| pv cd4 cells | #1 |
| major cii | #1 |
| spe acute phase | #1 |
| oxazolone inflammatory response | #1 |
| cells cia | #1 |
| mgpi325 | #1 |
| immunization cii | #1 |
| u1 antibodies patients | #1 |
| sialadenitis nodq | #1 |
| pia disease | #1 |
| collagen hybridomas | #1 |
| cartilage specific | #1 |
| cnbr‐fragment | #1 |
| cb268 cii | #1 |
| tregs ros | #1 |
| mice h2q | #1 |
| ciispecific monoclonal | #1 |
| increase ncf1 | #1 |
| partial advanced | #1 |
| tcell experimental cartilage | #1 |
| dba 1jpfp cia | #1 |
| cia31 | #1 |
| fecq3 locus | #1 |
| igg2a vivo | #1 |
| environments mice | #1 |
| cia development | #1 |
| ciif4 cartilage explants | #1 |
| h‐2b | #1 |
| arthritis loci | #1 |
| arthritis chronic | #1 |
| elisagenetyping | #1 |
| lewis rat cia | #1 |
| cia animal models | #1 |
| oxidases polymers | #1 |
| polymorphism ncf1 | #1 |
| arthritis development severity | #1 |
| cb11 fragment | #1 |
| protective alleles eae2 | #1 |
| region eae2 | #1 |
| cells dba mouse | #1 |
| treatment pia | #1 |
| cix cartilage | #1 |
| rats clec4b | #1 |
| inbred dba pepsin | #1 |
| recombinants rt1u | #1 |
| arthritis male | #1 |
| g6pi acute arthritis | #1 |
| pia9 | #1 |
| congenic polymorphism illness | #1 |
| treatment cii immunization | #1 |
| experimental collagen type | #1 |
| arthritis qtl chip | #1 |
| glycopeptide stimulation | #1 |
| protective role cia | #1 |
| ros adaptive immunity | #1 |
| ciic1 m2139 | #1 |
| nonglycosylated peptide | #1 |
| type collagen cia | #1 |
| neonatal mortality milk | #1 |
| mannaninduced | #1 |
| pia3 chromosome | #1 |
| m1j mice | #1 |
| arthritogenicity cells | #1 |
| reproductive performance identification | #1 |
| cartilage stability cartilage | #1 |
| pristane hydrocarbon oils | #1 |
| thymectomy transgenes | #1 |
| chromosome pia | #1 |
| collagen arthritis hyaluronanreceptor | #1 |
| arthritis pristane | #1 |
| strains nodq | #1 |
| oxa backcrosses | #1 |
| epitopes cb10 fragment | #1 |
| h2p h2q | #1 |
| oils induce | #1 |
| ul1 vivo | #1 |
| expression liver receptor | #1 |
| synthetic peptides cii | #1 |
| ifnbeta arthritis | #1 |
| pepsin cii | #1 |
| c1iii | #1 |
| h2p cia | #1 |
| cia2 cia9 | #1 |
| downregulating oestradiol | #1 |
| dr4 glycopeptides | #1 |
| arthritis traits | #1 |
| phagocytic nox2 complex | #1 |
| cells heterologous cii | #1 |
| flss tlr3 expression | #1 |
| major epitopes | #1 |
| post‐partum exacerbation | #1 |
| daf2cross | #1 |
| animal models acpa | #1 |
| recognition lysine | #1 |
| arthritis immunization | #1 |
| chromosome caia | #1 |
| arthritis males | #1 |
| cartilage cii | #1 |
| ifnbeta experimental arthritis | #1 |
| cii experimental autoantigens | #1 |
| ncf1 allele | #1 |
| chemical cartilage | #1 |
| cia melatonin | #1 |
| mechanism autoimmune | #1 |
| c3hq | #1 |
| presence sex hormones | #1 |
| anticd4 treatment immunization | #1 |
| acpa discriminate | #1 |
| hyaluronanreceptor | #1 |
| pristaneinduced arthritis pia | #1 |
| pristane primed | #1 |
| terpenes toll | #1 |
| eae39 locus cia | #1 |
| ncf1 ptpn22 | #1 |
| m1s1a | #1 |
| development pristaneinduced arthritis | #1 |
| function acpas | #1 |
| collagen‐induced arthritis | #1 |
| arthritis injection | #1 |
| cii anticd4 treatment | #1 |
| b10riii | #1 |
| methods | #1 |
| cia mtx | #1 |
| heterologous cii | #1 |
| pia rheumatoid arthritis | #1 |
| cartilage‐specific antibodiesis | #1 |
| marginal ankylosis | #1 |
| autoimmune accelerating | #1 |
| development oia | #1 |
| day acute arthritis | #1 |
| anticii abs | #1 |
| vivo imaging l012 | #1 |
| type collagens rats | #1 |
| cii immunization mice | #1 |
| caia lps | #1 |
| native cii | #1 |
| collagen langerhans cells | #1 |
| carcinoma tumors ros | #1 |
| qtl positional cloning | #1 |
| cii histocompatibility complex | #1 |
| mice ros | #1 |
| cii induce | #1 |
| ciic1 ciif4 | #1 |
| liver contributes hfdmets | #1 |
| pc4 pc8 | #1 |
| pristane hexadecane | #1 |
| b10q mice authors | #1 |
| scarce clinical samples | #1 |
| lack arthritis | #1 |
| nod incidence | #1 |
| mice salt concentrations | #1 |
| b10q1 | #1 |
| immunization heterologous cii | #1 |
| ncf1mutation | #1 |
| dba1 mice | #1 |
| idd5 loci | #1 |
| ctbcii | #1 |
| fecq3 | #1 |
| mbpc5a | #1 |
| pristane cell death | #1 |
| hfdmets expression | #1 |
| function targeted deletion | #1 |
| rfig lambda | #1 |
| drb10401positive | #1 |
| h2q haplotype | #1 |
| dth response mrl | #1 |
| congenic c57bl mice | #1 |
| innate immunity mip | #1 |
| cd2 human cells | #1 |
| polyi pia rats | #1 |
| immune response mbp | #1 |
| cii 256 | #1 |
| carbohydrates cii | #1 |
| genetic control pia | #1 |
| mbq mouse | #1 |
| experimental autoimmunity cells | #1 |
| synovium pia rats | #1 |
| induction postpartum flare | #1 |
| disease susceptibility castration | #1 |
| rat placenta uterus | #1 |
| antibodies pc4 | #1 |
| cia ros | #1 |
| cii ecm | #1 |
| inflammatory tissue attack | #1 |
| large numbers hybridomas | #1 |
| rats terpenes | #1 |
| caia cia | #1 |
| controlling onset | #1 |
| cii256 | #1 |
| cii antibodies | #1 |
| ciipeptide cells | #1 |
| cia mhc | #1 |
| induction cii | #1 |
| clec4b activation | #1 |
| cia collagen | #1 |
| tolerance arthritis protection | #1 |
| haplotypes h2q | #1 |
| oestrogen‐induced suppression | #1 |
| qa2 natural mutations | #1 |
| pia cia | #1 |
| cia rat | #1 |
| estrogenmediated suppression | #1 |
| superovulation rate | #1 |
| rabeximod arthritis | #1 |
| ciic1 fab | #1 |
| beta haplotype | #1 |
| genetically segregating crosses | #1 |
| striking phenotypic similarities | #1 |
| psoriasis single locus | #1 |
| ncf1 mutation | #1 |
| cii peptide molecules | #1 |
| homologous type pia | #1 |
| rats adjuvant oil | #1 |
| cia pathogenesis | #1 |
| chronic arthritis mice | #1 |
| rs201802880 | #1 |
| polymorphism autoimmune diseases | #1 |
| disease monitoring rats | #1 |
| mice ncf4 | #1 |
| sialadenitis incidence | #1 |
| intracellular processing cii | #1 |
| response splenocytes | #1 |
| elevated th17 cells | #1 |
| dependent autoimmune | #1 |
| anti type | #1 |
| cia homologous cii | #1 |
| mhv runting neonates | #1 |
| mab mab ciic1 | #1 |
| decreasing activation | #1 |
| congenic polymorphism | #1 |
| eae strains severity | #1 |
| cia mip | #1 |
| deficient ncf1 | #1 |
| pinealectomy exposure | #1 |
| mice arthritis | #1 |
| damage type collagen | #1 |
| cartilage explants ciic1 | #1 |
| swr nfr | #1 |
| kgf cia | #1 |
| ncf1 ncf1 mice | #1 |
| arthritis mutant strains | #1 |
| cartilage damage vivo | #1 |
| congenic mice vdr | #1 |
| hexadecane induce arthritis | #1 |
| eae2 eae3 | #1 |
| topoisomerase antagonist | #1 |
| functional nox2 complex | #1 |
| rheumatoid arthritis eae | #1 |
| ul1 ciif4 mab | #1 |
| nox2 agonists | #1 |
| impact topoisomerase antagonist | #1 |
| ncf4 nox2 complex | #1 |
| il10 mmc | #1 |
| vpba pnipaam | #1 |
| cii disease | #1 |
| cryogel matrix cells | #1 |
| development chronic arthritis | #1 |
| rat cb10 cb11 | #1 |
| c3hnb mice | #1 |
| citrullinated collagen arthritis | #1 |
| cartilage explants mabs | #1 |
| arthritis animals | #1 |
| disease suggestive locus | #1 |
| estrogen manifestations | #1 |
| interacting subloci | #1 |
| incidence nod | #1 |
| inability collagen | #1 |
| b10q strain | #1 |
| mip cia | #1 |
| congenic strains cia | #1 |
| ciispecific cells | #1 |
| preformed cartilage | #1 |
| vridine‐induced arthritis | #1 |
| cix cii | #1 |
| functional selective fpr1 | #1 |
| rats antibody cartilage | #1 |
| developed arthritis | #1 |
| pia model | #1 |
| functional ncf1 | #1 |
| mice ncf1m1j mutation | #1 |
| arthritis ul1 | #1 |
| genes ncf1 | #1 |
| cia5 region | #1 |
| ciiglycopeptides | #1 |
| hyaluronanreceptor cd44 | #1 |
| cia comp | #1 |
| region eae3 | #1 |
| cii cxi | #1 |
| disease cd8 deficiency | #1 |
| cell recognition cii | #1 |
| dth nzb mice | #1 |
| rat rt1ba genes | #1 |
| development inflammatory attack | #1 |
| cells synthetic glycopeptides | #1 |
| denidritic cells | #1 |
| nox2 function | #1 |
| illness cia | #1 |
| major role rp | #1 |
| dth antibody response | #1 |
| olive oil arthritis | #1 |
| rt1l haplotypes | #1 |
| proteolipoprotein peptide | #1 |
| dba 1 background | #1 |
| h2w17 | #1 |
| cell specificity cii | #1 |
| tlr3 tlr3 expression | #1 |
| b10q dba 1f1 | #1 |
| pia2–8 | #1 |
| tlr3 rna interference | #1 |
| citrullinated type | #1 |
| cia cartilage | #1 |
| cartilaginous joints | #1 |
| 371115tetramethyl2hexadecene1ol | #1 |
| induced arthritis rats | #1 |
| arthritis amino | #1 |
| oxidases receptors | #1 |
| protein ncf1m1j mice | #1 |
| tlr expression synovium | #1 |
| vivo monoclonal | #1 |
| severity arthritis | #1 |
| compsufficient mice | #1 |
| congenic arthritis | #1 |
| pia4 chromosome | #1 |
| b10riii riiis | #1 |
| cii polymer | #1 |
| effects cia | #1 |
| cartilage‐specific | #1 |
| loci eae39 | #1 |
| cii256 270 | #1 |
| healthy nzw | #1 |
| antibodies citrullinated peptide | #1 |
| hydrolyzed igg | #1 |
| ciiinduced | #1 |
| cxi 6 | #1 |
| tumors immunosuppressive leukocytes | #1 |
| mcii707 | #1 |
| arthritis protection | #1 |
| loci arthritis | #1 |
| strains b10q | #1 |
| arthritis castration | #1 |
| animal epitopes | #1 |
| ncf1 association | #1 |
| cxi | #1 |
| collagen arthritis iii | #1 |
| cii induced | #1 |
| disease lew | #1 |
| cii articular cartilage | #1 |
| experimental autoantigens | #1 |
| immunization heterologous peptide | #1 |
| tcell hybridomas cells | #1 |
| day ciispecific cells | #1 |
| glycosylated cii | #1 |
| experimental carcinogens | #1 |
| rats pia | #1 |
| dependent autoimmune arthritis | #1 |
| authors hgpi325339 peptide | #1 |
| strains polychondritis | #1 |
| 237 females | #1 |
| collagen cii | #1 |
| ros rheumatoid humans | #1 |
| aq molecules | #1 |
| rheumatoid arthritis complexity | #1 |
| arthritis b10q mice | #1 |
| methodspurified | #1 |
| cells mgps | #1 |
| peritonitis sod3 | #1 |
| onset animals arthritis | #1 |
| complex aq molecules | #1 |
| cells cii | #1 |
| mouse cii reactivity | #1 |
| ros autoimmune diseases | #1 |
| headache paradigm | #1 |
| region ncf1 | #1 |
| hladrβ10402 | #1 |
| anti comp | #1 |
| ecm mab | #1 |
| genetic control sialadenitis | #1 |
| aq molecule | #1 |
| mhc class injections | #1 |
| dominant hypersensitivity dth | #1 |
| pia7 | #1 |
| arthritis encephalomyelitis | #1 |
| rheumatoid drug evaluation | #1 |
| arthritis collagen | #1 |
| p47phox ncf1 | #1 |
| mice chronic arthritis | #1 |
| h2q h2r | #1 |
| pathway arthritis | #1 |
| cia21 | #1 |
| arthritis pnipaam | #1 |
| heterologous collagen | #1 |
| j1 epitope | #1 |
| h2p mice cia | #1 |
| oestradiol suppression | #1 |
| arthritis estrogen treatment | #1 |
| cells arthritis progression | #1 |
| nrc ova | #1 |
| mhc mbp | #1 |
| ciispecific cells day | #1 |
| cxb10qf2 | #1 |
| cia40 | #1 |
| comp lack | #1 |
| expression ncf1 | #1 |
| chemical collagen | #1 |
| cii responsiveness | #1 |
| da1u rats expression | #1 |
| lewis oia | #1 |
| arthritis ncf1 allele | #1 |
| mabs monoclonal arthritis | #1 |
| aplec locus | #1 |
| realtime pcr flss | #1 |
| predominant selection | #1 |
| plcpip | #1 |
| cia rheumatoid arthritis | #1 |
| chronic development | #1 |
| igg response cii | #1 |
| ciic1 mab ciif4 | #1 |
| cia model strains | #1 |
| pregq2 fragment | #1 |
| arthritis rat | #1 |
| cii vaccination | #1 |
| role eosinophilia | #1 |
| cxi chronic arthritis | #1 |
| nox2derived ros | #1 |
| acute arthritis neutrophils | #1 |
| role major epitopes | #1 |
| pia model rats | #1 |
| pristaneinduced arthritis rats | #1 |
| arthritogenic mabs | #1 |
| chromosome f1 males | #1 |
| dapia3 | #1 |
| human immunopeptidome lung | #1 |
| tolerance induction cii | #1 |
| arthritis mhc | #1 |
| inclusion negative predictive | #1 |
| pia experimental chromosomes | #1 |
| arthritis pia | #1 |
| chronic pristane | #1 |
| cii cb fragments | #1 |
| mice c3h background | #1 |
| autoimmune arthritis apcs | #1 |
| polymorphic fragment | #1 |
| cia reduction | #1 |
| peptides aq | #1 |
| bond requirements | #1 |
| citrullinated type collagen | #1 |
| function nox2 | #1 |
| caia monoclonal | #1 |
| publication animals arthritis | #1 |
| cii antigen presentation | #1 |
| da1u rat liver | #1 |
| arthritis | #1 |
| sialadenitis arthritis | #1 |
| gergaagiagpk | #1 |
| rats antibody response | #1 |
| functional ncf1 macrophages | #1 |
| cia caia | #1 |
| h2w3 | #1 |
| antigen presentation cii | #1 |
| cii recognition | #1 |
| arthritis control mice | #1 |
| ciic1 antibody | #1 |
| cxi comp | #1 |
| ros glucose transporter | #1 |
| mhc cii | #1 |
| development humanized models | #1 |
| anticii response | #1 |
| type epitopes | #1 |
| fecq4 fragment | #1 |
| arthritis cia | #1 |
| ncf1m1j mutation | #1 |
| mannan immune | #1 |
| b10qnss1 | #1 |
| immunodominant cii | #1 |
| modified glycopeptides | #1 |
| cia13 pia7 | #1 |
| wt ncf1 | #1 |
| eae b10riii mice | #1 |
| c3hnb | #1 |
| synovial membranes joints | #1 |
| rats pristane | #1 |
| humanized models disease | #1 |
| differences ncf1 | #1 |
| cii epitopes | #1 |
| concentrations rat cii | #1 |
| ll37 rcramp | #1 |
| cii swr mice | #1 |
| ncf1m1j mice | #1 |
| lymphocytes collagen | #1 |
| illness terpenes | #1 |
| tlr3 expression flss | #1 |
| ciif4 adverse effects | #1 |
| bal cells work | #1 |
| ciilysdnp | #1 |
| non‐mhc genes | #1 |
| animal histocompatibility | #1 |
| mutation ptdins3pbinding site | #1 |
| caia mutant mice | #1 |
| ncf1m1j | #1 |
| dth dominant hypersensitivity | #1 |
| cia32 | #1 |
| mice deficient ncf1 | #1 |
| spontaneous tissue inflammation | #1 |
| glycosylated determinant peptides | #1 |
| animal models arthritis | #1 |
| arthritis onset severity | #1 |
| cii rats | #1 |
| position cii256270 | #1 |
| cell‐deficient mice | #1 |
| b10q mice ncf1 | #1 |
| cryogel column antibodies | #1 |
| collagen autoantibody | #1 |
| cia experimental autoantibodies | #1 |
| pc117 | #1 |
| ciispecific antibodies | #1 |
| pristane induced | #1 |
| cii | #1 |
| constant light order | #1 |
| collagen epitopes | #1 |
| female preponderance development | #1 |
| antibody binding vivo | #1 |
| cii260‐270 | #1 |
| wild type ncf1 | #1 |
| rabeximod inflammatory cells | #1 |
| nss1 | #1 |
| cia21 lymph nodes | #1 |
| congenic strains rats | #1 |
| arthritis incidence | #1 |
| cia experimental arthritis | #1 |
| sialadenitis cell phenotypes | #1 |
| cii lewis | #1 |
| cia | #1 |
| kgf treatment onset | #1 |
| h‐2q mice | #1 |
| cii pepsin | #1 |
| arthritis humans | #1 |
| pregq2 | #1 |
| arthritis gene regions | #1 |
| potent disease accelerator | #1 |
| ifa rats | #1 |
| stages arthritis | #1 |
| breeding capacity | #1 |
| cii molecule | #1 |
| collagen citrullination | #1 |
| lew mol strain | #1 |
| cii citrullinated | #1 |
| c3hq mice cii | #1 |
| arthritis independent | #1 |
| nod nss1 | #1 |
| flss polyi | #1 |
| cia12 | #1 |
| experimental collagen | #1 |
| cia animal epitopes | #1 |
| caia cii | #1 |
| diagnostic accuracy acpa | #1 |
| chromosome congenic strains | #1 |
| innate‐associated disease | #1 |
| reduced oxidative burst | #1 |
| eae mtx | #1 |
| cia lysine | #1 |
| presentation cii | #1 |
| induction phase cia | #1 |
| histology vaccination | #1 |
| contrast nodq | #1 |
| anti cii acpa | #1 |
| cells galactosylated peptide | #1 |
| daxlewf1 | #1 |
| kgf chondrocytes | #1 |
| pepsin lewis | #1 |
| mice th1 cytokines | #1 |
| c3hnb h2p | #1 |
| lpscaia | #1 |
| arthritis suppression | #1 |
| cia5 cia21 | #1 |
| phagocyte oxidative burst | #1 |
| pia cix | #1 |
| dominant hypersensitivity | #1 |
| susceptibility cia | #1 |
| nonglycosylated epitope | #1 |
| exacerbation arthritis | #1 |
| rt1bβ | #1 |
| chronic intervention | #1 |
| rt1f haplotype | #1 |
| arthritis experimental | #1 |
| nox2 complex ncf4 | #1 |
| ciispecific cell responses | #1 |
| cell determinants cii | #1 |
| arthritis cell | #1 |
| cia21 cia22 | #1 |
| aq class | #1 |
| cia chromosome | #1 |
| clonal expansion arthritis | #1 |
| cells ncf1 | #1 |
| collageninduced arthritis | #1 |
| rheumatoid arthritis autoimmunity | #1 |
| severity ides | #1 |
| cia ifa | #1 |
| reactivity cb268 | #1 |
| eae39 control disease | #1 |
| 270 peptide | #1 |
| olive oil cii | #1 |
| hybridomas multispecific antibodies | #1 |
| nox2 functionality | #1 |
| positional identification | #1 |
| maintained pregnancy levels | #1 |
| fab2 ciic1 | #1 |
| collagens antibody | #1 |
| models collagen | #1 |
| fibroblast induced arthritis | #1 |
| antigenic adjuvant | #1 |
| psiechch | #1 |
| minor cartilage proteins | #1 |
| active arthritis complex | #1 |
| specificity ros rns | #1 |
| ciic1scfv | #1 |
| ncf1 polymorphism | #1 |
| eae2 locus | #1 |
| nod nss1 loci | #1 |
| cii mabs | #1 |
| activation cii | #1 |
| functional nox2 | #1 |
| cii ciif4 | #1 |
| denatured cii | #1 |
| il10 cia | #1 |
| cd43expressing cells | #1 |
| injection mannan | #1 |
| clec4b ncf1 | #1 |
| t‐cell epitope cii260‐270 | #1 |
| cii h2p | #1 |
| cii immunisation | #1 |
| rat type collagen | #1 |
| early onset development | #1 |
| rheumatoid arthritis cii | #1 |
| expressions cyp7a1 | #1 |
| immunization mouse cii | #1 |
| hdac3 pparγ | #1 |
| cia cells | #1 |
| rats ncf1 gene | #1 |
| m1j | #1 |
| rt1ba | #1 |
| pia3 | #1 |
| epitopes collagen | #1 |
| cii259 273 | #1 |
| periodontitis pristaneinduced arthritis | #1 |
| naive experimental chromosomes | #1 |
| h2g7 haplotype nod | #1 |
| spread psoriasis | #1 |
| oestradiol dth | #1 |
| mhc‐congenic mouse strains | #1 |
| severe polyarthritis | #1 |
| rat pia | #1 |
| arthritis naive mice | #1 |
| chlorophyll component | #1 |
| cxi collagen fibers | #1 |
| ccp2 negative | #1 |
| cii antibody | #1 |
| antitype collagen | #1 |
| cia f1 males | #1 |
| engagement fcgammar | #1 |
| inbred strains severity | #1 |
| animal models complexity | #1 |
| aq glycopeptide | #1 |
| enhanced autoimmunity | #1 |
| mice ncf1 | #1 |
| innate rats | #1 |
| comp disease monitoring | #1 |
| pristane tlr3 expression | #1 |
| arthritis autoimmune | #1 |
| cartilage collagen type | #1 |
| disease c4bp | #1 |
| ym1 pneumonitis | #1 |
| susceptible cia | #1 |
| cii carbohydrates | #1 |
| mhc aq | #1 |
| visual signs arthritis | #1 |
| autoantibody formation cia | #1 |
| homologous type | #1 |
| act389949 fpr2 | #1 |
| ros nox2 complex | #1 |
| cii triple | #1 |
| cia il10 | #1 |
| kgf thymus | #1 |
| compia | #1 |
| galactosylated peptide | #1 |
| psa mip | #1 |
| physiological doses development | #1 |
| nodq nod nodp | #1 |
| arthritis tlr3 | #1 |
| rat congenic data | #1 |
| dendritic cells collagen | #1 |
| nasal treatment ctbcii | #1 |
| arthritis b6n mice | #1 |
| arthritogenic mabs cii | #1 |
| rat comp | #1 |
| b10q mice | #1 |
| severity pia | #1 |
| pc8 pc117 | #1 |
| fls ppt medium | #1 |
| susceptible collagen | #1 |
| established arthritis | #1 |
| critical restriction site | #1 |
| macrophages autoimmune priming | #1 |
| caia riiis segment | #1 |
| lps caia | #1 |
| ros rns inflammation | #1 |
| role nox2derived ros | #1 |
| ifa cii ifa | #1 |
| reactivity cii | #1 |
| monoclonal cartilage cattle | #1 |
| clever1 type macrophages | #1 |
| eae39 | #1 |
| arthritogenic antibodies | #1 |
| muscle nox2 | #1 |
| cia22 | #1 |
| mrl mice estrogen | #1 |
| injection adjuvant oils | #1 |
| cii261 | #1 |
| anti collagen | #1 |
| locus arthritis | #1 |
| evokes peptide | #1 |
| sialadenitis strains | #1 |
| estrogeninduced suppression | #1 |
| tlr3 upregulation flss | #1 |
| p47phox mutant | #1 |
| development cia | #1 |
| cia congenic arthritis | #1 |
| inbred dba cii | #1 |
| arthritis susceptibility mice | #1 |
| congenic | #1 |
| emission tomography mannan | #1 |
| tlr3 expression fls | #1 |
| position mouse cii | #1 |
| mannan joints | #1 |
| mannan mice | #1 |
| driven psoriatic arthritis | #1 |
| h2p h2q haplotype | #1 |
| fcbinding | #1 |
| ros ncf1 | #1 |
| autologous cii | #1 |
| collagen antibodies | #1 |
| type collagen cii256−270 | #1 |
| qa2 gene clusters | #1 |
| cii259273 peptide | #1 |
| experimental arthritis antibodies | #1 |
| lpr mice granulocytes | #1 |
| anticcp2negative patients | #1 |
| ncf1da | #1 |
| antibody cartilage | #2 |
| early onset severity | #2 |
| neutrophil functions modulation | #2 |
| induction cia | #2 |
| castrated mice day | #2 |
| igkeegfp lentivirus expression | #2 |
| ß62 | #2 |
| chitosanagarosegelatin | #2 |
| 18fbicyclo610nonyne | #2 |
| mannan induced | #2 |
| transgenic oxidases zymosan | #2 |
| arthritis models rats | #2 |
| hydroxyethylene | #2 |
| oestrogen pregnancy | #2 |
| antibodies cep1 | #2 |
| i‐a molecule | #2 |
| ides treatment | #2 |
| igsecretors | #2 |
| elastaseinduced emphysema nox2 | #2 |
| antibodies disease onset | #2 |
| fibroblast induced | #2 |
| adjuvant rats | #2 |
| fpr1 neutrophils | #2 |
| anti cii | #2 |
| ptpn22 c129s | #2 |
| cell dependent | #2 |
| maintenance induced resistance | #2 |
| arthritis gender | #2 |
| immunocap isac performance | #2 |
| terpenes animals | #2 |
| arthritis g6pi | #2 |
| pia rats | #2 |
| dxeb | #2 |
| fpr1 agonist | #2 |
| dr4 cii259 | #2 |
| oestrogen myelin | #2 |
| b10qncf1 mice | #2 |
| anticii antibody | #2 |
| mrl mice stages | #2 |
| control subjects samples | #2 |
| paws mice | #2 |
| granulomas cgd mice | #2 |
| heterologous collagens arthritis | #2 |
| rp animal ear | #2 |
| citrullinated peptides development | #2 |
| caia oestradiol | #2 |
| mog79 | #2 |
| animal model arthritis | #2 |
| monodeoxygenation | #2 |
| hkatpasecontaining vesicles | #2 |
| homologous cia | #2 |
| murine locus eae2 | #2 |
| autoimmunity autoantibodies | #2 |
| cartilage proteins sera | #2 |
| galactosyl moiety | #2 |
| comp cartilage | #2 |
| rats da1u | #2 |
| l10d9 antibody | #2 |
| ere activation treatment | #2 |
| cartilage‐specific autoimmunity | #2 |
| caia | #2 |
| c2ta mhcii expression | #2 |
| positive anticcp2 test | #2 |
| utility comp | #2 |
| ciif4 | #2 |
| eosinophilia arthritis | #2 |
| incidence nephritis | #2 |
| m2139 ciif4 | #2 |
| analyses comp | #2 |
| mbp 87110 peptide | #2 |
| severity collagen arthritis | #2 |
| collagen arthritis cii | #2 |
| glut4dependent | #2 |
| titres ccp2 | #2 |
| chromosome rats | #2 |
| granulomas macrophages | #2 |
| symptoms anti ccp2 | #2 |
| circulating medium | #2 |
| binding sites autoimmune | #2 |
| design glycopeptides | #2 |
| raloxifene oestradiol | #2 |
| alterations neuroendocrine profile | #2 |
| lew mol | #2 |
| antitoxin immunoglobulin | #2 |
| cd19 cells egfp | #2 |
| percentage peripheral cells | #2 |
| ovx ncf1 mice | #2 |
| implanted melanoma | #2 |
| eno5 | #2 |
| adjuvant oils arthritis | #2 |
| b10g | #2 |
| antipan | #2 |
| g6pi arthritis | #2 |
| ccp2 diagnostic accuracy | #2 |
| cia anti | #2 |
| oestradiol cia | #2 |
| cia disease | #2 |
| nox2 complex sle | #2 |
| rats lymphocytes | #2 |
| mabs collagen | #2 |
| arthritis oia | #2 |
| synovial immune reactions | #2 |
| functional ncf1 variants | #2 |
| wtc5a | #2 |
| h2q response | #2 |
| development combination | #2 |
| altered formation | #2 |
| multiple antibody reactivities | #2 |
| cia mice mice | #2 |
| macrophagespecific nox2 | #2 |
| ability arthritis | #2 |
| skg model | #2 |
| kinloch | #2 |
| antibodies fibß62 | #2 |
| ptpn22 ncf1 | #2 |
| vivo cii | #2 |
| cell tolerance c5a | #2 |
| citcii | #2 |
| disease cyclosporin treatment | #2 |
| incidence insulitis | #2 |
| arthritogenic challenge | #2 |
| fil307 | #2 |
| congenic mice autoimmune | #2 |
| dancf1da | #2 |
| antileukoproteinase alp | #2 |
| 18ffluoromannan | #2 |
| b10qf1 | #2 |
| sialadenitis mice | #2 |
| das28 acpa reactivities | #2 |
| diseases collagen | #2 |
| sialadenitis animals | #2 |
| transgenic protein processing | #2 |
| fibβ36 | #2 |
| mph induction | #2 |
| tlymphocyte arthritis arthritis | #2 |
| experimental cloning | #2 |
| myelin ppd | #2 |
| sequences mbp89 | #2 |
| neuroendocrine profile | #2 |
| das28 values p001 | #2 |
| transgenic osteoporosis oestradiol | #2 |
| rats polymorphism | #2 |
| epitope glycosylation | #2 |
| peptides chronic eae | #2 |
| igg glycosylation arthritis | #2 |
| higher levels anas | #2 |
| fibα563 | #2 |
| cia day | #2 |
| smash recommendations | #2 |
| h2q | #2 |
| type collagen cii | #2 |
| arthritis fb | #2 |
| nadph oxidase deficiency | #2 |
| arthritogenic mab cii | #2 |
| flow cytometry ovx | #2 |
| hiit skeletal | #2 |
| human animal models | #2 |
| glycopeptides histocompatibility | #2 |
| psychosocial stress hpaaxis | #2 |
| mice susceptible | #2 |
| psoriatic disease models | #2 |
| autoimmune recognition | #2 |
| oxidation increased severity | #2 |
| dominant suppressive | #2 |
| nox2 macrophages | #2 |
| clever1 tumor | #2 |
| autoimmune membrane proteins | #2 |
| c129s mutant disulfide | #2 |
| arthritis development rats | #2 |
| celldependent phase | #2 |
| macrophagespecific nox2 development | #2 |
| tolerance cii | #2 |
| micro dams transgenic | #2 |
| rats disease onset | #2 |
| suppressive oestrogen | #2 |
| fibα580 | #2 |
| chronic arthritis treatment | #2 |
| congenic polychondritis | #2 |
| mab cii | #2 |
| liver mice rna | #2 |
| l10d9 antibody cxi | #2 |
| sle nadph oxidase | #2 |
| induction p47phoxmutated mph | #2 |
| apc naïve cells | #2 |
| eae dxea strain | #2 |
| aetiology2–4 | #2 |
| antibody fine | #2 |
| endoglycosidase treatment | #2 |
| selective fpr1 | #2 |
| snecs neutrophils | #2 |
| h2q mice mice | #2 |
| arthritogenic | #2 |
| oestrogen suppressive | #2 |
| tregs mph ros | #2 |
| pia rat | #2 |
| 12 590 | #2 |
| hiit skeletal muscle | #2 |
| tcells recognition | #2 |
| microscopic scoring arthritis | #2 |
| mhcii experimental arthritis | #2 |
| symptoms antibodies | #2 |
| glycan activation | #2 |
| increased severity development | #2 |
| genetic encephalomyelitis | #2 |
| cgd mice kynurenine | #2 |
| derived ros | #2 |
| ciic1 | #2 |
| mbp peptides immunization | #2 |
| arthritogenic capacity | #2 |
| antibodies development | #2 |
| autoimmune congenic arthritis | #2 |
| p47phoxmutated | #2 |
| collagen citrullination adhesion | #2 |
| severity collagen | #2 |
| ncf1gene | #2 |
| arthritis mice | #2 |
| animal haplotypes | #2 |
| bmd caia | #2 |
| igke promoter | #2 |
| suggestive locus | #2 |
| da1u rats | #2 |
| disease promoting | #2 |
| ros peroxide | #2 |
| citcii311 | #2 |
| immunization sch | #2 |
| h12919 | #2 |
| allelic variant type | #2 |
| redox regulation ptpn22 | #2 |
| comp cia | #2 |
| cia animals | #2 |
| 111 vivo treatment | #2 |
| ean6 | #2 |
| matrilin cartilage proteins | #2 |
| rt1bb | #2 |
| tgfbeta spinal cord | #2 |
| cia monkeys | #2 |
| nodq | #2 |
| alp monoclonal arthritis | #2 |
| immunological requirements | #2 |
| tregs mph | #2 |
| c2ta genetic | #2 |
| anticd4 treatment | #2 |
| cii injection | #2 |
| putative vulnerability locus | #2 |
| influence chromosome | #2 |
| mph ros | #2 |
| arthritis raloxifene | #2 |
| oxidation c129s | #2 |
| cii citrullination | #2 |
| binding cartilage | #2 |
| immunosuppressive leukocytes | #2 |
| linomide homologous cia | #2 |
| biologicals 24 months | #2 |
| dxea strain | #2 |
| intrinsic tolerance | #2 |
| lymphoproliferative gene | #2 |
| cxi l10d9 antibody | #2 |
| 034positive | #2 |
| genetic regions psoriasis | #2 |
| collagen antibody | #2 |
| ptpn22 disulfide | #2 |
| immunization mbp89 | #2 |
| granulocytes alp | #2 |
| b10qncf1 mice cia | #2 |
| agonist study | #2 |
| fibß62 | #2 |
| antibodies cartilage | #2 |
| l10d9 antibody cartilage | #2 |
| mhc congenic | #2 |
| etoposide serum concentrations | #2 |
| re04 | #2 |
| pristane rats | #2 |
| c1epitope | #2 |
| antibody response development | #2 |
| cms eae | #2 |
| disease humanized mice | #2 |
| new immunomodulatory drug | #2 |
| glycopeptide complexes | #2 |
| citc1359 | #2 |
| macrophages enhances | #2 |
| human lung nox2 | #2 |
| models autoimmune | #2 |
| nadph oxidase elevations | #2 |
| l10d9 | #2 |
| cii311 | #2 |
| antibody‐mediated arthritis | #2 |
| knockout illness | #2 |
| chronic relapsing disease | #2 |
| ros source | #2 |
| species susceptible haplotypes | #2 |
| nadph oxidase 2 | #2 |
| collagen ii‐induced arthritis | #2 |
| cytosolic ros production | #2 |
| chronic autoimmune polyarthritis | #2 |
| eae cia | #2 |
| cells arthritis | #2 |
| mice bacterial infections | #2 |
| igke | #2 |
| osteoclasts flow cytometry | #2 |
| shared epitope cxi | #2 |
| rats utility | #2 |
| oestradiol induction phase | #2 |
| matrilin vivo | #2 |
| pathogenic igg antibodies | #2 |
| comp titers | #2 |
| animal granulomatous disease | #2 |
| neutrophil fpr2 | #2 |
| antileukoproteinase modulation | #2 |
| cd8 cells incidence | #2 |
| mbp89 | #2 |
| disease development presence | #2 |
| dxeb strain immunization | #2 |
| m2139 | #2 |
| c57bl 10 background | #2 |
| matrilin 1 | #2 |
| arthritis female | #2 |
| mycobacteria granulomas | #2 |
| lack functional nox2 | #2 |
| mice genistein treatment | #2 |
| c2ta genetic polymorphisms | #2 |
| tracheolaryngeal cartilage rp | #2 |
| cartilage respiratory tract | #2 |
| conditions igke promoter | #2 |
| das28 24 months | #2 |
| ncf1 ean6 | #2 |
| anticcp2negative presence | #2 |
| gender rats | #2 |
| receptor‐specific manner | #2 |
| caia eae | #2 |
| arthritis treatment | #2 |
| raloxifene estradiol treatment | #2 |
| ptpn22 protein disulfide | #2 |
| beta 10b | #2 |
| eae protein rna | #2 |
| arthritis progression | #2 |
| arthritis heterologous cia | #2 |
| lymphocytes animals | #2 |
| snp position | #2 |
| cpg2088 | #2 |
| granulomas ros | #2 |
| cep1 fibß62 | #2 |
| sequence analysis indel | #2 |
| injection w3 13 | #2 |
| vaccination strategy c5a | #2 |
| rats arthritogenic challenge | #2 |
| sera rheumatoid arthritis | #2 |
| collagen arthritis immunization | #2 |
| mrl joints stages | #2 |
| collageninduced arthritis mice | #2 |
| lack ifngamma | #2 |
| class immunoenzyme | #2 |
| mice collagen | #2 |
| caia effector phase | #2 |
| osteoclastogenesis endogenous dna | #2 |
| lymphocytelike | #2 |
| rats heterologous cii | #2 |
| mhc iii | #2 |
| cii ciic1 | #2 |
| α3xi | #2 |
| w3 13 | #2 |
| pristane injection | #2 |
| agonist fpr2 | #2 |
| mitochondria polymorphism | #2 |
| cia arthritis | #2 |
| single nucleotide rats | #2 |
| enhanced arthritis | #2 |
| mabs comp | #2 |
| staphylococcal infections mice | #2 |
| immunization mouse collagen | #2 |
| igke promoter expression | #2 |
| rats ifngamma | #2 |
| acpa reactivities | #2 |
| ncf1 mutants | #2 |
| nox2 neuropathological alterations | #2 |
| mog rats | #2 |
| da1u | #2 |
| anticcp2negative | #2 |
| prophylactic treatment linomide | #2 |
| rheumatoid binding | #2 |
| chain l10d9 antibody | #2 |
| exclusive reactivity | #2 |
| ros tregs | #2 |
| epitope‐specific recognition | #2 |
| sle cgd | #2 |
| eae caia | #2 |
| egfp cd19 cells | #2 |
| hladr2dq6 | #2 |
| igkeegfp lentivirus | #2 |
| mbp peptide eae | #2 |
| ifngamma spinal cord | #2 |
| toe stiffness | #2 |
| cia mechanisms | #2 |
| arthritis ethanol | #2 |
| iaexpressing cells | #2 |
| mhciii | #2 |
| c5ay35 | #2 |
| cartilage respiratory | #2 |
| ala261 | #2 |
| disease 111 | #2 |
| dxea strain tgfbeta | #2 |
| mbp89 peptides | #2 |
| genotypes ovx | #2 |
| cii depletion | #2 |
| ros granulomas | #2 |
| fpr1 signaling | #2 |
| ncf1 oxidation | #2 |
| pnipaam vpba | #2 |
| multiple sclerosis maps | #2 |
| arthritis antibody response | #2 |
| wildtype mice macrophages | #2 |
| salt intake vivo | #2 |
| arthritis scoring | #2 |
| rno12 | #2 |
| rats da1u rats | #2 |
| liver histone | #2 |
| oestrogen ean | #2 |
| disease genotype hybridization | #2 |
| epitopes rat | #2 |
| integrin‐binding‐domain | #2 |
| nox2 cgd | #3 |
| antibodies citc1iii | #3 |
| rs729749 | #3 |
| macrophages involvement | #3 |
| oxidase 2 | #3 |
| incidence antinuclear antibodies | #3 |
| osteoclasts release | #3 |
| c2ta | #3 |
| cia strains | #3 |
| ifnbetadeficient mice | #3 |
| reactive idiotope | #3 |
| arthritis resistance | #3 |
| allogeneic pregnancy | #3 |
| mice environments | #3 |
| antigen presentation mhcii | #3 |
| points acs | #3 |
| cbrh7919 cells | #3 |
| lew ztm | #3 |
| db1 treatment day | #3 |
| acpas human serum | #3 |
| neutrophil cytosolic factor | #3 |
| nadph oxidase complex | #3 |
| rheumatoid arthritis complement | #3 |
| twins acpas | #3 |
| processing cii | #3 |
| lew1f | #3 |
| disease anti lymphocyte | #3 |
| origin suggestive linkage | #3 |
| autoimmunity pia | #3 |
| genetic influence susceptibility | #3 |
| patients monoclonal chimeric | #3 |
| disease w3 13 | #3 |
| dnfb ears | #3 |
| fibα591 vim60 | #3 |
| vim60 | #3 |
| cia hdac1 | #3 |
| arthritis autoimmunity | #3 |
| acpa combination | #3 |
| disease risk subsets | #3 |
| anti‐type | #3 |
| major cell epitope | #3 |
| eae1 | #3 |
| cryogel bioreactor | #3 |
| nerve terminallike profiles | #3 |
| total abrogation | #3 |
| eae5r1 | #3 |
| ifngammali | #3 |
| rheumatoid crosses | #3 |
| autoimmune models | #3 |
| hdac1 rheumatoid arthritis | #3 |
| hfdmets rats | #3 |
| mice copolymers | #3 |
| apc cia | #3 |
| ifngammali neurons | #3 |
| early phase disease | #3 |
| antibodies induce | #3 |
| clever1 macrophages | #3 |
| citrullinated peptides multiplex | #3 |
| genotype knowledge | #3 |
| dthreaction | #3 |
| cep1 filaggrin | #3 |
| recombination rt1a | #3 |
| h2qbearing | #3 |
| induced immunospecific tolerance | #3 |
| rtlu | #3 |
| cii elisa | #3 |
| immunization addition | #3 |
| acpa multiplex | #3 |
| db1 treatment | #3 |
| onset combination | #3 |
| acpa titers | #3 |
| arthritis effects | #3 |
| complex autoimmune diseases | #3 |
| low production | #3 |
| female immunoenzyme | #3 |
| rodents6 | #3 |
| pathogenesis pia | #3 |
| ctla4 adult mice | #3 |
| c57bl mice illness | #3 |
| carriers hladrb104 | #3 |
| allopregnancy | #3 |
| genes disease development | #3 |
| eae16 | #3 |
| ncf4 rs729749 | #3 |
| 95 cvrelated death | #3 |
| fibα573 | #3 |
| pia | #3 |
| mice rheumatoid | #3 |
| bcg ros | #3 |
| cia animals arthritis | #3 |
| antibodies citrullinated | #3 |
| ciic1 cii | #3 |
| acpas fine specificities | #3 |
| minimal adjuvant requirement | #3 |
| chronic collagen | #3 |
| treatment arthritis | #3 |
| citrulline inflammation | #3 |
| stroke cvrelated death | #3 |
| fibβ74 onset | #3 |
| rheumatoid cloning | #3 |
| igl genes | #3 |
| antibodies vim60 | #3 |
| inflamed synovial tissues | #3 |
| advanced intercross eae5 | #3 |
| cartilage proteins | #3 |
| citrullinated cyclic | #3 |
| role ros | #3 |
| acpas twins | #3 |
| arthritis susceptibility | #3 |
| response immune response | #3 |
| eae5 pia4 | #3 |
| model arthritis | #3 |
| mnc salivary glands | #3 |
| anticollagen antibodies | #3 |
| nox2 pathogenesis | #3 |
| fibβ62 81b | #3 |
| cvrelated death adjustment | #3 |
| rheumatoid autoimmune | #3 |
| ctla4 deletion | #3 |
| cd4∶cd8 lineage | #3 |
| eae17 chromosome | #3 |
| mice constant light | #3 |
| multiple sclerosis hladr2 | #3 |
| pia6 | #3 |
| experimental cell | #3 |
| eae17 genetic heterogeneity | #3 |
| cd4∶cd8 lineage commitment | #3 |
| glycosylated type | #3 |
| disease genotype immunity | #3 |
| mhc class betachain | #3 |
| rt1a tap2 | #3 |
| oxidases reactive | #3 |
| female preponderance | #3 |
| mca ean | #3 |
| human cii | #3 |
| disease immunization | #3 |
| macroporous gel particles | #3 |
| type c2ta | #3 |
| fibβ74 | #3 |
| citcii355 | #3 |
| monoclonal cartilage sections | #3 |
| development collagen arthritis | #3 |
| antibodies specific sets | #3 |
| height disease | #3 |
| activated cells mice | #3 |
| cvrelated death | #3 |
| transgenic osteoporosis | #3 |
| autoimmunity cartilage | #3 |
| eae17 | #3 |
| dxea | #3 |
| cells naïve mice | #3 |
| development acpas | #3 |
| rats mog | #3 |
| targeting toll | #3 |
| sialadenitis | #3 |
| eae5 ncf1 | #3 |
| hydrocarbon oils | #3 |
| type collagen vivo | #3 |
| differences citrullinated peptides | #3 |
| subspecificities associations | #3 |
| cdk6 padi4 | #3 |
| citc1iii | #3 |
| natural alleles genes | #3 |
| fibα573 fibα591 | #3 |
| citc1iii fibα573 | #3 |
| cvrelated death association | #3 |
| cytotoxic t‐lymphocyte | #3 |
| spe dce | #3 |
| citc1iii filaggrin | #3 |
| arthritogenicity | #3 |
| endogenous ifnbeta | #3 |
| common mouse model | #3 |
| combination acpa | #3 |
| cii species | #3 |
| restricted role | #3 |
| acpas genetic factors | #3 |
| antigen monoclonal arthritis | #3 |
| rt11 rats | #3 |
| dce spe | #3 |
| presence drb104 | #3 |
| disease development contribution | #3 |
| arthritis model | #3 |
| acpapositive twins | #3 |
| rats disease | #3 |
| cystatin cdeficient mice | #3 |
| cd8 cells ean | #3 |
| fibα591 | #3 |
| ncf1 cldn4 | #3 |
| disease height | #3 |
| swedish patients antibodies | #3 |
| hladrb104 cochranmantelhaenszel test | #3 |
| ros deficiency | #3 |
| complex genetic control | #3 |
| occurrence subspecificities | #3 |
| lupus nets | #3 |
| levels fibα591 | #3 |
| animal glycosylation humans | #3 |
| keratinocytes langerhans cells | #3 |
| arthritogenic mab | #3 |
| rs729749 ncf4 | #3 |
| disease disease development | #3 |
| ean mca | #3 |
| class antigens keratinocytes | #3 |
| crossreactive idiotope | #3 |
| aureus arthritis mice | #3 |
| citrullinated peptides time | #3 |
| species lymphocytes | #3 |
| hladrb104 mann whitney | #3 |
| acpa subspecificities | #3 |
| development arthritis | #3 |
| immuniozation | #3 |
| fibα573 fibβ74 | #3 |
| eae31 | #3 |
| day disease duration | #3 |
| h2aalpha | #3 |
| rats rheumatoid arthritis | #3 |
| binding aq | #3 |
| anticollagen antibody | #3 |
| antigens collagen | #3 |
| experimental arthritis | #3 |
| mice development | #3 |
| arthritis susceptible | #3 |
| subspecificities occurrence | #3 |
| neutrophils eae | #3 |
| arthritis review | #3 |
| arthritis animal model | #3 |
| pnippam | #3 |
| cyp7a1 abca1 | #3 |
| mmc mice | #3 |
| twins acpapositive | #3 |
| loci antibodies | #3 |
| 81b | #3 |
| h2p mice | #3 |
| hdac1 pathogenesis | #3 |
| dancf1e3 | #3 |
| acpas plasma | #3 |
| vivo control mice | #3 |
| models arthritis | #3 |
| pfp mice | #3 |
| acpa specificities presence | #3 |
| wildtype mice granulomas | #3 |
| chromosome eae17 | #3 |
| dual manner | #3 |
| arthritis levels | #3 |
| pristane‐induced arthritis | #3 |
| isotypes acpas | #3 |
| antigens keratinocytes | #3 |
| ifngamma neurons | #3 |
| cii reactive | #3 |
| autoimmune mrl | #4 |
| collagen glycopeptides | #4 |
| elimination cd8 cells | #4 |
| vav1 rheumatoid arthritis | #4 |
| ethylene isosteres | #4 |
| development sialadenitis | #4 |
| adjuvant oil | #4 |
| cia mouse | #4 |
| onset clinical arthritis | #4 |
| type collagen arthritis | #4 |
| experimental arthritis humans | #4 |
| inbred dba peptides | #4 |
| krönke | #4 |
| arthritis collageninduced arthritis | #4 |
| strains arthritis | #4 |
| autoimmune experimental phenotype | #4 |
| bxsb chromosome | #4 |
| mice etoposide | #4 |
| collagen immune | #4 |
| cii peptide | #4 |
| species regulate | #4 |
| cia b10q mice | #4 |
| tcell activation development | #4 |
| endos igg | #4 |
| autoimmunity rats | #4 |
| immunoglobulin deficient | #4 |
| dae3 | #4 |
| c129s | #4 |
| il‐4‐deficient mice | #4 |
| cell response immunization | #4 |
| lxrα pparγ | #4 |
| dth reaction | #4 |
| experimental cattle cells | #4 |
| cia suppression | #4 |
| response arthritis | #4 |
| rheumatoid arthritis rats | #4 |
| immune response cii | #4 |
| diseases rheumatoid | #4 |
| tsc mice | #4 |
| locus mouse chromosome | #4 |
| pathogenesis histone | #4 |
| glend2 | #4 |
| estrogen cia | #4 |
| arthritis comp | #4 |
| positional cloning genes | #4 |
| rp sle | #4 |
| stages disease development | #4 |
| immunodominant cell | #4 |
| cathelicidins ll37 | #4 |
| arthritis mouse | #4 |
| mrl dth | #4 |
| cd4 cells stage | #4 |
| cia lia | #4 |
| α1ii chain | #4 |
| citrullinated protein antibodies | #4 |
| mrl b6 | #4 |
| cii ifa | #4 |
| inpp4b474r 548p | #4 |
| cii animal epitopes | #4 |
| genistein addition | #4 |
| anti‐t‐cell | #4 |
| acpas serum | #4 |
| congenic rats rats | #4 |
| ox8 | #4 |
| rs682626 | #4 |
| synovial endothelium | #4 |
| type collagen autoimmunity | #4 |
| normal mouse igg | #4 |
| k8 k8 mice | #4 |
| shared autoimmunity | #4 |
| cells cryogel column | #4 |
| peptide mbp | #4 |
| experimental arthritis cii | #4 |
| arthritis severity | #4 |
| antigen sequence deletion | #4 |
| affinity case | #4 |
| dead cell remnants | #4 |
| cells cryogel | #4 |
| pathogenic antibody | #4 |
| cells maternal origin | #4 |
| smoking antibodies | #4 |
| cellular transfer | #4 |
| lnchc | #4 |
| cia6 | #4 |
| sh3gl1 | #4 |
| collagen rheumatoid | #4 |
| macrophages mycobacteria | #4 |
| placental mhc | #4 |
| epitope collagen | #4 |
| genetic association vav1 | #4 |
| potent immunomodulator | #4 |
| treg cells ctla4 | #4 |
| knowledge genetic association | #4 |
| rs12979659 | #4 |
| cb10 fragment | #4 |
| mip mice | #4 |
| fcγr regulation | #4 |
| variance animals arthritis | #4 |
| fpr2 recognition | #4 |
| strain eae | #4 |
| mhc eae | #4 |
| cytosolic ros | #4 |
| collagen type | #4 |
| multispecific antibodies | #4 |
| elevated th1 | #4 |
| pristane‐induced | #4 |
| autoantibodies type collagen | #4 |
| experimental genetic | #4 |
| type collagen rat | #4 |
| antibody response mog | #4 |
| citrullinated peptides autoantibodies | #4 |
| cyclic software | #4 |
| catabolism kynurenine | #4 |
| parathyroid antibodies | #4 |
| glands sialadenitis | #4 |
| dth mrl | #4 |
| antibodies citrullinated peptides | #4 |
| subsets presence | #4 |
| estrus cycling | #4 |
| candidate genes rats | #4 |
| antitype collagen antibodies | #4 |
| arthritis defined | #4 |
| mp‐lpr | #4 |
| congenic c57bl | #4 |
| interaction monoclonal antibody | #4 |
| mutation ncf1 | #4 |
| tnfα p38 mapk | #4 |
| estrogen levels levels | #4 |
| fibβ62 | #4 |
| type‐ii collagen | #4 |
| cryogel matrix | #4 |
| higher levels melatonin | #5 |
| cartilage type | #5 |
| ros mca | #5 |
| biomarkers 2 polyradiculoneuropathy | #5 |
| development acpa | #5 |
| puccetti | #5 |
| tsst1producing | #5 |
| nox complex | #5 |
| immunized animals controls | #5 |
| pathogenesis autoimmune arthritis | #5 |
| collagen anti | #5 |
| mice acpa | #5 |
| multiparous mice | #5 |
| rt1eu | #5 |
| cia type collagen | #5 |
| citrullinated peptides ccp | #5 |
| oestradiol vehicle | #5 |
| field nox | #5 |
| rats developed | #5 |
| backcrossed | #5 |
| glycopeptide fragment | #5 |
| symptom onset frequency | #5 |
| overexpression hdac3 | #5 |
| dba 1 mice | #5 |
| tlr3 macrophages | #5 |
| nox o2• h2o2 | #5 |
| hydroxynorvaline | #5 |
| lethal inflammatory disorder | #5 |
| measurement nox activity | #5 |
| cd8 deficiency | #5 |
| delayed immunization rats | #5 |
| tubule cells kidney | #5 |
| symptoms development | #5 |
| igg endos | #5 |
| arthritis onset | #5 |
| multiplex analyses | #5 |
| ovalbumin pepsin | #5 |
| cbrh7919 | #5 |
| chromosome cia7 | #5 |
| symptoms rheumatoid arthritis | #5 |
| swr mouse | #5 |
| o2• h2o2 nox | #5 |
| patients acpa levels | #5 |
| tcell hybridomas | #5 |
| resistance cia | #5 |
| antibodies filaggrin | #5 |
| osteoclasts stromal cells | #5 |
| α10i | #5 |
| nox animal models | #5 |
| lipidomic remodeling | #5 |
| dba mouse | #5 |
| citrullinated peptides | #5 |
| asparaginelinked glycan | #5 |
| regulating rat | #5 |
| tcell mrl | #5 |
| type collagen cix | #5 |
| c‐glycoside analogue | #5 |
| antileukoproteinase | #5 |
| egfp flow cytometry | #5 |
| autoimmune disease models | #5 |
| exercise hiit | #5 |
| ii‐induced | #5 |
| pineal gland development | #5 |
| collageninduced arthritis cia | #5 |
| immunization male | #5 |
| cgd hyperinflammation | #5 |
| epitope cii | #5 |
| lew1n | #5 |
| monoclonal antibody alpha | #5 |
| il4deficient mice | #5 |
| aureus arthritis | #5 |
| classical adjuvant | #5 |
| chick cii | #5 |
| ly female | #5 |
| recovery ean | #5 |
| painlike behavior | #5 |
| streptococcus pyogenes ides | #5 |
| arthritogenic cells | #5 |
| tlr3 expression | #5 |
| subsets rheumatoid arthritis | #5 |
| oia | #5 |
| immunological involvement | #5 |
| oxidative radicals | #5 |
| glycopeptide | #5 |
| b‐cell epitope | #5 |
| severe arthritis mice | #5 |
| multiplex array | #5 |
| low dose tolerance | #5 |
| position type collagen | #5 |
| severe sialadenitis | #5 |
| tbb infection | #5 |
| congenic nod | #5 |
| absence c5 | #5 |
| uterus cells | #5 |
| ros macrophages | #5 |
| commonly model | #5 |
| beta 11 cells | #5 |
| interaction cartilage | #5 |
| raloxifene disease activity | #5 |
| apc cii | #5 |
| autologous type | #5 |
| mrvalues | #5 |
| immunization type collagen | #5 |
| experimental breeding | #5 |
| avridineinduced arthritis | #5 |
| arthritis rats | #5 |
| cia model | #5 |
| smoking prior | #5 |
| eae5 | #5 |
| glycopeptidomimetics | #5 |
| cgd mice | #5 |
| wellknown role | #5 |
| female lymphocyte | #6 |
| treatment oestradiol | #6 |
| mrna tgfbeta | #6 |
| recombinant rat interferongamma | #6 |
| transgenic mice arthritis | #6 |
| tsst1 mice | #6 |
| active arthritis | #6 |
| cia cd4 cells | #6 |
| betaoestradiol | #6 |
| joints rats | #6 |
| activity neuroinflammation | #6 |
| acpa anti | #6 |
| mhcii alleles | #6 |
| ccp2 positive | #6 |
| pristane squalene | #6 |
| igg autoantibodies sera | #6 |
| disease protective | #6 |
| induced psoriasis | #6 |
| controls arthritis | #6 |
| murine loci | #6 |
| experimental postmenopausal | #6 |
| arthritis autoantibodies | #6 |
| metabolic nuclear receptors | #6 |
| lys270 | #6 |
| hdac1 class | #6 |
| pv loss | #6 |
| autoimmunity arthritis | #6 |
| mice sialadenitis | #6 |
| heterogeneous stock mice | #6 |
| affinity ligand protein | #6 |
| rheumatoid arthritis comp | #6 |
| arthritis antibodies | #6 |
| cd4∶cd8 | #6 |
| rheumatoid arthritis collagen | #6 |
| glycoproteins nadph | #6 |
| cell recognition | #6 |
| staphylococcus aureus arthritis | #6 |
| loci controlling | #6 |
| eae mhc | #6 |
| k8 mice | #6 |
| autoimmune experimental genes | #6 |
| knockout receptors igg | #6 |
| data ros | #6 |
| acpa specificities | #6 |
| l3t4positive cells | #6 |
| rheumatoid arthritis model | #6 |
| peptides arthritis | #6 |
| immunization peptides | #6 |
| b10 mouse | #6 |
| monoclonal encephalomyelitis autoimmune | #6 |
| collagen cia | #6 |
| contrasting roles | #6 |
| macrophages mph | #6 |
| c57bl 6 background | #6 |
| animal genetic | #6 |
| pathogenic events | #6 |
| dominant suppression | #6 |
| arthritis models | #6 |
| erosive polyarthritis | #6 |
| ltab | #6 |
| collagen arthritis | #6 |
| mice congenic | #6 |
| relapsing polychondritis rp | #6 |
| anti ccp2 | #6 |
| cells affinity surface | #6 |
| functional selective | #6 |
| mice investigated | #6 |
| cartilage collagens | #6 |
| rcramp | #6 |
| complex mhc | #6 |
| pyramidal neurons loss | #6 |
| develop arthritis | #6 |
| nox2 mediates | #6 |
| glycopeptide specificity | #6 |
| isotypes patients | #6 |
| collagen cells | #6 |
| cia26 | #6 |
| regulatory cells macrophages | #7 |
| impaired induction | #7 |
| yaa gene | #7 |
| effector phase | #7 |
| autoantibodies citrullinated peptides | #7 |
| locus chromosome | #7 |
| transgenic class | #7 |
| arthritis strains | #7 |
| chronic experimental | #7 |
| g6pi | #7 |
| collagen arthritis rats | #7 |
| ciireactive cells | #7 |
| autoimmunity collagen | #7 |
| macrophages alternative activation | #7 |
| induction arthritis | #7 |
| collagen epitope | #7 |
| 3xi | #7 |
| response immunization | #7 |
| region syntenic | #7 |
| autoantibodies lymphocytes | #7 |
| mice constant darkness | #7 |
| oestrogen rats | #7 |
| type collagen | #7 |
| cognate activation | #7 |
| analysis crosses | #7 |
| hydrolases polymorphism | #7 |
| symptoms disease onset | #7 |
| glycosylated collagen | #7 |
| cii apc | #7 |
| mouse collagen | #7 |
| strains disease | #7 |
| psoriasiform skin disease | #7 |
| acpa titres | #7 |
| mediated vasculitis | #7 |
| citrullinated peptide antigens | #7 |
| cia mice | #7 |
| arthritis type collagen | #7 |
| aplec | #7 |
| rats phases | #7 |
| polychondritis relapsing | #7 |
| impact cia | #7 |
| castrated females | #7 |
| snecs | #7 |
| cia5 | #7 |
| protective influences | #7 |
| periodontitis arthritis | #7 |
| mbp peptide | #7 |
| antibodies citrullinated antigens | #7 |
| raassociated molecules | #7 |
| congenic mouse | #7 |
| autoimmune human | #7 |
| murine psoriasis | #7 |
| nonarthritogenic | #7 |
| isomerase peptide | #7 |
| ean animals | #7 |
| antigens differentiation arthritis | #7 |
| cii anti | #7 |
| collagen arthritis cia | #7 |
| cab3 | #7 |
| arthritis genes | #7 |
| antibodyinduced arthritis | #7 |
| congenic strains | #7 |
| animal immunization injections | #7 |
| rheumatoid arthritis role | #7 |
| responses cii | #7 |
| chronic phase arthritis | #7 |
| role raloxifene | #7 |
| cryogel column | #7 |
| conventional environment | #7 |
| parathyroid glands receptors | #8 |
| sialadenitis mrl | #8 |
| clinical signs ean | #8 |
| hdac3 expression | #8 |
| ifa cii | #8 |
| onset day day | #8 |
| autoimmune congenic mice | #8 |
| rt1f | #8 |
| expression hdac3 | #8 |
| diseases loci | #8 |
| 42 rats | #8 |
| cia animal model | #8 |
| typeii collagen | #8 |
| dominant cell epitope | #8 |
| cosphox | #8 |
| chronic autoimmune arthritis | #8 |
| chromosomes loci | #8 |
| rats mhc | #8 |
| incidence cia | #8 |
| autoantibodies subset | #8 |
| eae genetic encephalomyelitis | #8 |
| experimental binding | #8 |
| α1‐microglobulin | #8 |
| destructive effects | #8 |
| hladrb11001 | #8 |
| 297 cases | #8 |
| ros interplay | #8 |
| polymeric cryogels | #8 |
| humans experimental arthritis | #8 |
| mumt mice | #8 |
| inflamed synovia | #8 |
| b10 background | #8 |
| mice techniques | #8 |
| onset incidence | #8 |
| heterologous peptide | #8 |
| neutrophil cytosolic | #8 |
| eae3 | #8 |
| medium mem | #8 |
| experimental autoimmune disease | #8 |
| oia2 | #8 |
| fcγr2b | #8 |
| lyme arthritis severity | #8 |
| oxidized peptides | #8 |
| treatment monoclonal | #8 |
| autoantibodies collagen type | #8 |
| murinised | #8 |
| mbp mog | #8 |
| haematogenously | #8 |
| rheumatoid autoimmunity | #8 |
| antigenspecific priming | #8 |
| patients type collagen | #8 |
| supermacroporous cryogel | #8 |
| t‐cell priming | #8 |
| antibody vivo | #8 |
| arthritis lymphocytes | #8 |
| murine locus | #8 |
| cia2 | #8 |
| rheumatoid chromosome | #8 |
| underlying genes | #8 |
| autologous peptide | #8 |
| antibodies acpas | #8 |
| hybridomas antibodies | #8 |
| illness igg | #8 |
| mice ifnbeta | #8 |
| ptpn22620w | #8 |
| non‐mhc | #8 |
| hlase alleles | #8 |
| induced neuropathology | #8 |
| persistent joint pain | #8 |
| collagen female | #9 |
| rats rat | #9 |
| antibodies vivo | #9 |
| rheumatoid autoantibodies | #9 |
| experimental arthritis rats | #9 |
| loci rats | #9 |
| early joint erosions | #9 |
| inbred lew tlymphocytes | #9 |
| differentiation autoimmune | #9 |
| hgpi325 | #9 |
| 2 nadph | #9 |
| acpas patients | #9 |
| oil adjuvants | #9 |
| human immunopeptidome | #9 |
| nodp | #9 |
| class allele | #9 |
| disease strains | #9 |
| specific sets | #9 |
| inbred dba mice | #9 |
| ean myelin | #9 |
| bovine cii | #9 |
| murine collagen | #9 |
| histone 1 hdac1 | #9 |
| arthritis skg mice | #9 |
| psychological tyrosine | #9 |
| ox19 | #9 |
| illness receptor | #9 |
| development autoimmune arthritis | #9 |
| mammalian disease models | #9 |
| hitr | #9 |
| b10riii mice | #9 |
| serum interferon | #9 |
| rt1u | #9 |
| collagen complement | #9 |
| reduced arthritis | #9 |
| acpas | #9 |
| rheumatoid joints | #9 |
| bound carbohydrates | #9 |
| effects mabs | #9 |
| response mouse | #9 |
| oligomeric matrix | #9 |
| specific nox2 | #9 |
| postmenopausal arthritis | #9 |
| posttranslational glycosylation | #9 |
| pristane | #9 |
| cia transgenic mice | #9 |
| avridine | #9 |
| experimental genes | #9 |
| eae immunization | #9 |
| animal models urgent | #9 |
| adaptive inflammation | #9 |
| il10 role | #9 |
| alpha1inhibitor3 | #9 |
| induced metabolic syndrome | #9 |
| patients acpas | #9 |
| idiotype‐specific | #9 |
| mouse peptide | #9 |
| autoimmunogenic | #9 |
| arthritis cross | #9 |
| intranasal animals arthritis | #9 |
| antibody alpha | #9 |
| variants acpa | #9 |
| acutephase response rats | #10 |
| acpa diagnosis | #10 |
| knockout nadph | #10 |
| hlase smoking | #10 |
| inbred dba | #10 |
| antibody collagen | #10 |
| rheumatoid arthritis dr4 | #10 |
| passive transfer experiments | #10 |
| axotomized motor neurons | #10 |
| animal models | #10 |
| experimental cartilage | #10 |
| nih heterogeneous stock | #10 |
| severe erosive | #10 |
| presence acpa | #10 |
| ifnbeta mice | #10 |
| o2• h2o2 | #10 |
| immunization rats | #10 |
| native collagen type | #10 |
| cartilage oligomeric | #10 |
| prl effects | #10 |
| monoclonal arthritis | #10 |
| cell‐deficient | #10 |
| alpha collagen chains | #10 |
| mutated mice | #10 |
| cells development | #10 |
| development severity | #10 |
| pain animal models | #10 |
| tertbutylacrylamide | #10 |
| abp gene | #10 |
| genetic experiments | #10 |
| rats lewis rats | #10 |
| citrullinated antigen | #10 |
| antibodies specific | #10 |
| cd4 cells spleen | #10 |
| onset chromosome | #10 |
| mbp peptides | #10 |
| collagen autoimmunity | #10 |
| mice nadph | #10 |
| endogenous collagen | #10 |
| stock mice | #10 |
| dense fractions | #10 |
| cartilage arthritis | #10 |
| cartilage collagen fibrils | #10 |
| beta 11 | #10 |
| oestrogen | #10 |
| h2ap | #10 |
| extracellular cartilage | #10 |
| reactivity acpas | #10 |
| cii mice | #10 |
| mice genistein | #10 |
| cells increased production | #10 |
| mice cii | #10 |
| autoimmune disease humans | #10 |
| activation male | #10 |
| monoclonal antigens rats | #10 |
| potential autoantigens | #11 |
| monoclonal rheumatoid factors | #11 |
| 84–102 | #11 |
| stromal cells macrophages | #11 |
| antibodies association | #11 |
| development rheumatoid | #11 |
| nodb10h2b mice | #11 |
| chondrocytes ecm | #11 |
| liver receptor lxrα | #11 |
| rat liver rats | #11 |
| dss wt | #11 |
| naïve cells cells | #11 |
| cells pia | #11 |
| lentiviral vector expression | #11 |
| 2xi | #11 |
| isotypes | #11 |
| rat arthritis | #11 |
| mhc control | #11 |
| mice cd1 | #11 |
| loci regulating | #11 |
| tailbase | #11 |
| cia30 | #11 |
| gad6 | #11 |
| arthritis absence | #11 |
| species respiratory | #11 |
| ptpn22 smoking | #11 |
| fragments anti | #11 |
| individuals onset | #11 |
| chronic arthritis | #11 |
| antibody type collagen | #11 |
| cia7 | #11 |
| antigen variability | #11 |
| rat collagen | #11 |
| mice mhc | #11 |
| inflammatory arthritis role | #11 |
| mice comp | #12 |
| type collagen immunization | #12 |
| psoriasis mouse model | #12 |
| lymphoid cells development | #12 |
| mutated mouse | #12 |
| frequencies antibodies | #12 |
| illness sex characteristics | #12 |
| treatment experimental arthritis | #12 |
| fpr2 agonists | #12 |
| antibodies structures | #12 |
| α1ii | #12 |
| study arthritis | #12 |
| serum concentrations comp | #12 |
| nonselfdiscrimination | #12 |
| qa2 | #12 |
| structure antibodies | #12 |
| mutation nadph | #12 |
| associations antibodies | #12 |
| animal immunohistochemistry | #12 |
| rats cia | #12 |
| autoimmune monoclonal antigens | #12 |
| peptide study | #12 |
| stages pathogenesis | #12 |
| role arthritis | #12 |
| immunodominant | #12 |
| bovine type collagen | #12 |
| major haplotype | #12 |
| lung macrophages mice | #12 |
| increased litter size | #12 |
| natural polymorphism | #12 |
| pia1 | #12 |
| backgroundantibodies | #12 |
| encephalomyelitis induced | #12 |
| psoriasis arthritis | #12 |
| onset symptoms | #12 |
| reduces severity | #12 |
| chronic erosive arthritis | #12 |
| myelin ean | #12 |
| matrilin | #12 |
| cii patients | #12 |
| hydroxylysines | #12 |
| mbp response | #12 |
| rats expression | #12 |
| loci disease | #12 |
| genetic contamination | #12 |
| icmediated | #12 |
| natural loss | #12 |
| cross rats | #12 |
| riiis | #12 |
| cell responses cii | #12 |
| stage cia | #12 |
| lew1w | #13 |
| doses ici | #13 |
| oxidase nox2 | #13 |
| bcelldeficient mice | #13 |
| nonobese diabetic mouse | #13 |
| species deficiency | #13 |
| hladrb1 ptpn22 | #13 |
| major loci | #13 |
| native type collagen | #13 |
| expression egfp | #13 |
| sequence collagen | #13 |
| cells salivary glands | #13 |
| anticii | #13 |
| b10p | #13 |
| dba molecular | #13 |
| macroscopic scoring | #13 |
| arthritis knowledge | #13 |
| citrullinated | #13 |
| levels nabs | #13 |
| strains incidence | #13 |
| mannan | #13 |
| mouse strains | #13 |
| 24dinitro1fluorobenzene | #13 |
| antibodies citrullinated proteins | #13 |
| genes mouse chromosome | #13 |
| immunohistochemistry interferon | #13 |
| l012 | #13 |
| t‐cell epitope | #13 |
| epitope immunization | #13 |
| cyclic citrullinated | #13 |
| oxidative regulation | #13 |
| μ chain | #13 |
| behavioral alterations rats | #13 |
| development type collagen | #13 |
| factor isotypes | #13 |
| dr1 transgenic | #13 |
| rfigg | #13 |
| cell epitope | #13 |
| advanced intercross | #13 |
| joints blood | #13 |
| ccp2 antibodies | #13 |
| mtec aire | #13 |
| multispecific | #13 |
| nos2derived | #13 |
| complement complement activation | #13 |
| idd5 | #13 |
| ho4 | #13 |
| protein collagen | #14 |
| efficient promotion | #14 |
| cia expression | #14 |
| arthritic paws | #14 |
| thr233 | #14 |
| molecular disease models | #14 |
| immune regulators | #14 |
| presence mcv | #14 |
| b6n mice | #14 |
| candidate autoantigens | #14 |
| involvement cells | #14 |
| sirt1 mmp9 | #14 |
| macrophages immune response | #14 |
| loci rheumatoid | #14 |
| mhc class region | #14 |
| osteoclasts vivo | #14 |
| collagen comp | #14 |
| experimental interferon | #14 |
| blymphocyte female humans | #14 |
| murine collageninduced arthritis | #14 |
| collagen disease | #14 |
| autoimmune arthritis | #14 |
| antifilaggrin antibodies | #14 |
| smallmolecule compound | #14 |
| peptides anti | #14 |
| immunized rat | #14 |
| nasal inhalation | #14 |
| humans nadph | #14 |
| deficient production | #14 |
| aggregated nets | #14 |
| autoimmunity animals | #14 |
| specific inflammation | #14 |
| arlacel | #14 |
| loci interaction | #14 |
| gut protection | #14 |
| exaggerates | #15 |
| mhc class molecule | #15 |
| nodb10h2b | #15 |
| dcii | #15 |
| ros cii | #15 |
| experimental allergic neuritis | #15 |
| treatment cia | #15 |
| murine cia | #15 |
| translationally modified | #15 |
| regulation adaptive immunity | #15 |
| monolithic cryogel | #15 |
| raloxifene estradiol | #15 |
| rat genetics | #15 |
| cdr regions | #15 |
| monoclonal arthritis rats | #15 |
| antibodies arthritis | #15 |
| lentiviral gene delivery | #15 |
| apcs macrophages | #15 |
| arthritis development | #15 |
| neuritis rats | #15 |
| polychondritis | #15 |
| arthritis role | #15 |
| presence anticarp antibodies | #15 |
| 2 weight | #15 |
| osteoporosis development | #15 |
| mice type collagen | #15 |
| aire mtec | #15 |
| integrated bioprocess | #15 |
| tflask | #15 |
| type collagen development | #15 |
| anticollagen | #15 |
| amps development | #15 |
| rats monoclonal antigens | #15 |
| involvement pathogenesis | #15 |
| rheumatoid arthritis presence | #15 |
| antigenic epitope | #15 |
| immune complex formation | #15 |
| congenic rats | #15 |
| mice immunization | #15 |
| cultured human chondrocytes | #15 |
| rt1a | #15 |
| citrullinated peptides patients | #15 |
| disease mice mice | #16 |
| oligomeric matrix protein | #16 |
| antinuclear autoimmunity | #16 |
| acute inflammation mice | #16 |
| subspecificities | #16 |
| rheumatoid arthritis genes | #16 |
| congenic mice mice | #16 |
| n305 | #16 |
| arthritis severity mice | #16 |
| rno10 | #16 |
| staphylococcal arthritis | #16 |
| indirect genetic predisposition | #16 |
| development rheumatoid arthritis | #16 |
| males onset | #16 |
| autologous collagen | #16 |
| lethal inflammatory | #16 |
| levels natural antibodies | #16 |
| fewer osteoclasts | #16 |
| genes animals | #16 |
| pparγ lxrα | #16 |
| mumt | #16 |
| epitopes mice mice | #16 |
| mhc genes | #16 |
| hla–drb1 shared epitope | #16 |
| rheumatoid factor production | #16 |
| nonglycosylated form | #16 |
| matrilin proteins | #16 |
| arthritis cii | #16 |
| cep1 | #16 |
| h2p | #16 |
| lew1 | #16 |
| rt1 | #16 |
| rats experimental arthritis | #16 |
| anti‐t | #16 |
| class transplantation | #16 |
| mhcii ciita | #16 |
| cells female mice | #17 |
| cells presenting cells | #17 |
| nox2 derived | #17 |
| onset rheumatoid arthritis | #17 |
| animals congenic | #17 |
| rats lewis | #17 |
| skg | #17 |
| polyphosphate4 | #17 |
| rheumatoid arthritis subsets | #17 |
| genistein mice | #17 |
| native denatured | #17 |
| rt1av1 | #17 |
| periodontitis antibodies | #17 |
| collagen induced arthritis | #17 |
| human fcγriia | #17 |
| clever1 | #17 |
| cab4 | #17 |
| strains lymphocytes | #17 |
| allergic neuritis | #17 |
| leuphe | #17 |
| mice rheumatoid arthritis | #17 |
| spleen peyers patches | #17 |
| arthritis rheumatoid autoantibodies | #17 |
| ethanol development | #17 |
| triplehelical conformation | #17 |
| collagen specific | #17 |
| cells collagen | #17 |
| inbred lew | #17 |
| progesterone development | #17 |
| cartilage collagen | #17 |
| cartilage type collagen | #18 |
| day arthritis | #18 |
| collagen autoantibodies | #18 |
| adjuvant arthritis rats | #18 |
| joint inflammatory | #18 |
| autoimmune illness | #18 |
| arthritis anti | #18 |
| ealkene | #18 |
| cuiiida | #18 |
| langerhans cells cells | #18 |
| day immunization | #18 |
| galactose moiety | #18 |
| phenotypic feature | #18 |
| ros data | #18 |
| salivary glands mice | #18 |
| expression lxrα | #18 |
| addition ros | #18 |
| h2z | #18 |
| keratinocytes induction | #18 |
| purified anti | #18 |
| short‐term administration | #18 |
| defined epitope | #18 |
| disease duration onset | #18 |
| dra0101 | #18 |
| genes spleen | #18 |
| anti cd44 | #18 |
| hybridomas mice mice | #18 |
| humanized transgenic mice | #18 |
| moginduced eae | #18 |
| trimolecular complex | #19 |
| collagen response | #19 |
| inflammatory attack | #19 |
| castrated female rats | #19 |
| mrl mp mice | #19 |
| elisa cia | #19 |
| protective alleles | #19 |
| vivo elimination | #19 |
| mice develop | #19 |
| mice congenic mice | #19 |
| patients polychondritis | #19 |
| cd4 transgenic | #19 |
| rats snp | #19 |
| blood monocytes neutrophils | #19 |
| future utility | #19 |
| suppression dth | #19 |
| three‐dimensional culture | #19 |
| beta oestradiol | #19 |
| gly262 | #19 |
| citrullinated proteins acpa | #19 |
| new avenues | #19 |
| peyers patches spleen | #19 |
| protein comp | #19 |
| cia eae | #19 |
| single intradermal injection | #19 |
| tbetarii gene | #19 |
| supermacroporous | #19 |
| mbp rats | #20 |
| stress phospholipids | #20 |
| glycosylated | #20 |
| ciita mhcii | #20 |
| serm raloxifene | #20 |
| response mbp | #20 |
| progesterone oestrogen | #20 |
| loci chromosomes | #20 |
| pvg1av1 | #20 |
| enhanced tcr | #20 |
| littermate | #20 |
| ncr3 | #20 |
| matrilin1 | #20 |
| human rheumatoid arthritis | #20 |
| 5r5 | #20 |
| role nox | #20 |
| monkeys rodents | #20 |
| rt1d | #20 |
| experimental autoimmunity | #20 |
| nox1deficient mice | #20 |
| 5p14 | #20 |
| underlying gene | #20 |
| antibody treatment | #20 |
| imaging reactive | #20 |
| fls tnfα | #20 |
| development disease | #20 |
| mhc class alleles | #20 |
| prominent infiltration | #20 |
| inflammation mice | #20 |
| highly susceptible | #20 |
| mice cia | #20 |
| knockout mice transgenic | #20 |
| rats development | #21 |
| supermacroporous cryogels | #21 |
| igg fcgammar | #21 |
| nox2 activity | #21 |
| α1acidglycoprotein | #21 |
| diseases lymphocytes | #21 |
| linomide treatment | #21 |
| conserved haplotype | #21 |
| n286 | #21 |
| suppressor cytotoxic cells | #21 |
| genes controlling | #21 |
| experimental rheumatoid | #21 |
| cia treatment | #21 |
| cells adaptive immune | #21 |
| onset severity | #21 |
| arthritis pregnancy | #21 |
| positional cloning | #21 |
| individual acpa | #21 |
| mice mutant strains | #21 |
| triplehelical peptides | #21 |
| muscle ros | #21 |
| pathogenesis rheumatoid | #21 |
| granule mobilization | #21 |
| nitratenitriteno pathway | #21 |
| illness autoimmune | #21 |
| nox2 mice | #21 |
| ean rats | #21 |
| drb11001 | #21 |
| chronic relapsing | #21 |
| n141 | #21 |
| serum levels comp | #21 |
| olahsd | #21 |
| identification susceptibility genes | #22 |
| 81a | #22 |
| association pv | #22 |
| ul1 | #22 |
| animal epitopes humans | #22 |
| experimental phenotype | #22 |
| determinant selection | #22 |
| induced eae | #22 |
| mice independent | #22 |
| response myelin | #22 |
| semiallogenic | #22 |
| cultured hepatic cells | #22 |
| antiidiotypic antibody | #22 |
| c57bl mice subfamily | #22 |
| rats loss | #22 |
| vh j558 | #22 |
| samples onset | #22 |
| ccp negative | #22 |
| rats nonalcoholic steatohepatitis | #22 |
| 270 | #22 |
| tgfbeta resistance | #23 |
| citrullinated protein | #23 |
| antibodies acpa | #23 |
| animal genes | #23 |
| diseases autoimmunity | #23 |
| phage clones | #23 |
| monoclonal antigens autoimmune | #23 |
| 4npa | #23 |
| arthritis type | #23 |
| lymphocytes amino | #23 |
| peptide activation | #23 |
| complex influences | #23 |
| immunopeptides | #23 |
| anti‐cd5 | #23 |
| loss collagen | #23 |
| experimental autoimmune diseases | #23 |
| inflammation absence | #23 |
| cryogel beads | #23 |
| citrullinated antigens | #23 |
| citrullinated epitopes | #23 |
| b10r | #23 |
| cells presentation | #23 |
| 17 betaoestradiol | #23 |
| comp | #23 |
| cells b10 | #23 |
| experimental chromatography | #23 |
| onset cia | #23 |
| rats inbred lew | #23 |
| mbp eae | #23 |
| mace association | #23 |
| castration rats | #23 |
| severity ali | #24 |
| y35 | #24 |
| severity chronicity | #24 |
| flss patients | #24 |
| ftirm | #24 |
| controls anti | #24 |
| levels comp | #24 |
| 339 | #24 |
| mice nox2 | #24 |
| loci chromosome | #24 |
| experimental cells | #24 |
| postpartum flare | #24 |
| monoclonal anti | #24 |
| subloci | #24 |
| animal epistasis | #24 |
| mediated arthritis | #24 |
| rat induction | #24 |
| autoantibodies rheumatoid | #24 |
| antinuclear apoptosis | #24 |
| chronic autoimmune diseases | #24 |
| c57bl 10 mice | #24 |
| cells c3h | #24 |
| secondary immune response | #24 |
| new mouse | #24 |
| mouse models development | #24 |
| inflammation arthritis | #24 |
| experimental lupus | #24 |
| bnda | #25 |
| complex male | #25 |
| beta lymphocytes | #25 |
| ros | #25 |
| common autoimmune disease | #25 |
| arginine arthritis | #25 |
| arthritis experimental arthritis | #25 |
| cell hybridomas | #25 |
| cells immunization | #25 |
| autoimmune diseases humans | #25 |
| interleukin2 mice receptors | #25 |
| specific epitopes | #25 |
| immunodominant epitope | #25 |
| collagen cartilage | #25 |
| inbred lew rats | #25 |
| proteinarginine deiminase type | #25 |
| congenic animals | #25 |
| autoantibody response | #25 |
| cix | #25 |
| autoimmune messenger | #25 |
| relapsing polychondritis | #25 |
| monocytes nadph | #25 |
| immunization development | #25 |
| rno4 | #25 |
| 8 antibodies | #25 |
| b6 balb | #25 |
| tolerized rats | #25 |
| production monoclonal | #25 |
| murine lyme arthritis | #25 |
| massive infiltration | #25 |
| parasitemia survival | #25 |
| rat mhc | #25 |
| local exposure | #26 |
| gene regions | #26 |
| anti citrullinated | #26 |
| viable chondrocytes | #26 |
| igg2a mice | #26 |
| hydrocarbon oil | #26 |
| nitrophenylalanine | #26 |
| cb11 | #26 |
| eae development | #26 |
| glutamax | #26 |
| granulocytes cells | #26 |
| post translationally | #26 |
| polychondritis rp | #26 |
| autoantibodies citrullinated proteins | #26 |
| helperinducer animals antibodies | #26 |
| cells joints | #26 |
| mice gammadelta cells | #26 |
| trypsination | #27 |
| physiological level | #27 |
| antibodies type | #27 |
| rheumatoid factor isotypes | #27 |
| interleukin21 tlymphocytes | #27 |
| nonmhc genes | #27 |
| hladrb1 shared epitope | #27 |
| c1i | #27 |
| intercrossed | #27 |
| ccp2 | #27 |
| individuals antibodies | #27 |
| immunodominant response | #27 |
| innate interleukin10 | #27 |
| pannus tissue | #27 |
| pointmutation | #27 |
| disease immunoglobulin | #27 |
| immunospecific | #27 |
| perforin deficiency | #27 |
| anti rat | #28 |
| severity day | #28 |
| antily6g | #28 |
| nr8383 | #28 |
| autoimmune inflammatory | #28 |
| mediated effects | #28 |
| w3 25 | #28 |
| protein peptides | #28 |
| cartilage vivo | #28 |
| rat strain | #28 |
| cia3 | #28 |
| antigenspecific tolerance | #28 |
| mrna ifngamma | #28 |
| upregulation cytokines | #28 |
| onset day | #28 |
| ros induction | #28 |
| antibodies mab | #28 |
| animal models neurodegeneration | #28 |
| chronicity | #28 |
| lysine position | #28 |
| eae susceptibility | #28 |
| immunopathogenicity | #29 |
| presence synovial fluid | #29 |
| peptide anti | #29 |
| antibody producing cells | #29 |
| hiit exercise | #29 |
| membrane lymphocytes | #29 |
| chronic dss | #29 |
| rfigm | #29 |
| smoking presence | #29 |
| 246trinitrophenyl | #29 |
| absence inflammation | #29 |
| ros production macrophages | #29 |
| suboptimal doses | #29 |
| acpa | #29 |
| parotid secretory protein | #29 |
| phenomes | #29 |
| ls2616 | #29 |
| cfa cia | #29 |
| glucose transport capacity | #29 |
| mice mab | #29 |
| disease immunity | #30 |
| alphabetat | #30 |
| vgenes | #30 |
| treatment raloxifene | #30 |
| synovial cells patients | #30 |
| paws | #30 |
| development experimental | #30 |
| dba mice | #30 |
| 11 cells | #30 |
| translational rats | #30 |
| plasminogendeficient mice | #30 |
| increased salt | #30 |
| linkage disease | #30 |
| metabolic syndrome rats | #30 |
| chronic autoimmune | #30 |
| ctla4 mice | #30 |
| chain collagen | #30 |
| cultivation cells | #30 |
| vivo exercise | #30 |
| acpa fine | #30 |
| hlase | #30 |
| adult thymectomy | #30 |
| vpba | #30 |
| variable heavy chain | #30 |
| expressing cells | #31 |
| psoriasis model | #31 |
| selfprotein | #31 |
| pristaneinduced lupus | #31 |
| immunization | #31 |
| acute‐phase response | #31 |
| rats autoimmune | #31 |
| ige cd23 | #31 |
| trimolecular | #31 |
| perpetuated | #31 |
| common chain | #31 |
| disease development | #31 |
| synovial fluid blood | #31 |
| monoclonal antibody production | #31 |
| nox2 nox1 | #31 |
| comparative genetic analysis | #31 |
| littermate controls | #31 |
| phytol | #31 |
| hiit training | #31 |
| human type collagen | #31 |
| drugs addition | #31 |
| apc development | #31 |
| caia mice | #32 |
| nadph oxidases nox | #32 |
| rt11 | #32 |
| 11 cell | #32 |
| steen | #32 |
| cells uterus | #32 |
| methods serum samples | #32 |
| h2aq | #32 |
| beta mice | #32 |
| influence genes | #32 |
| differentiation arthritis | #32 |
| acpa rheumatoid arthritis | #32 |
| receptor preference | #32 |
| hladrb104 | #32 |
| ra33 | #32 |
| genomewide genotyping | #32 |
| presence acpas | #32 |
| mucosal tolerance | #32 |
| arthritis therapy | #32 |
| specificity function | #32 |
| cell ratio | #32 |
| nonb cells | #32 |
| polymorphic genes | #32 |
| role osteoclastogenesis | #32 |
| ros rns | #32 |
| type antibody | #32 |
| congenic mice | #32 |
| nodes mice | #32 |
| epitope antibodies | #32 |
| bound peptides | #32 |
| tcell receptor | #33 |
| arthritic mice | #33 |
| cytosolic factor | #33 |
| autoimmune demyelinating disease | #33 |
| role vav1 | #33 |
| tolerance immunization | #33 |
| type cross | #33 |
| induced immunization | #33 |
| delayed type | #33 |
| antigenpresenting cells cells | #33 |
| multiplex analysis | #33 |
| skews | #33 |
| modified collagen | #33 |
| epitopes antibodies | #33 |
| autoantibody activity | #33 |
| rheumatoid joint | #33 |
| c4bp | #34 |
| nox2 deficiency | #34 |
| fpr1 | #34 |
| natural antibodies nabs | #34 |
| interferon activity | #34 |
| promiscuous expression | #34 |
| patients animal models | #34 |
| cells dendritic cells | #34 |
| neurodegeneration role | #34 |
| chronic polyarthritis | #34 |
| heterogeneous stock | #34 |
| joint pathology | #34 |
| monoclonal rheumatoid | #35 |
| phagotope | #35 |
| vdr cells | #35 |
| infectious disease models | #35 |
| triple helical | #35 |
| nets neutrophils | #35 |
| autoreactive | #35 |
| antiarthritis | #35 |
| complex arthritis | #35 |
| plasminogen deficiency | #35 |
| development chronic | #35 |
| antirat | #35 |
| patients populations | #35 |
| arthritis disease | #35 |
| destructive arthritis | #35 |
| acs stroke | #35 |
| major regulators | #35 |
| hybridomas | #35 |
| 1xi | #35 |
| accessible sites | #35 |
| psoriasiform skin | #35 |
| phagocyte | #36 |
| dth | #36 |
| protein specific | #36 |
| cartilage joints | #36 |
| nk cells recognition | #36 |
| oxidases rna | #36 |
| arthritis cartilage | #36 |
| induction tregs | #36 |
| animals antigen | #36 |
| variance animals antibodies | #36 |
| techniques mice | #36 |
| h2g7 | #36 |
| tolerance tlymphocytes | #36 |
| specificity sera | #36 |
| flow cytometry expression | #36 |
| h2r | #36 |
| dinitro1 | #36 |
| comparative genetics | #36 |
| cii cfa | #36 |
| female histocompatibility | #36 |
| synthetic glycopeptides | #37 |
| genetic control | #37 |
| mif pathogenesis | #37 |
| c129 | #37 |
| role gamma interferon | #37 |
| cii protein | #37 |
| recombinant vaccine | #37 |
| immunopathological features | #37 |
| encephalomyelitis | #37 |
| peptides binding | #37 |
| acpa positive | #37 |
| lymphocytes disease | #37 |
| susceptibility autoimmune diseases | #37 |
| rich lipid | #37 |
| dba1 | #37 |
| oxidases oxidation | #37 |
| joint cartilage | #37 |
| spontaneous arthritis | #37 |
| animal models pain | #38 |
| innovative tools | #38 |
| snat | #38 |
| sialophorin | #38 |
| cochranmantelhaenszel test | #38 |
| target autoantigens | #38 |
| human blood neutrophils | #38 |
| cldn4 | #38 |
| nitrogen species | #38 |
| antibodies animals | #38 |
| ym1 | #39 |
| ccia | #39 |
| cell tolerance | #39 |
| wasting syndrome | #39 |
| resultsrats | #39 |
| measurement activity | #39 |
| autoreactive cells | #39 |
| allogeneically | #39 |
| clonal expansion cells | #39 |
| oestrogen treatment | #39 |
| endoβnacetylglucosaminidase | #39 |
| nzw | #39 |
| benoist | #39 |
| acpa response | #39 |
| b6n | #39 |
| nfr | #39 |
| data myelin | #39 |
| addition impact | #40 |
| polyclonal cell activation | #40 |
| rt1c | #40 |
| genetic complexity | #40 |
| antigens arthritis | #40 |
| peptide cell | #40 |
| adjuvant induced | #40 |
| disease animal models | #40 |
| isostere | #40 |
| positive rheumatoid | #40 |
| priming phase | #41 |
| severity incidence | #41 |
| autoimmune | #41 |
| rats anti | #41 |
| congenic mapping | #41 |
| genes loci | #41 |
| immunocap isac | #41 |
| rat myelin | #41 |
| mhc haplotype | #41 |
| effects experiments | #41 |
| ncii | #41 |
| autoimmune inflammatory diseases | #41 |
| aq | #41 |
| species receptors | #42 |
| pineal gland melatonin | #42 |
| p38 mapk nfκb | #42 |
| mhc class class | #42 |
| cartilage bone destruction | #42 |
| drb1 shared | #42 |
| th17 axis | #42 |
| expected onset | #42 |
| spleen weight | #42 |
| fibroblasts mice | #42 |
| ptpn22 locus | #42 |
| articular collagen | #42 |
| antibody isotypes | #42 |
| lew rats | #43 |
| lew lymphocytes | #43 |
| anticitrullinated | #43 |
| type‐ii | #43 |
| autoreactive cell | #43 |
| kgf treatment | #43 |
| treatment autoimmune diseases | #43 |
| rats sex | #43 |
| crosses genetic | #43 |
| pc8 | #43 |
| anticyclic | #43 |
| congeneic | #43 |
| immunodominant epitopes | #43 |
| arthritis data | #43 |
| spinal glia | #43 |
| mice autoimmune | #43 |
| collagen | #43 |
| cd11bly6g | #43 |
| mathis | #44 |
| chloro23 | #44 |
| epitopes lymphocyte | #44 |
| defensins humans | #44 |
| homozygous form | #44 |
| neuritis ean | #44 |
| genetic linkage analysis | #44 |
| peptide induced | #44 |
| c4bbinding protein c4bp | #44 |
| addition order | #44 |
| inflammation animals | #44 |
| mice mice autoimmune | #44 |
| mice adulthood | #44 |
| provocations | #44 |
| chromosome development | #45 |
| potent suppression | #45 |
| nzb | #45 |
| susceptibility arthritis | #45 |
| outbred rats | #45 |
| phagotopes | #45 |
| genetic encoding | #45 |
| disease histocompatibility | #45 |
| relapsing disease | #45 |
| lower severity | #46 |
| alphachains | #46 |
| rat2 | #46 |
| c227 | #46 |
| mhc class humans | #46 |
| eae mbp | #46 |
| locus controlling | #46 |
| disease induction | #46 |
| neuritis autoimmune | #46 |
| affinity purified | #46 |
| specific tolerance | #46 |
| isosteres | #46 |
| carp antibodies | #46 |
| cocrystallisation | #46 |
| posttranslationally | #46 |
| rheumatoid factors | #47 |
| diagnostic accuracy diagnosis | #47 |
| posttranslational rats receptors | #47 |
| f1 hybrid mice | #47 |
| complex mediated | #47 |
| protective allele | #47 |
| intercrosses | #47 |
| idiotypic antibody | #47 |
| antibody reactivities | #47 |
| association hladrb1 alleles | #47 |
| f1 crosses | #48 |
| cia rats | #48 |
| collagen glycosylation | #48 |
| lupus disease | #48 |
| collagen peptide | #48 |
| experimental arthritis mice | #48 |
| synovial lining layer | #48 |
| peptide recognized | #48 |
| acetylchitobiose | #48 |
| mice carrying | #48 |
| γchains | #48 |
| tlr12 | #48 |
| humanized model | #48 |
| antibody specificity | #48 |
| mice nzb | #48 |
| histone hdacs | #49 |
| mice caia | #49 |
| mouse cartilage | #49 |
| polyvinylcaprolactam | #49 |
| tcell stimulation | #49 |
| monoclonal autoimmune diseases | #49 |
| experimental crosses | #49 |
| immune nervous | #49 |
| class major | #49 |
| sex genes | #49 |
| comp levels | #49 |
| bystander activation | #49 |
| mice tolerance | #50 |
| antigenantibody | #50 |
| disease rats | #50 |
| dependent chronic | #50 |
| alagly | #50 |
| inflammation kynurenine | #50 |
| cytometry analyses | #50 |
| parathyroid cells | #50 |
| animal cell culture | #50 |
| anticarbamylated protein | #50 |
| monoclonal epitopes | #50 |
| glutamine uptake | #50 |
| loci animals | #50 |
| ciiia | #50 |
| complex region | #50 |
| glycosylated form | #50 |
| fewer cells | #51 |
| rheumatoid factor activity | #51 |
| aire mice | #51 |
| tolerized | #51 |
| antibodies cells | #51 |
| inbred c57bl autoimmune | #51 |
| lentiviral particles | #51 |
| cells ova | #51 |
| tracheal cartilage | #51 |
| autoantibodies rheumatoid arthritis | #51 |
| delayed immunization | #51 |
| runting | #51 |
| c57bl 6j background | #51 |
| evidence animal models | #51 |
| derived type | #51 |
| xor activity | #52 |
| model collagen | #52 |
| ptpn22 | #52 |
| matrix protein | #52 |
| antigenpresenting cells | #52 |
| macrophages skin | #52 |
| aged peptides | #53 |
| triple helical structure | #53 |
| production reactive | #53 |
| arthritis induction | #53 |
| protein antibodies | #53 |
| physiological doses | #53 |
| gastric parietal cell | #53 |
| lysosomal compartments | #53 |
| melatonin day | #53 |
| patients rheumatic conditions | #53 |
| cartilage erosion | #53 |
| carbamylated proteins | #53 |
| induced autoimmunity | #53 |
| antibodies epitopes | #53 |
| predating | #54 |
| antigens myelomonocytic arthritis | #54 |
| melatonin animals | #54 |
| carbamylated protein | #54 |
| rats social isolation | #54 |
| imitating | #54 |
| yaa | #54 |
| major epitope | #54 |
| crossbreeding | #54 |
| nodes lymphocyte | #54 |
| strain rats | #54 |
| animals autoimmune | #54 |
| development individuals | #54 |
| inflammatory manifestations | #55 |
| arthritis genetic | #55 |
| autoimmune reactions | #55 |
| macrophage mannose receptor | #55 |
| susceptibility autoimmune disease | #55 |
| complex genetic disease | #55 |
| autoimmune nzb | #55 |
| alpha1microglobulin | #56 |
| mhc | #56 |
| new animal | #56 |
| labels superoxide | #56 |
| animals antibody | #56 |
| cells salivary | #56 |
| selfreactive cells | #56 |
| igg abs | #57 |
| antibodies bind | #57 |
| cd1 mice | #57 |
| animals antirheumatic | #57 |
| antibodies | #57 |
| collagen sequence | #57 |
| development autoimmune | #57 |
| arthritis pathogenesis | #57 |
| vivo depletion | #57 |
| oestrogen progesterone | #58 |
| schafer | #58 |
| rat type | #58 |
| peptide response | #58 |
| urokinase activity | #58 |
| chronic eae | #58 |
| articular joints | #59 |
| anti cell | #59 |
| anticarp antibodies | #59 |
| hydroxylase diet | #59 |
| genes mhc | #59 |
| resistance eae | #59 |
| oligoclonal igg bands | #59 |
| cartilage matrix protein | #59 |
| anti cd8 | #59 |
| encephalitogenicity | #59 |
| hpaaxis | #60 |
| inflammatory cells macrophages | #60 |
| joint erosions | #60 |
| protein peptide | #60 |
| alternative activation macrophages | #60 |
| immunohistopathology | #60 |
| dichotomous effects | #60 |
| macrophage mannose | #60 |
| assay epitopes | #60 |
| serum comp | #61 |
| differentiation myelomonocytic arthritis | #61 |
| species reactive | #61 |
| epitope spreading | #61 |
| alpha1m | #61 |
| major histocompatibility | #61 |
| experimental evoked potentials | #61 |
| experimental rats rats | #61 |
| incidence severity | #61 |
| cells innate immune | #61 |
| adaptive immune | #62 |
| toxin1 | #62 |
| placenta uterus | #62 |
| interferon‐β | #62 |
| cyclic sensitivity | #62 |
| antigens class histocompatibility | #62 |
| reduced oxidative | #62 |
| fpr2 | #62 |
| autoantibody formation | #62 |
| syngeneically | #62 |
| mice susceptibility | #62 |
| basic characterization | #62 |
| rats strain | #63 |
| induced experimental | #63 |
| glycoprotein myelin | #63 |
| collagen cell | #63 |
| transfer animals | #63 |
| igaproducing cells | #63 |
| protein disease | #63 |
| hypersensitivity dth | #63 |
| duval | #63 |
| constant darkness | #63 |
| nadph oxidases | #63 |
| specificity tumor | #63 |
| mog1 | #63 |
| delayed interferon | #63 |
| peptide specific | #63 |
| mice polyi | #63 |
| post‐partum | #63 |
| specific stages | #63 |
| tolerance model | #64 |
| freund adjuvant | #64 |
| role apc | #64 |
| maternal origin | #64 |
| secondary immune | #64 |
| lower capacity | #64 |
| model chronic | #65 |
| induced suppression | #65 |
| hindpaws | #65 |
| histocompatibility complex | #65 |
| weight variation | #65 |
| major subset | #65 |
| flss | #65 |
| autoimmunity humans | #65 |
| resemblances | #66 |
| rheumatoid synovial cells | #66 |
| spontaneous disease | #66 |
| chromosomes mammalian | #66 |
| hladr2 | #66 |
| multispecificity | #66 |
| experimental lymphocytes | #66 |
| negative rheumatoid | #66 |
| thy1 antigen | #66 |
| phagocytosis oxidative burst | #66 |
| peripheral joints | #66 |
| acute arthritis | #66 |
| mice induced | #67 |
| mice cell | #67 |
| rheumatoid arthritis susceptibility | #67 |
| fibrinogen genotype | #67 |
| strains susceptible | #67 |
| dendritic cells epitopes | #67 |
| experimental encephalomyelitis | #67 |
| key interactions | #67 |
| endos | #67 |
| development cell | #67 |
| experimental allergic | #67 |
| myelomonocytic arthritis | #67 |
| complex class | #68 |
| frequent infections | #68 |
| severity periodontitis | #68 |
| female sex hormones | #68 |
| anti carp | #68 |
| individuals positive | #68 |
| sodium diethyldithiocarbamate | #68 |
| tolerized mice | #68 |
| iggrf | #68 |
| helper phenotype | #68 |
| class region | #68 |
| cells mhc class | #68 |
| rheumatoid chromosomes | #68 |
| cells mouse | #69 |
| relapsing | #69 |
| zap‐70 | #69 |
| vertebrate immune | #69 |
| rheumatoid disease | #69 |
| frequency antibodies | #69 |
| direct damage | #69 |
| lymphocytes chronic | #69 |
| prolonged graft survival | #70 |
| presence rheumatoid factor | #70 |
| role cells | #70 |
| mrl mice | #70 |
| translationally | #70 |
| response type | #70 |
| immunoglobulin interferon | #70 |
| human psoriasis | #71 |
| cartilage mice | #71 |
| swr | #71 |
| expression pparγ | #71 |
| ztm | #71 |
| cb10 | #71 |
| susceptibility female | #71 |
| isolated rats | #71 |
| naïve mice | #72 |
| lathyritic | #72 |
| napdh | #72 |
| dark agouti rats | #72 |
| delayedtype hypersensitivity dth | #72 |
| autoimmunity lymphocytes | #72 |
| interphalangeal joints | #72 |
| study antibodies | #72 |
| antibodies binding | #72 |
| oxidase complex | #73 |
| knockout protein processing | #73 |
| membrane animals | #73 |
| environmental lighting | #73 |
| bovine type | #73 |
| mrl lpr | #73 |
| treatment stages | #73 |
| species ros | #73 |
| type ifn signature | #73 |
| peptides sequences | #74 |
| antigens class | #74 |
| igarf | #74 |
| cartilage explants | #74 |
| hypersensitivity delayed | #74 |
| pregnancyinduced | #74 |
| dth mice | #75 |
| inbred dba receptors | #75 |
| cell reactivity | #75 |
| genetic disease models | #75 |
| diabetes arthritis | #75 |
| acpapositive | #75 |
| oestradiol | #75 |
| effects development | #75 |
| anti carbamylated | #76 |
| type collagens | #76 |
| peptide mhc | #76 |
| disease rheumatoid arthritis | #76 |
| rat splenocytes | #76 |
| rats eae | #77 |
| new animal model | #77 |
| cell deficient | #77 |
| pain inflammation | #77 |
| eae induced | #77 |
| inbred mouse strains | #77 |
| development insulitis | #77 |
| lpr mrl | #77 |
| regulatory vaccines | #77 |
| cyp7a1 | #77 |
| rt1n | #77 |
| nerve conduction velocity | #77 |
| collagen chains | #77 |
| oligomeric | #77 |
| rats respiratory | #78 |
| cartilage integrity | #78 |
| mhc expression | #78 |
| pythons | #78 |
| pathogenesis rheumatoid arthritis | #78 |
| autoantigenic | #78 |
| clinical arthritis | #78 |
| 1ii | #79 |
| inflammatory autoimmune | #79 |
| susceptibility disease | #79 |
| mononuclear lung | #79 |
| shared epitope | #79 |
| autoimmune experimental epitopes | #79 |
| detection autoantibodies | #80 |
| erosive arthritis | #80 |
| chromosome study | #80 |
| oxidases | #80 |
| hnrnpa2 | #81 |
| sex linkage | #81 |
| estrogen suppression | #81 |
| aspartic acid position | #81 |
| arthritis cells | #81 |
| dr1 antigen | #81 |
| spleen study | #81 |
| class antigen expression | #81 |
| mrl mp | #81 |
| expression ll37 | #81 |
| mog mbp | #81 |
| inflammatory phase | #81 |
| type macrophages | #81 |
| mhcii expression | #81 |
| induced leukocyte | #81 |
| 14weeks | #82 |
| nadphoxidase | #82 |
| pannus formation | #82 |
| bcg infection | #83 |
| tlymphocyte genes | #83 |
| mice igg | #83 |
| cell independent | #83 |
| drug encephalomyelitis | #83 |
| expression mhc | #83 |
| multiple sclerosis evidence | #84 |
| naïve cells | #84 |
| epidermal cells | #84 |
| spontaneous development | #84 |
| rat cardiac allografts | #84 |
| reactive cells | #84 |
| strains animals | #84 |
| arthritis day | #84 |
| knockout receptors | #85 |
| cells recognize | #85 |
| homopentamer | #85 |
| inflammation joints | #85 |
| inflammation joint | #85 |
| class molecule | #85 |
| antiifngamma | #85 |
| gfoger | #86 |
| preclinical stage | #86 |
| mutant strains | #86 |
| phagocyte nadph | #86 |
| severe eae | #86 |
| classical humans | #86 |
| monoclonal antibodies mab | #86 |
| animal humans | #86 |
| contribution genes | #86 |
| anti cd4 | #86 |
| smash | #87 |
| inbred rat strains | #87 |
| estrogen induced | #87 |
| alpha1acid glycoprotein | #87 |
| mhc class gene | #87 |
| thps | #88 |
| inguinal lymph nodes | #88 |
| copy variation | #88 |
| narac | #88 |
| levels anti | #88 |
| fine specificities | #88 |
| peptide immunization | #89 |
| genetic quantitative | #89 |
| depletion cd8 cells | #89 |
| arthritic | #89 |
| mabs mab | #89 |
| experimental autoimmune | #89 |
| mice antibodies | #89 |
| ilc2 activation | #90 |
| susceptible | #90 |
| monkeys mice | #90 |
| rheumatoid arthritis cells | #90 |
| arthritis compared | #90 |
| autoimmune inbred c57bl | #90 |
| genistein treatment | #90 |
| adjuvant arthritis | #90 |
| mediated mechanisms | #90 |
| pineal hormone melatonin | #90 |
| backgroundan | #91 |
| protein induced | #91 |
| histological sections | #91 |
| cells apc | #91 |
| cattle collagen | #91 |
| activation cd4 cells | #91 |
| synovial fluid serum | #91 |
| anticitrullinated protein | #92 |
| abdominal region | #92 |
| humans immunodominant | #92 |
| experimental mouse models | #92 |
| difco | #92 |
| nod mhc | #92 |
| mice melatonin | #93 |
| 290 patients | #93 |
| cellspecific | #93 |
| xor | #93 |
| animals autoantibodies | #93 |
| knockout myelin | #93 |
| natural polymorphisms | #93 |
| fcγrs | #94 |
| galactosylated | #94 |
| macrophages development | #94 |
| endosomal acidification | #94 |
| activated cells cells | #94 |
| autosomal genes | #94 |
| moderateintensity exercise | #95 |
| binding integrins | #95 |
| induced sarcoma | #95 |
| chronic phase disease | #95 |
| nonglycosylated | #96 |
| messenger tolllike receptor | #96 |
| romani | #96 |
| cell alpha | #96 |
| fetal rejection | #96 |
| data rats | #96 |
| pregnancy disease | #96 |
| lung emphysema | #96 |
| macrophages stimulation | #96 |
| ifnbeta | #96 |
| cathelicidins | #97 |
| complex mice | #97 |
| genetic female genes | #97 |
| macrophages fibroblasts | #97 |
| rheumatoid lymphocytes | #97 |
| antiimmunoglobulin | #97 |
| citrullinated fibrinogen | #97 |
| il33r | #97 |
| hydroxylysine | #97 |
| swr mice | #98 |
| ean | #98 |
| rheumatoid cartilage | #98 |
| autoimmune experimental | #98 |
| acpa igg | #98 |
| autoimmune rats | #98 |
| alternative pathways | #99 |
| rat chromosomes | #99 |
| interleukin‐4 | #99 |
| collagen cytokines | #99 |
| thy1 antigens | #100 |
| rats monoclonal antibodies | #100 |
| cultured crosses | #100 |
| inducer animals | #100 |
| tlymphocyte immunity | #100 |
| ccp anti | #100 |
| protein antibody | #100 |
| invading pathogens | #100 |
| peptides cells | #100 |
| tap2 | #100 |
| safety drugs | #101 |
| diarthrodial | #101 |
| bone degradation | #101 |
| cell determinants | #101 |
| eira | #101 |
| fprs | #101 |
| singlenucleotide polymorphism | #101 |
| susceptible strain | #101 |
| mouse monoclonal antibodies | #102 |
| brucei infection | #102 |
| findings treatment | #102 |
| candidate autoantigen | #102 |
| eae animal encephalomyelitis | #102 |
| drb10401 | #103 |
| ros homeostasis | #103 |
| pathogenesis emphysema | #103 |
| agalactosyl | #103 |
| hla dr1 | #103 |
| oxidative burst | #103 |
| synchrotron infrared | #104 |
| mhcii | #104 |
| mutation mice | #104 |
| male mice mice | #104 |
| f1 males | #104 |
| thelper cells | #104 |
| arthritic disease | #104 |
| haplotypes histocompatibility | #104 |
| nonarthritic | #104 |
| skg mice | #104 |
| autoreactivity | #105 |
| fcγr | #105 |
| dmaam | #105 |
| development antibodies | #105 |
| vivo macrophages | #105 |
| osteoclasts mice | #105 |
| hybridoma cell | #105 |
| type 22 | #105 |
| disease dose | #106 |
| proteoglycan loss | #106 |
| primed cells | #106 |
| 273 | #106 |
| tcell immunity | #106 |
| arthritis hla | #106 |
| limited cross | #106 |
| cells synovial | #107 |
| c3h mice | #107 |
| nzb mice | #107 |
| littermates | #108 |
| study tolerance | #108 |
| fpr | #108 |
| development autoimmune disease | #108 |
| enthesophytes | #109 |
| structural polymorphism | #109 |
| citrullinated proteins | #109 |
| type hypersensitivity | #109 |
| monoclonal igg | #109 |
| reactive cell | #109 |
| autoantibodies autoantigens | #109 |
| delayedtype hypersensitivity | #109 |
| presentation cells | #109 |
| carcinoma tumors | #110 |
| autoimmune encephalomyelitis | #110 |
| backcross | #111 |
| streptococcal cell wall | #111 |
| experimental female | #111 |
| mog eae | #111 |
| cartilage | #111 |
| inbred dba microscopy | #111 |
| dba 1j mice | #111 |
| female hypersensitivity | #111 |
| toxic shock syndrome | #111 |
| amide bond | #112 |
| humoral autoimmunity | #112 |
| alphabeta receptors antigen | #112 |
| presymptomatic individuals | #112 |
| extensive literature search | #112 |
| anti idiotypic antibodies | #112 |
| restricted cell | #113 |
| db1 | #113 |
| tcra | #113 |
| autoimmune c57bl mice | #113 |
| adjuvant properties | #113 |
| mice collageninduced arthritis | #113 |
| trait loci | #113 |
| oligoclonality | #113 |
| xid mice | #113 |
| ifngammaproducing cells | #114 |
| adjuvantinduced arthritis | #114 |
| mice disease | #115 |
| rats collagen | #115 |
| anti mcv | #115 |
| autoantigens autoimmunity | #115 |
| proinflammatory cytokine | #115 |
| drb10402 | #115 |
| lymphocyte female | #116 |
| lutz | #116 |
| susceptibility eae | #116 |
| ccp patients | #116 |
| immunosorbents | #116 |
| experimental epitopes | #116 |
| transgenic peptides receptors | #116 |
| glycopeptides | #116 |
| pathogenesis autoimmune diseases | #116 |
| glyco | #116 |
| congenic lines | #117 |
| mice type | #117 |
| antibodies reactive | #117 |
| tolerance induced | #117 |
| encephalomyelitis autoimmune | #117 |
| antiarthritic | #117 |
| fluorescence nf | #117 |
| rats immunized | #118 |
| psoriasiform dermatitis | #118 |
| class expression | #118 |
| alpha1acid | #118 |
| pineal hormone | #118 |
| α enolase | #118 |
| myelin oligodendrocyte | #118 |
| samples individuals | #118 |
| radiological damage | #119 |
| 05m | #119 |
| response cells | #119 |
| rheumatoid arthritis review | #119 |
| cd4 tcells | #119 |
| psa rheumatoid arthritis | #119 |
| neutrophils nets | #120 |
| protein mbp | #120 |
| experimental animal models | #121 |
| vivo animal models | #121 |
| chondrocyte cultures | #121 |
| immune complex deposition | #122 |
| acpa negative | #122 |
| transgenic neurons receptors | #122 |
| transfer arthritis | #122 |
| genes age | #122 |
| t‐lymphocyte | #122 |
| patients acpa | #122 |
| treatment progesterone | #122 |
| pharmacological potential | #122 |
| symptoms associations | #123 |
| type cytokines | #123 |
| cell monoclonal | #123 |
| c5b | #123 |
| alphabeta cells | #123 |
| nox2 activation | #123 |
| inbred mouse | #124 |
| cartilage surface | #124 |
| tlr4 stimulation | #124 |
| disease mechanisms | #125 |
| genetic rats | #125 |
| qtl genes | #125 |
| oxidases neutrophils | #125 |
| general mechanisms | #125 |
| helperinducer | #125 |
| blocking antigens | #125 |
| cryogel | #125 |
| immunodominant peptide | #125 |
| preimmunized | #125 |
| allelic variations | #125 |
| cyclic polymorphism | #126 |
| nonobese diabetic | #126 |
| pnipaam | #126 |
| female immunization | #126 |
| nzb nzw | #126 |
| microarray detection | #127 |
| absence cells | #127 |
| atp8 | #127 |
| knockout murine | #127 |
| animal enzyme | #127 |
| deiminases | #128 |
| chronic inflammatory disease | #128 |
| dominant epitope | #128 |
| lining layer | #128 |
| anticitrullinated peptide | #128 |
| multiple epitopes | #129 |
| rats patients | #129 |
| spleen rats | #129 |
| bxsb | #129 |
| cells eae | #130 |
| psd1 | #130 |
| nos2 | #130 |
| vivo absence | #130 |
| oestradiol testosterone | #130 |
| disease induced | #130 |
| epitope specific | #131 |
| onset arthritis | #131 |
| lipomannan | #131 |
| disease cgd | #132 |
| intercross | #132 |
| pronociceptive | #132 |
| induction regulatory cells | #132 |
| kgf | #132 |
| linomide | #132 |
| mineral oils | #132 |
| leukosialin | #133 |
| ggaa | #133 |
| rat chromosome | #133 |
| reduced severity | #133 |
| mice estrogen | #134 |
| plasma synovial fluid | #134 |
| knockout receptors antigen | #134 |
| species animals | #134 |
| accentuate | #134 |
| eae | #134 |
| patients cytokines | #134 |
| myocellular | #134 |
| interstitial collagens | #134 |
| peptides cyclic | #135 |
| igg immune complexes | #135 |
| spinal glial | #135 |
| intracellular reactive | #136 |
| macrophages dendritic | #136 |
| chronic autoimmune disease | #136 |
| immunizing | #136 |
| stimulated muscle | #137 |
| immunopathological | #137 |
| receptor upregulation | #137 |
| innate lymphocytes | #137 |
| ditiocarb | #138 |
| mice deficient | #138 |
| control development | #139 |
| immunomodulatory drug | #139 |
| dmannitol | #139 |
| autoimmune mice | #139 |
| tcrdelta | #140 |
| oligoclonal expansion | #141 |
| producing cell | #141 |
| thermoresponsive polymer | #141 |
| gamma lymphocyte | #142 |
| interferon‐γ | #142 |
| phadia | #142 |
| genetic factors development | #142 |
| or113 | #142 |
| rejection tolerance | #142 |
| smfish | #142 |
| single subcutaneous injection | #142 |
| mice beta | #143 |
| phosphate isomerase | #143 |
| cell hybridoma | #143 |
| class haplotypes | #143 |
| tcell alphabeta receptors | #143 |
| synovial hyperplasia | #144 |
| mhc haplotypes | #144 |
| rat strains | #144 |
| rheumatoid arthritis | #144 |
| treatment ici | #145 |
| lyme arthritis | #145 |
| tnf production | #145 |
| severe chronic | #145 |
| syngenic | #145 |
| tcr gamma delta | #145 |
| inbred buf rats | #145 |
| neonatal growth | #146 |
| rats induced | #146 |
| ccp antibodies | #147 |
| gammainterferon | #147 |
| pregnancy levels | #147 |
| function cells | #147 |
| systemic challenge | #147 |
| cellular heterogeneity | #147 |
| interestingly | #148 |
| autoimmune disease | #148 |
| α2i | #148 |
| cell surface antigen | #148 |
| phagocyte nadph oxidase | #148 |
| redox regulation | #148 |
| human autoimmune diseases | #149 |
| complex diseases | #149 |
| mhc binding | #150 |
| larsen score | #150 |
| drb104 | #150 |
| receptor rats | #151 |
| differential gene expression | #151 |
| epicutaneously | #151 |
| mice animals | #151 |
| humans hybridomas | #151 |
| levels antibodies | #151 |
| alphabeta receptors | #152 |
| arthritic animals | #153 |
| levels pregnancy | #153 |
| mononuclear cells | #153 |
| key player | #153 |
| pepsin | #153 |
| male rats rats | #154 |
| daf1 | #154 |
| expression class | #154 |
| fcgammar | #154 |
| c4bbinding protein | #154 |
| critical event | #154 |
| selfpeptides | #154 |
| immune priming | #154 |
| joint inflammation | #154 |
| mace acs | #155 |
| infiltrating cells | #155 |
| serum synovial fluid | #155 |
| arthritis rheumatoid | #155 |
| padi4 | #155 |
| autoantibodies autoimmune | #155 |
| f1 mice | #155 |
| suppressive role | #156 |
| mhc region | #156 |
| stabilin1 | #156 |
| specificities | #156 |
| adjuvanticity | #157 |
| downstream signals | #157 |
| murine keratinocytes | #157 |
| genetic diabetes mellitus | #158 |
| analysis structure | #158 |
| parentals | #158 |
| hypersensitivity reaction | #158 |
| consensus motif | #159 |
| systemic mice mice | #159 |
| arthritis infectious | #159 |
| inbred c3h mice | #159 |
| animals autoimmunity | #159 |
| meaib | #159 |
| day onset | #161 |
| nursed | #161 |
| benzylated | #161 |
| gamma interferon | #161 |
| specific autoimmunity | #161 |
| knockout severity | #161 |
| factors anti | #161 |
| epitope | #162 |
| cd152 | #162 |
| psors1 | #162 |
| arthritis inflammation | #162 |
| rheumatoid autoantigens | #162 |
| binding collagen | #162 |
| anti ccp | #162 |
| βarrestin recruitment | #162 |
| chains humans | #163 |
| laboratory rats | #163 |
| onset disease | #163 |
| mouse type | #163 |
| mrl | #164 |
| genes qtl | #164 |
| rats induction | #164 |
| striking similarities | #164 |
| agalactosyl igg | #164 |
| endobetanacetylglucosaminidase | #164 |
| progesterone effects | #164 |
| autoantibody responses | #164 |
| cells macrophages | #165 |
| animal humans immunity | #165 |
| nonimmunized | #166 |
| melatonin mice mice | #166 |
| epitope alleles | #166 |
| tolerance induction | #166 |
| pathogenic pathways | #166 |
| nox2 | #167 |
| class mice | #167 |
| seronegative | #167 |
| tlymphocyte humans | #167 |
| human autoimmunity | #167 |
| ag7 | #167 |
| cd1 | #168 |
| mice cd4 cells | #168 |
| genetic backgrounds | #168 |
| phase disease | #168 |
| denoted | #169 |
| acpa levels | #169 |
| oxazole | #169 |
| p12 | #169 |
| mirp | #170 |
| joints male | #170 |
| pathogenesis arthritis | #170 |
| cryogels | #170 |
| experimental animal | #170 |
| lymph node cells | #170 |
| inherited disorder | #170 |
| encephalomyelitis eae | #171 |
| ros nitric oxide | #171 |
| oxazolone | #171 |
| single nucleotide polymorphism | #172 |
| autoimmunity cell | #172 |
| peripheral lymphoid organs | #172 |
| rat placenta | #172 |
| rheumatoid | #172 |
| autoimmune eae | #172 |
| lst1 | #172 |
| sod3 | #173 |
| inbred dba models | #173 |
| monoclonal autoantibodies | #173 |
| studies pain | #174 |
| presence autoantibodies | #174 |
| class gene | #174 |
| resistant rats | #174 |
| nasal cartilage | #174 |
| understanding pathogenesis | #175 |
| mice mutation | #175 |
| ifn signature | #175 |
| maternal decidua | #175 |
| mammalian crosses | #176 |
| skin disease | #176 |
| secondary challenge | #176 |
| strains molecular | #176 |
| tryptophan catabolism | #176 |
| moab | #176 |
| new mouse model | #176 |
| lymphotoxinα | #177 |
| hladrb1 alleles | #178 |
| histocompatibility | #178 |
| ctla‐4 | #178 |
| protein anti | #179 |
| nod genes | #179 |
| dextran sulphate sodium | #179 |
| mice role | #179 |
| alternative pathway complement | #179 |
| immunized | #179 |
| complex disease | #180 |
| cgd patients | #180 |
| epitopes female | #180 |
| arthritis methods | #180 |
| molecular adaptations | #181 |
| autoimmunity disease | #181 |
| genetic influence | #181 |
| alleles arthritis | #181 |
| arginine deiminases | #182 |
| hormone melatonin | #182 |
| immunoglobulin mice mice | #185 |
| rats reactive | #186 |
| antigen processing presentation | #186 |
| multistep process | #186 |
| cells lymph nodes | #186 |
| drb1 chains | #187 |
| dba | #187 |
| tcell recognition | #187 |
| b10 | #187 |
| substrains | #188 |
| chondritis | #188 |
| molecular peptide | #188 |
| mtec | #189 |
| cells disease | #189 |
| hnrnpa2b1 | #190 |
| inflamed joint | #190 |
| synovial membranes | #190 |
| positionally | #190 |
| oligodendrocyte glycoprotein | #191 |
| autoantibody profiles | #192 |
| cross‐reactivity | #192 |
| ly1 | #192 |
| fmlf | #193 |
| passive mice mice | #193 |
| proteins myelin | #194 |
| glycoprotein peptide | #194 |
| cyclic predictive | #194 |
| perpetuate | #195 |
| mice mutant | #195 |
| chapter 16 | #195 |
| mhv | #195 |
| lewis rat | #196 |
| tcell response | #196 |
| oophorectomized | #196 |
| mhc class expression | #196 |
| myelin glycoprotein | #196 |
| multiplex assay | #197 |
| acutephase response | #197 |
| evidence development | #197 |
| pannus | #197 |
| igmrf | #198 |
| early appearance | #198 |
| genetic links | #198 |
| swedish patients | #198 |
| rat genome | #199 |
| dr4 antigen | #199 |
| interleukin17 | #199 |
| cell collagen | #200 |
| citrullinated peptide | #200 |
| hla association | #200 |
| pathogenesis autoimmune | #201 |
| instigation | #202 |
| dendritic cells macrophages | #202 |
| myelin proteolipid protein | #202 |
| myelin proteins myelin | #202 |
| acpa status | #202 |
| complete elimination | #203 |
| mice cells | #203 |
| immunization immunoglobulin | #204 |
| spleen staining | #204 |
| 2 complex | #204 |
| class molecules | #204 |
| native collagen | #205 |
| nonparametric tlymphocytes | #205 |
| dth response | #205 |
| suppresses | #205 |
| ides | #205 |
| macrophages mice | #205 |
| betaestradiol | #206 |
| defb4 | #206 |
| wild rats | #206 |
| desmoglein 3 | #207 |
| interleukin4 mice mice | #207 |
| mice peptide | #207 |
| intranasal challenge | #207 |
| alternative complement pathway | #207 |
| induced upregulation | #207 |
| insulitis diabetes | #207 |
| noxs | #207 |
| parental strains | #207 |
| naive mice | #208 |
| vivo patients | #208 |
| highest probability | #208 |
| immunization mice | #208 |
| antigen presenting | #208 |
| severity disease | #208 |
| immunoglobulin vh | #209 |
| disease rheumatoid | #209 |
| cotwins | #209 |
| susceptible strains | #210 |
| valuable tools | #210 |
| citrullinated vimentin | #210 |
| highfatdiet | #210 |
| vav1 | #210 |
| specific antibodies | #210 |
| natural antibodies | #211 |
| hla dr4 | #211 |
| diseases genetic | #211 |
| purified protein derivative | #211 |
| glucose6 phosphate | #211 |
| large numbers | #212 |
| association rheumatoid arthritis | #212 |
| cells immobilized | #212 |
| mice injected | #213 |
| antibody binding | #213 |
| psoriasiform | #213 |
| tsst1 | #214 |
| triethylsilane | #215 |
| antigen induced | #215 |
| inbred rat | #215 |
| cytofluorometric | #215 |
| central tolerance | #215 |
| mhc class antigens | #215 |
| dissect | #216 |
| lower level | #216 |
| training hiit | #216 |
| joints mice | #217 |
| rats immunization | #217 |
| inflammatory infiltrates | #217 |
| cd23 | #217 |
| induced autoimmune | #217 |
| resistant strain | #217 |
| lentiviral vector | #217 |
| antigen tcell | #218 |
| treatment onset | #218 |
| k8 | #219 |
| peptide antibodies | #219 |
| granuloma formation | #219 |
| autoimmunity | #219 |
| fcrγ | #219 |
| cells autoimmune | #220 |
| hyl | #220 |
| bone erosions | #220 |
| peptidylarginine deiminases | #220 |
| cyclosporin treatment | #221 |
| agouti rats | #221 |
| redox signaling | #221 |
| fine specificity | #221 |
| rheumatoid factor | #221 |
| targeted deletion | #221 |
| cells dendritic | #221 |
| pinealectomy | #221 |
| cybb | #222 |
| monoclonal antigens differentiation | #222 |
| thymectomized | #222 |
| cartilage damage | #222 |
| wkymvm | #222 |
| multiplex | #223 |
| carbamylated | #223 |
| igg2a | #223 |
| experimental autoimmune neuritis | #223 |
| expressing | #224 |
| inflammation vivo | #224 |
| established disease | #225 |
| interleukin‐10 | #225 |
| clinical scoring | #225 |
| lew | #225 |
| cells antigen | #225 |
| disease locus | #226 |
| pathogenic antibodies | #226 |
| j1 | #227 |
| macrophagelike cells | #227 |
| arthritis objective | #228 |
| presenting cells | #228 |
| delayed type hypersensitivity | #228 |
| cell selection | #229 |
| presence anti | #229 |
| eae rats | #230 |
| site inflammation | #230 |
| human rheumatoid | #231 |
| ls1 | #231 |
| reactive oxygen | #232 |
| monoclonal immunohistochemistry | #232 |
| production ros | #233 |
| ameliorated | #233 |
| synovial joints | #233 |
| lack expression | #233 |
| role eosinophils | #233 |
| centimorgan | #234 |
| lower numbers | #234 |
| chromosome 14 | #235 |
| mhc gene | #235 |
| chronic psychosocial stress | #235 |
| staphylococcal infection | #235 |
| specificity animals | #236 |
| immune complex | #236 |
| pathological mechanisms | #237 |
| control strain | #237 |
| autoimmune chronic | #238 |
| progression arthritis | #238 |
| c5 | #239 |
| trait locus | #239 |
| inbred dba tlymphocytes | #240 |
| study plasma | #241 |
| strong influence | #242 |
| joint pain | #242 |
| protected | #243 |
| hla drb1 | #243 |
| multicomponent | #243 |
| monoclonal antigen | #243 |
| positive anti | #243 |
| class genetic | #243 |
| cutaneous infection | #244 |
| estrus cycle | #244 |
| crosses | #244 |
| inflammation cartilage | #244 |
| treatment autoimmune | #244 |
| common denominator | #244 |
| binding antibodies | #245 |
| rt1l | #246 |
| allelic differences | #246 |
| development emphysema | #246 |
| antibody response | #247 |
| florescence | #247 |
| antibodies anti | #247 |
| normal cartilage | #247 |
| inbred strain | #247 |
| new model | #247 |
| activity assays | #248 |
| efficient expression | #248 |
| oxygen species | #249 |
| induced chronic | #249 |
| arthritic joints | #250 |
| node cells | #250 |
| fragments rats | #250 |
| mouse rat | #250 |
| inflammation score | #250 |
| picryl | #250 |
| conditional knockout mice | #251 |
| hyperinflammation | #251 |
| develops | #251 |
| treatment rats | #251 |
| nadph oxidase | #251 |
| mice lymphocytes | #252 |
| mice lack | #252 |
| role model | #252 |
| dark agouti | #252 |
| response disease | #252 |
| class mhc | #254 |
| proteins glycoproteins | #254 |
| onset clinical | #254 |
| lpr mice | #254 |
| cartilage matrix | #254 |
| dinitrofluorobenzene | #254 |
| lacking | #254 |
| autoimmune response | #255 |
| inbred c3h | #255 |
| specific subgroups | #256 |
| anti arthritic | #256 |
| postmenopausal bone | #256 |
| inflammatory disorder | #256 |
| specific neutralizing | #256 |
| disease cell | #257 |
| additive interaction | #258 |
| class mhc molecules | #259 |
| mir144 | #260 |
| relationship immunologic | #260 |
| chronic granulomatous | #260 |
| autoimmune neuritis | #261 |
| mediated suppression | #261 |
| mice expressing | #261 |
| denatured | #261 |
| lymphocytes helper | #261 |
| secondary osteoporosis | #261 |
| immunologic animals | #262 |
| selfantigen | #263 |
| primary immunization | #265 |
| mouse strain | #265 |
| genetic techniques | #265 |
| tolerance mice | #265 |
| pregnancy mice | #265 |
| crossreactive | #265 |
| rats animals | #267 |
| vim2 | #267 |
| cysteine proteases | #267 |
| antigen specific | #267 |
| lentiviral gene | #268 |
| xid | #268 |
| posttranslational modifications | #268 |
| mann whitney | #269 |
| pathogenic roles | #269 |
| complement c5 | #270 |
| oxpl | #270 |
| melatonin effects | #271 |
| monosodium urate crystals | #271 |
| selfantigens | #271 |
| castrated | #271 |
| experimental model | #273 |
| amino acid transporters | #273 |
| lewis rats | #274 |
| nasally | #275 |
| tcells | #275 |
| hdac1 | #275 |
| synovial lining | #275 |
| inhibitory peptide | #275 |
| macrophages dendritic cells | #276 |
| fcgr3b | #276 |
| viral female hepatitis | #277 |
| producing cells | #277 |
| rheumatoid arthritis association | #277 |
| deiminase type | #277 |
| metabolic properties | #278 |
| recognize | #278 |
| interferongamma | #279 |
| colon length | #279 |
| gp70 | #279 |
| dinucleotide phosphate | #280 |
| induced tolerance | #280 |
| recipient mice | #281 |
| inflammatory conditions | #281 |
| neonatal mice | #281 |
| immunological receptors antigen | #281 |
| passive transfer | #281 |
| hemiacetal | #282 |
| disease susceptibility | #283 |
| inbred nod | #283 |
| igg2b | #283 |
| isoflavone genistein | #283 |
| factor production | #283 |
| severe colitis | #284 |
| helper inducer | #284 |
| increased serum levels | #284 |
| aire | #284 |
| theilovirus | #285 |
| idiotope | #285 |
| publication animals antibodies | #285 |
| endophilin | #285 |
| aureus strain | #285 |
| maintained | #285 |
| complete protection | #285 |
| emulsified | #286 |
| hla dr2 | #287 |
| melatonin release | #288 |
| melatonin mice | #288 |
| antibody production | #288 |
| myelin basic protein | #288 |
| tlr9 mice | #288 |
| mice immunized | #289 |
| cells autoimmunity | #289 |
| ctla4 expression | #291 |
| synovial cells | #291 |
| disease cells | #291 |
| rheumatic conditions | #292 |
| autoimmune mechanisms | #292 |
| induced ros | #293 |
| collagen receptors | #293 |
| cytokines disease | #293 |
| increased copy | #293 |
| mouse genes | #294 |
| unique model | #294 |
| c3h | #295 |
| gastric parietal | #295 |
| c57bl 6 mice | #295 |
| antigen processing | #295 |
| 6week | #296 |
| nerve conduction | #296 |
| immunological receptors | #296 |
| tissue‐specific | #296 |
| helical peptides | #297 |
| murine dendritic cells | #297 |
| phosphopyruvate | #297 |
| dnfb | #297 |
| gene selection | #298 |
| vivo imaging | #298 |
| ppad | #298 |
| cd19 cells | #298 |
| solidphase synthesis | #299 |
| transplantation antigens | #299 |
| citrullination | #299 |
| tcr beta | #300 |
| neutrophil extracellular traps | #301 |
| posttranslational rats | #301 |
| alphabeta | #302 |
| draining lymph | #302 |
| extraembryonic tissues | #302 |
| peptide antibody | #302 |
| strains mice | #303 |
| 1 interferon | #303 |
| pathogeneses | #303 |
| epidemiological investigation | #303 |
| animals antibodies | #303 |
| conditioned disease models | #304 |
| cgd | #304 |
| autoimmune diseases | #304 |
| igg glycosylation | #304 |
| cells tcr | #305 |
| cartilage development | #305 |
| mutant strains mice | #305 |
| immunological function | #305 |
| hcdr3 | #306 |
| αgalcer | #306 |
| immunological studies | #306 |
| murine colitis | #306 |
| gammaifn | #306 |
| inpp4b | #307 |
| class histocompatibility | #307 |
| immunisation | #307 |
| basal metabolic rate | #308 |
| chromosome 10 | #309 |
| basal metabolic | #309 |
| arthritis study | #310 |
| articular cattle cells | #310 |
| multiple sclerosis eae | #311 |
| perpetuation | #311 |
| inflamed joints | #312 |
| synthetic peptide | #312 |
| alleles animals | #312 |
| disease symptoms | #312 |
| c3bi | #313 |
| exuberant | #313 |
| epitopes | #313 |
| activatory | #314 |
| induced colitis | #314 |
| mice genes | #315 |
| r620w | #315 |
| intradermally | #315 |
| trypanosoma brucei brucei | #316 |
| onset rheumatoid | #318 |
| classical risk factors | #318 |
| tubule cells | #319 |
| galactosyl | #319 |
| genetic interactions | #319 |
| genomewide linkage analysis | #320 |
| spleen bone marrow | #320 |
| mice subjected | #320 |
| deiminase | #320 |
| cells specific | #323 |
| il21r | #323 |
| expressing human | #324 |
| daf2 | #324 |
| impact disease | #324 |
| ccp1 | #324 |
| specific cell | #325 |
| expression cells | #325 |
| rat gene | #325 |
| surprisingly | #326 |
| mgps | #327 |
| resembles | #327 |
| allelic variant | #328 |
| c57bl mice | #328 |
| publication adjuvants | #329 |
| constant light | #329 |
| immunoenzyme | #329 |
| complex genes | #330 |
| early arthritis | #331 |
| nucleotide polymorphism | #332 |
| glycoprotein mog | #332 |
| fcgammariia | #332 |
| rheumatoid synovial | #332 |
| mouse hepatitis virus | #333 |
| anticcp | #333 |
| 35ssulfate | #334 |
| joint tissues | #335 |
| susceptibility genes | #335 |
| mrl lpr mice | #335 |
| autoimmune inflammation | #336 |
| cell response | #338 |
| delayed onset | #340 |
| cells spleen | #340 |
| epitope specificity | #340 |
| adjuvants immunologic | #341 |
| erosive | #341 |
| rat | #341 |
| ros oxygen species | #341 |
| activation macrophages | #341 |
| incident cardiovascular events | #342 |
| specific autoimmune | #342 |
| 6weeks | #342 |
| animal enzyme inhibitors | #342 |
| rats injection | #343 |
| rapid spread | #343 |
| diabetic mouse | #343 |
| sequence animals | #343 |
| drb1 alleles | #343 |
| monoclonals | #344 |
| 182780 | #344 |
| favor | #345 |
| acpa positivity | #345 |
| energetic costs | #346 |
| intraperitoneal injection | #347 |
| pemphigus vulgaris pv | #348 |
| complement activity | #349 |
| neuritis | #349 |
| reduced capacity | #349 |
| igg autoantibodies | #350 |
| phenotype rats | #351 |
| methylcholanthrene | #352 |
| thymic selection | #352 |
| mice induction | #353 |
| c3h hej | #353 |
| anti cyclic | #353 |
| immunoregulation | #353 |
| mice cd4 | #354 |
| arthritis synovial | #354 |
| autoantigens autoimmune | #354 |
| splenic macrophages | #355 |
| dsg3 | #357 |
| tbetarii | #358 |
| cells autoantibodies | #358 |
| adjuvant activity | #358 |
| neuritogenic | #359 |
| injected | #359 |
| enos | #359 |
| tcrbeta | #360 |
| tlr3 | #361 |
| pvg | #361 |
| freund | #361 |
| hla transgenic | #362 |
| murine lupus | #362 |
| mouse chromosome | #363 |
| allergic encephalomyelitis | #363 |
| identification genes | #363 |
| determines | #363 |
| generation ros | #363 |
| cells anti | #364 |
| recognized | #364 |
| hladr4 | #364 |
| immune deviation | #366 |
| sex chromosomes | #366 |
| glycoproteins mice | #366 |
| european journal | #366 |
| psychosocial stress | #367 |
| antiidiotypic antibodies | #367 |
| ncf2 | #368 |
| toxic shock | #368 |
| affinity ligand | #368 |
| autoimmune responses | #368 |
| loci | #368 |
| 100 micrograms | #368 |
| histocompatibility antigens | #369 |
| pentameric | #369 |
| nasal administration | #369 |
| immune pathogenesis | #370 |
| increased production | #370 |
| regulate | #371 |
| serum transfer | #371 |
| clinical onset | #371 |
| newborn antibodies | #372 |
| role mif | #372 |
| alternative activation | #373 |
| autoantigens | #375 |
| rheumatoid cell | #375 |
| acutephase proteins | #376 |
| undifferentiated arthritis | #376 |
| glucose6 | #377 |
| gia | #379 |
| reparixin | #380 |
| induced lupus | #381 |
| mouse monoclonal antibody | #381 |
| oxidase deficiency | #381 |
| fragments immunoglobulin | #382 |
| fia | #382 |
| granulomatous | #383 |
| specific loci | #384 |
| naive rats | #384 |
| c1a | #384 |
| granulomatous disease | #384 |
| postmenopausal bone loss | #385 |
| shock syndrome | #385 |
| cell specificity | #386 |
| pc4 | #386 |
| ptpn22 gene | #387 |
| backcrosses | #387 |
| filaggrin | #387 |
| antioxid | #387 |
| inbred nod receptors | #388 |
| phase response | #388 |
| downregulating | #389 |
| ovulation rate | #390 |
| deficient | #390 |
| greater 50 | #390 |
| peptidylarginine | #391 |
| radiological progression | #391 |
| anaphylatoxin c5a | #391 |
| finetune | #392 |
| rf1 | #394 |
| il4 il10 | #394 |
| ameliorating | #395 |
| induced metabolic | #397 |
| draining | #397 |
| autoantibody levels | #397 |
| juvenile chronic arthritis | #398 |
| protein myelin | #399 |
| immunized mice | #399 |
| regulation animals | #399 |
| reactive oxygen species | #400 |
| inflammatory reactions | #400 |
| antibody formation | #401 |
| genes cells | #401 |
| immunopeptidome | #403 |
| inflammation demyelination | #403 |
| biacore | #403 |
| beta chain | #404 |
| fcγriib | #404 |
| experimental | #405 |
| basic protein | #405 |
| n31 | #407 |
| rheumatoid case | #407 |
| effects models | #407 |
| pam3csk4 | #408 |
| immunogenetics | #409 |
| major locus | #409 |
| diabetes loci | #410 |
| 3hproline | #410 |
| intracellular processing | #410 |
| hladrb1 | #412 |
| cd43 | #412 |
| cell phenotypes | #412 |
| titres | #413 |
| susceptibility loci | #413 |
| characteristic feature | #414 |
| reproductive performance | #414 |
| cultured collagen | #415 |
| igk | #415 |
| female mice | #416 |
| levels autoantibodies | #416 |
| spontaneous mutation | #417 |
| synovial inflammation | #417 |
| lupus mice | #417 |
| genetically modified mice | #418 |
| induced pain | #419 |
| class hdacs | #419 |
| wtccc | #419 |
| molecular interactions | #419 |
| ameliorate | #420 |
| hiit | #420 |
| tcell | #421 |
| dr4 | #422 |
| lower affinity | #422 |
| lipidomic | #423 |
| restricted | #424 |
| subsets animals | #424 |
| hyaline cartilage | #425 |
| congenic strain | #426 |
| regulatory animals | #426 |
| inflammatory cells | #426 |
| carbohydrate moiety | #429 |
| nonimmunogenic | #430 |
| postimmunization | #430 |
| epitopes humans | #430 |
| nod mouse | #430 |
| immunoregulatory | #431 |
| il10 mice | #433 |
| patients healthy individuals | #433 |
| cells antibodies | #434 |
| factor 5 | #435 |
| spontaneous autoimmune | #435 |
| reactivities | #436 |
| cells beta | #436 |
| crystallizable | #437 |
| mass spectrometric analysis | #437 |
| decalcified | #437 |
| chromosomes chromosome | #437 |
| immunised | #438 |
| specific antigens | #438 |
| mice effects | #438 |
| helperinducer tlymphocytes | #438 |
| cells | #439 |
| joint swelling | #439 |
| nod | #440 |
| wildtype mice | #440 |
| vitro techniques leukocytes | #441 |
| normal rats rats | #441 |
| effector functions | #441 |
| female immunoglobulin | #441 |
| mice activation | #442 |
| patients population | #442 |
| complete adjuvant | #442 |
| mhc class molecules | #443 |
| methylβcyclodextrin | #443 |
| myelin basic | #444 |
| tlr2 expression | #444 |
| systemic mice | #445 |
| skeletal muscle function | #445 |
| genomewide scan | #445 |
| mice humans | #445 |
| mouse models | #445 |
| ros production | #447 |
| control mice | #448 |
| inbred strains receptors | #448 |
| induced mice | #448 |
| pain model | #448 |
| complement factor | #449 |
| synovial tissue | #449 |
| tcell responses | #449 |
| innate adaptive | #450 |
| apcs | #451 |
| igg anti | #451 |
| heterologous | #452 |
| hybridoma cells | #452 |
| reduced production | #452 |
| differs | #454 |
| lglutamine | #456 |
| cells chronic | #456 |
| inbred c57bl tlymphocytes | #457 |
| raloxifene | #457 |
| resembling | #459 |
| priming | #459 |
| rheumatoid cells | #459 |
| lung macrophages | #459 |
| eae cns | #459 |
| antibodies monoclonal | #460 |
| neutrophil functions | #462 |
| autoantigen | #462 |
| 256 | #462 |
| gilt | #463 |
| fab fragments | #464 |
| autoantibody production | #465 |
| salivary glands | #466 |
| receptor tcr | #466 |
| cells lymph | #467 |
| earlier onset | #469 |
| titers | #469 |
| disease mice | #474 |
| arthritic rats | #474 |
| antibody mediated | #474 |
| anticyclic citrullinated peptide | #474 |
| cartilage cells | #475 |
| human autoimmune | #476 |
| mice exhibited | #477 |
| cluster genes | #477 |
| mediated inflammation | #478 |
| therapeutic vaccination | #478 |
| female hla | #479 |
| apoptosis arthritis | #479 |
| laboratory rat | #479 |
| deacetylase 1 | #480 |
| aggravated | #480 |
| quantitative trait loci | #480 |
| anti idiotypic | #482 |
| polymorphonuclear cells | #482 |
| immune reactions | #484 |
| immunologists | #485 |
| immunoglobulin male | #486 |
| oxyntic | #487 |
| controlling | #487 |
| tcralpha | #487 |
| jca | #487 |
| insulitis | #488 |
| invariant natural | #488 |
| specific immune | #488 |
| gland animals | #489 |
| normal mice | #490 |
| cytoplasmic calcium | #494 |
| nacetylglucosaminidase | #495 |
| gammadelta cells | #496 |
| early rheumatoid | #496 |
| conclude | #496 |
| reactive nitrogen | #496 |
| h2b | #496 |
| mbp | #498 |
| small effects | #498 |
| receptor 9 | #499 |
| biologicals | #500 |
| autoreactive cd4 | #503 |
| nadph | #503 |
| immunoenzyme techniques | #503 |
| pathogenic | #506 |
| chondrocytes collagen | #507 |
| immunofluorescence analysis | #507 |
| persistent pain | #508 |
| mab mabs | #508 |
| mineral oil | #508 |
| isopropyl | #508 |
| immunization passive | #509 |
| gingipain | #509 |
| orosomucoid | #509 |
| mice knockout mice | #510 |
| mhc class | #510 |
| differential gene | #511 |
| deficient mice | #511 |
| c3h hej mice | #511 |
| systemic spread | #511 |
| 812 | #511 |
| blymphocytes | #512 |
| mrp8 | #515 |
| behavioral alterations | #517 |
| hydroxyquinolines | #517 |
| antibody complex | #518 |
| u1 | #518 |
| chronic granulomatous disease | #519 |
| inflammation | #519 |
| suggestive linkage | #519 |
| tcr recognition | #520 |
| modified form | #521 |
| ttg | #522 |
| dextran sulfate sodium | #522 |
| pcorr | #522 |
| inflammation role | #523 |
| data peptide | #523 |
| p47phox | #524 |
| litter size | #524 |
| encephalitogenic | #524 |
| neutrophil granulocytes | #525 |
| tconv | #526 |
| mechanical hypersensitivity | #526 |
| mnc | #526 |
| maternal antibodies | #527 |
| spleen cells | #527 |
| disease acute | #527 |
| larsen | #528 |
| tolonium | #528 |
| vaccinates | #528 |
| primed | #528 |
| ifa | #529 |
| displayed | #529 |
| tolllike receptor tlr4 | #529 |
| rat rats | #529 |
| cell antibodies | #530 |
| isac | #530 |
| pathogenesis sle | #530 |
| antigen presentation | #530 |
| autoantibody | #530 |
| ratg | #531 |
| epistatic | #532 |
| bred | #532 |
| complex role | #533 |
| lyt2 | #533 |
| posttranslational receptors | #534 |
| translational modification | #536 |
| resorptions | #536 |
| spleen lymphocytes | #536 |
| urokinase | #537 |
| synovial | #537 |
| animals | #538 |
| cells inflammatory | #538 |
| experimental rats | #538 |
| antigen recognition | #540 |
| fibroblast synoviocytes | #540 |
| suppressive | #540 |
| joints | #540 |
| membrane attack complex | #541 |
| rheumatoid humans | #543 |
| specific autoantibodies | #544 |
| protein tyrosine phosphatase | #545 |
| regulating | #545 |
| hypomorphic | #546 |
| shortcut | #547 |
| animal gene | #547 |
| tlymphocytes | #547 |
| immunohistochemical methods | #548 |
| entheses | #548 |
| formyl peptide receptors | #548 |
| mog | #550 |
| immunoglobulin fab | #552 |
| mixed lymphocyte reaction | #553 |
| nox activity | #554 |
| breeder | #555 |
| cell epitopes | #557 |
| stronger association | #557 |
| beta animals | #557 |
| cells control | #558 |
| early onset | #559 |
| healthy mice | #560 |
| elispot assay | #561 |
| transgenic molecular | #562 |
| inbred strains | #563 |
| negative selection | #563 |
| ptdins3p | #563 |
| neutrophil depletion | #564 |
| deeper layers | #565 |
| therapeutic treatment | #565 |
| target tissue | #566 |
| earlier | #566 |
| immunoglobulin heavy chains | #566 |
| darkness | #566 |
| crucial | #567 |
| interferon signature | #568 |
| outbred | #568 |
| disease loci | #568 |
| cells pathogenesis | #569 |
| neutrophilia | #569 |
| mycobacteria | #569 |
| concomitantly | #570 |
| mice compared | #571 |
| btla | #572 |
| transgenic mouse models | #572 |
| keratin8 | #573 |
| col2 | #574 |
| pepstatins | #576 |
| presenting | #576 |
| terpenes | #577 |
| estrogen treatment | #577 |
| prolactin prl | #578 |
| keratinocyte growth factor | #578 |
| sera patients | #579 |
| ptm | #579 |
| triple helix | #580 |
| methotrexate mice | #581 |
| f1 hybrids | #581 |
| hybridoma | #583 |
| inflammatory joint | #583 |
| production ifngamma | #583 |
| exaggerated | #584 |
| time onset | #584 |
| lymphocyte antigens | #584 |
| antibody reactions | #585 |
| traps nets | #590 |
| antigen antibody | #591 |
| environmental triggers | #591 |
| oligoclonal | #592 |
| lxrα | #592 |
| immunological tolerance | #592 |
| transgenic models | #593 |
| noncollagenous | #593 |
| adaptive immunity | #594 |
| macrophages | #594 |
| autoimmune disorders | #594 |
| clonal expansion | #595 |
| multiplexing | #595 |
| th1 cytokines | #595 |
| xanthine oxidoreductase | #596 |
| tcell activation | #599 |
| cells study | #599 |
| develop | #600 |
| spite | #602 |
| th2 cytokines | #602 |
| augmented | #602 |
| n85 | #602 |
| mouse monoclonal | #603 |
| common diseases | #603 |
| pemphigus vulgaris | #603 |
| cells involved | #604 |
| cells male | #604 |
| phagosomal | #604 |
| oxa | #606 |
| mice inbred | #606 |
| animal rats | #606 |
| class humans | #607 |
| frozen sections | #608 |
| genotype hla | #608 |
| spleen animals | #609 |
| inefficiently | #610 |
| regulatory role | #610 |
| naive | #611 |
| production ifn | #611 |
| positive individuals | #612 |
| quantitative trait locus | #615 |
| acetophenones | #616 |
| autoantibodies | #616 |
| exponential phase | #616 |
| class antigens | #616 |
| alpha chains | #616 |
| th1 type | #616 |
| idiotypic | #616 |
| mutant strains receptors | #616 |
| nonobese | #617 |
| oral immunization | #617 |
| beta type | #618 |
| day mice | #619 |
| wistar restraint | #620 |
| promiscuous | #620 |
| consequent | #621 |
| inflammatory role | #621 |
| receptor 3 | #621 |
| nicotinamide adenine | #622 |
| receptors antigen | #624 |
| fluorine18 | #624 |
| loci identified | #625 |
| chronic stage | #625 |
| cytoplasmic ca2 | #628 |
| animal mice | #628 |
| local injection | #629 |
| cross reactions | #630 |
| inflammatory disease | #630 |
| reactive antibodies | #632 |
| healthy rats | #632 |
| development eae | #633 |
| fibromodulin | #634 |
| highintensity interval training | #634 |
| langerhans cells | #635 |
| vivo binding | #635 |
| nabs | #637 |
| ifn beta | #637 |
| cells inhibition | #638 |
| class genes | #638 |
| estrogens female | #640 |
| inflammation autoimmunity | #640 |
| biotinylated | #643 |
| mouse lung | #644 |
| cell binding | #645 |
| immune serum | #646 |
| haplotype | #649 |
| patients sera | #650 |
| antigen specificity | #650 |
| genetic disease | #652 |
| hexadecane | #654 |
| idiotypic antibodies | #654 |
| interphalangeal | #655 |
| antibody titres | #655 |
| new pathway | #658 |
| genetic linkage | #658 |
| axotomized | #659 |
| cyba | #660 |
| sialoprotein | #660 |
| peptide binding | #661 |
| acute inflammation | #661 |
| inbred cba mice | #661 |
| mutated | #662 |
| cartilage destruction | #663 |
| ifng | #664 |
| delayed hypersensitivity | #665 |
| animal ear | #665 |
| receptors igg | #666 |
| superantigens | #666 |
| reactive | #666 |
| lymphoid organs | #666 |
| 264 | #666 |
| activation mice | #669 |
| drb1 | #670 |
| apeced | #670 |
| disease autoimmune | #671 |
| purified proteins | #673 |
| cells induce | #674 |
| treatment protocol | #674 |
| genetic epistasis | #675 |
| pyramidal neurons | #675 |
| desmoglein | #675 |
| strikingly | #676 |
| idiotypes | #677 |
| germinal center | #677 |
| adherent cells | #677 |
| china cohort | #678 |
| major genes | #679 |
| igg response | #679 |
| il12p70 | #679 |
| thelper | #680 |
| cells role | #682 |
| lymphocytes mice | #682 |
| puzzle | #683 |
| inbred c57bl mice | #683 |
| normal animals | #683 |
| specific antibody | #684 |
| helper cell | #684 |
| intradermal injection | #686 |
| transgenic receptors | #687 |
| βarrestin | #688 |
| subsets | #689 |
| delayed | #689 |
| foot joints | #689 |
| early rheumatoid arthritis | #690 |
| rendered | #690 |
| production autoantibodies | #691 |
| disease genes | #692 |
| muscle glucose | #695 |
| knockout polymorphism | #695 |
| igg antibodies | #696 |
| paam | #696 |
| luminex | #697 |
| anas | #697 |
| mice model | #698 |
| disease hla | #698 |
| uterus | #700 |
| heavy chain genes | #701 |
| microspectroscopy | #703 |
| inbred | #704 |
| quantitative trait | #704 |
| complete freund | #706 |
| fibroblastlike synoviocytes | #707 |
| histopathological analysis | #707 |
| extracellular trap | #708 |
| estradiol female | #710 |
| specific cells | #710 |
| igl | #712 |
| posttranslational | #713 |
| spleens | #716 |
| predetermined | #716 |
| mice lacking | #717 |
| antibodies patients | #718 |
| acute bout | #718 |
| lymphocyte depletion | #719 |
| proliferative response | #720 |
| regulatory function | #720 |
| buf | #721 |
| deficiency syndromes | #721 |
| surrounding tissues | #722 |
| th1 th17 | #723 |
| macrophages mice mice | #725 |
| human hand | #725 |
| cd1d | #728 |
| dmaema | #728 |
| th2 cytokine | #729 |
| ccps | #729 |
| mhc molecules | #729 |
| cdk6 | #730 |
| cholesterol metabolism | #732 |
| animals antigens antigens | #732 |
| administrated | #732 |
| cns inflammation | #732 |
| excessive inflammation | #734 |
| finding | #735 |
| net formation | #736 |
| rats treatment | #736 |
| locus | #737 |
| cheeks | #739 |
| operates | #740 |
| c57bl | #740 |
| cd5 cells | #741 |
| species specificity | #741 |
| nkt | #742 |
| tissue destruction | #742 |
| immunologic deficiency | #743 |
| vivo mice | #743 |
| cell responses | #743 |
| treatment anti | #744 |
| role disease | #746 |
| mycobacterial infections | #747 |
| intensity interval | #749 |
| autoantibodies autoimmunity | #749 |
| keratinocyte | #749 |
| nonobese diabetic mice | #749 |
| preclinical phase | #751 |
| transferred | #751 |
| control disease | #753 |
| tlr activation | #755 |
| ere | #755 |
| metabolomic | #755 |
| hapten | #755 |
| mice anti | #757 |
| phenotypic differences | #758 |
| disease protection | #758 |
| autoantibodies type | #758 |
| hyperinflammatory | #759 |
| reacted | #759 |
| knockout tlymphocytes | #760 |
| linkage region | #760 |
| ifngamma production | #761 |
| ccp | #761 |
| polycytidylic | #762 |
| immunocap | #763 |
| gamma ifn | #765 |
| glut4 translocation | #767 |
| periarticular | #772 |
| hkexchanging | #773 |
| redox signal | #773 |
| cells apcs | #773 |
| peripheral tolerance | #774 |
| afflicted | #777 |
| fab fragment | #778 |
| diseases cell | #778 |
| interacted | #779 |
| inbred nzb | #780 |
| acid transporters | #781 |
| pathogenic role | #782 |
| nox1 | #782 |
| arthritis osteoarthritis | #782 |
| development autoimmunity | #782 |
| arthritis psa | #783 |
| chronic colitis | #784 |
| clinical scores | #786 |
| transgenic mutation | #789 |
| peptide fragments | #790 |
| inflammatory lesions | #790 |
| transgenic receptors antigen | #790 |
| reduced incidence | #790 |
| pineal gland | #791 |
| polyarthritis | #792 |
| cell gamma | #793 |
| antibodies directed | #794 |
| cell humans | #794 |
| interval training | #796 |
| neutrophil function | #796 |
| neutrophil extracellular | #796 |
| pathogen free | #797 |
| genes immunoglobulin | #798 |
| lymphocyte proliferation | #798 |
| carbohydrate moieties | #800 |
| matrix proteins | #801 |
| polyi | #801 |
| innate adaptive immunity | #802 |
| thy1 | #802 |
| monoclonal binding | #802 |
| blymphocyte chain genes | #802 |
| redox control | #805 |
| induces | #805 |
| helper cells | #805 |
| count male | #805 |
| multinucleated giant cells | #808 |
| backcrossing | #809 |
| bone erosion | #810 |
| function mutation | #811 |
| catabolism | #811 |
| strains receptors | #812 |
| resident cells | #812 |
| acc1 | #812 |
| febuxostat | #813 |
| nonreceptor type | #815 |
| ctb | #817 |
| arginines | #817 |
| leads | #820 |
| auricle | #820 |
| cd8 antigens | #821 |
| collagen cross | #821 |
| leukocyte infiltration | #822 |
| piece | #823 |
| humoral immune response | #824 |
| colocalizes | #824 |
| electroporated | #824 |
| prominently | #825 |
| genetic environmental | #825 |
| psoriasis psoriatic arthritis | #825 |
| muscle training | #826 |
| response animals | #826 |
| chondroid | #827 |
| class antigen | #829 |
| growth factor beta | #829 |
| producing | #830 |
| effects immune | #830 |
| cross reactivity | #834 |
| lpr | #841 |
| inbred c57bl | #841 |
| peyers patches | #842 |
| immunoglobulin mice | #842 |
| diabetic nod | #844 |
| therapeutic approaches | #844 |
| il25 | #845 |
| chronic active | #845 |
| mice transgenic | #846 |
| inflammatory arthritis | #846 |
| induce | #848 |
| intermingled | #850 |
| macroscopically | #851 |
| lymphocyte | #852 |
| antigen cell | #852 |
| new possibilities | #854 |
| leukocyte migration | #854 |
| ms275 | #855 |
| tcell receptors antigen | #855 |
| strongest association | #856 |
| alveolar mice mice | #856 |
| importantly | #856 |
| mcv | #858 |
| post translational | #861 |
| immune defence | #862 |
| treatment reduced | #865 |
| lyme | #866 |
| mediated inflammatory | #867 |
| mice reduced | #867 |
| knockin mice | #867 |
| factor anti | #867 |
| strongest | #868 |
| cross reactive | #868 |
| hinge region | #869 |
| parietal cells | #869 |
| lentiviral | #869 |
| lnc | #872 |
| immune tolerance | #873 |
| dextran sulfate | #873 |
| parasitemia | #874 |
| lower expression | #874 |
| elisas | #875 |
| cells expressing | #876 |
| granulomas | #877 |
| fcγri | #878 |
| synovial fluid patients | #878 |
| arthritis inflammatory | #879 |
| antigen4 | #881 |
| adoptive | #881 |
| systemic autoimmune diseases | #882 |
| pregnancy animal | #882 |
| testosterone treatment | #883 |
| fluid synovial | #884 |
| cartilaginous | #888 |
| standard therapies | #890 |
| psoriasis vulgaris | #891 |
| genetic dissection | #891 |
| basic | #893 |
| regulator | #895 |
| completely | #896 |
| intranasal administration | #897 |
| inflammation mediators | #897 |
| ctla4 antigen | #898 |
| interleukin1alpha | #898 |
| phosphatase receptor | #902 |
| partly | #904 |
| granulocytes | #904 |
| inception cohort | #905 |
| infiltrations | #906 |
| γδ cells | #906 |
| rats inbred | #907 |
| lipocalins | #908 |
| extracellular traps | #909 |
| immunohistochemical analyses | #910 |
| immunoglobulin levels | #911 |
| single injection | #911 |
| liu | #911 |
| chromosome 16 | #912 |
| mitochondrial ros | #913 |
| lectin pathway | #913 |
| ciita | #914 |
| pneumonitis | #914 |
| proliferate | #915 |
| enolase | #915 |
| allelic variation | #915 |
| immunemediated diseases | #916 |
| cytokine response | #923 |
| psoriatic arthritis psa | #924 |
| neutrophil chemotaxis | #924 |
| antibodies antibody | #924 |
| fluorobenzene | #925 |
| cd200 | #925 |
| chromosome mapping | #925 |
| nkt cells | #926 |
| phenotypic analysis | #926 |
| repertoires | #929 |
| burst | #930 |
| tissue transglutaminase | #931 |
| data role | #932 |
| hydratase | #933 |
| citrulline | #933 |
| alpha animals | #935 |
| macropinocytosis | #936 |
| alters | #937 |
| arthritides | #938 |
| lymphocyte activation | #938 |
| 1040 | #939 |
| synovia | #939 |
| immune reactivity | #940 |
| rns | #940 |
| analysed | #940 |
| disease model | #941 |
| collagen structure | #941 |
| genetic analysis | #941 |
| vitro stimulation | #941 |
| mediated autoimmune | #944 |
| sciatic nerves | #945 |
| association hla | #945 |
| mice mice | #947 |
| inflammatory pathways | #948 |
| fluid patients | #948 |
| clinical observations | #948 |
| humanized mice | #949 |
| riii | #950 |
| vivo | #950 |
| l3t4 | #954 |
| environmental determinants | #955 |
| nos1 | #957 |
| carrying | #958 |
| differentiation tlymphocyte antigens | #959 |
| levels ros | #962 |
| mhc peptide | #962 |
| chronic disease | #963 |
| cellular immunization | #965 |
| cells lymphocytes | #967 |
| animals cytokines | #967 |
| monoclonal antigens | #967 |
| cytotoxic tlymphocytes | #967 |
| cell transfer | #969 |
| lower frequency | #969 |
| chromosome 15 | #971 |
| draining lymph nodes | #972 |
| secreting cells | #973 |
| susceptibility locus | #978 |
| cartilage articular | #979 |
| synovial membrane | #981 |
| genes chromosome | #982 |
| lymphocytes | #982 |
| w5 | #982 |
| binding peptides | #983 |
| pain behavior | #984 |
| tbb | #987 |
| tallele | #988 |
| microspectrophotometry | #990 |
| macrophages cells | #991 |
| knockout models | #991 |
| allergic contact dermatitis | #992 |
| immunodominance | #992 |
| cells reactive | #993 |
| patients rp | #994 |
| transgenic expression | #994 |
| 510 | #994 |
| cartilage bone | #995 |
| hej | #995 |
| formyl peptide | #997 |
| spontaneously | #997 |
| knee joints | #997 |
| laminin fibronectin | #998 |
| antigen expression | #999 |
| immunoglobulin fragments | #1000 |
| lymphocyte subpopulations | #1002 |
| multiple loci | #1003 |
| processing presentation | #1004 |
| expands | #1004 |
| aggravate | #1004 |
| protective role | #1007 |
| igg subclasses | #1011 |
| nrc | #1012 |
| cyclic peptides | #1012 |
| 95 stroke | #1013 |
| interleukin21 | #1013 |
| model multiple | #1015 |
| direct comparison | #1015 |
| igg | #1015 |
| cellular composition | #1016 |
| cells mast | #1016 |
| nerve roots | #1016 |
| aged arthritis | #1017 |
| patients early | #1019 |
| melatonin levels | #1019 |
| cd4 antigens | #1020 |
| immunoglobulin variable | #1022 |
| cysteine protease | #1025 |
| diseases animals | #1026 |
| genetic humans | #1027 |
| innate killer cells | #1028 |
| il4 | #1029 |
| baseline 24 months | #1031 |
| dr1 | #1031 |
| mice treated | #1032 |
| oxidase | #1034 |
| major regulator | #1036 |
| species production | #1039 |
| tramp | #1040 |
| arthritis psoriatic | #1041 |
| expression mrna | #1042 |
| complementary genes | #1043 |
| das28 | #1045 |
| parental strain | #1050 |
| myelin proteins | #1050 |
| patients rheumatoid | #1051 |
| chromosome 5 | #1052 |
| gamma delta | #1055 |
| inflammatory macrophages | #1055 |
| antigens differentiation | #1056 |
| immune defense | #1056 |
| mannans | #1057 |
| rat cells | #1060 |
| sterile inflammation | #1062 |
| lymphocytes cells | #1062 |
| morula | #1062 |
| transgenic | #1063 |
| tarsus | #1066 |
| disease humans polymorphism | #1069 |
| role immune | #1069 |
| oxazoles | #1069 |
| decidua | #1069 |
| synovial fluids | #1071 |
| transgenic cells | #1075 |
| fcγ | #1076 |
| radiological | #1077 |
| peptidylarginine deiminase | #1078 |
| epistasis | #1079 |
| key steps | #1080 |
| adjuvant cfa | #1080 |
| lymphoid cells | #1082 |
| reestablishment | #1082 |
| irf1 | #1086 |
| dependent regulation | #1087 |
| al2 | #1088 |
| haplotypes | #1089 |
| uppsala | #1089 |
| enlarged | #1091 |
| inflamed | #1092 |
| osteoclast formation | #1093 |
| 7 weeks | #1096 |
| oligodendrocyte | #1098 |
| inkt cells | #1102 |
| igs | #1103 |
| effector mechanisms | #1104 |
| cells increased | #1105 |
| arginine deiminase | #1114 |
| molecular mimicry | #1115 |
| fibril | #1115 |
| subdominant | #1115 |
| clinical disease | #1116 |
| sclerosis myelin | #1116 |
| cd5 | #1117 |
| disulfide | #1117 |
| deamidation | #1117 |
| animal immunity | #1117 |
| genetic factors | #1117 |
| antitoxin | #1117 |
| antigenic peptides | #1118 |
| pil | #1121 |
| lymphocytes regulatory | #1123 |
| recognizing | #1126 |
| primary immunodeficiency | #1127 |
| predisposing | #1128 |
| foreign antigens | #1128 |
| isomerase | #1128 |
| cells ifn | #1128 |
| humans lymphocyte | #1128 |
| dissected | #1130 |
| treatment day | #1132 |
| skeletal muscle fibers | #1132 |
| superantigen | #1134 |
| immune response | #1135 |
| cryosections | #1135 |
| overlapped | #1136 |
| glucosyl | #1136 |
| vivo administration | #1136 |
| c57 | #1137 |
| peptide sequence | #1138 |
| underline | #1138 |
| editorial | #1139 |
| anticardiolipin antibodies | #1139 |
| cd4foxp3 | #1142 |
| mice rats | #1146 |
| syntenic | #1147 |
| treatment animals | #1149 |
| helpers | #1149 |
| agonist | #1150 |
| cd4 cells | #1151 |
| subcloned | #1155 |
| disease onset | #1157 |
| antibody affinity | #1160 |
| lxr | #1161 |
| inactivating | #1161 |
| respiratory burst | #1163 |
| prolactin rats | #1164 |
| stainings | #1168 |
| demonstrating | #1168 |
| increased severity | #1170 |
| activated cells | #1171 |
| transduction toll | #1174 |
| gp91phox | #1175 |
| nadph oxidoreductases | #1176 |
| inflamed tissues | #1178 |
| models disease | #1178 |
| 10b | #1179 |
| recombinant interferon | #1180 |
| preponderance | #1180 |
| genetic background | #1181 |
| destructive | #1182 |
| chemiluminescent | #1182 |
| arginine residues | #1184 |
| disease haplotypes humans | #1186 |
| objective investigate | #1186 |
| lymphocytes cell | #1188 |
| synovial fibroblasts | #1188 |
| human type | #1190 |
| ileitis | #1191 |
| rat human | #1192 |
| splenic cells | #1192 |
| antiphospholipid | #1193 |
| infiltrates | #1195 |
| primary sjögrens syndrome | #1195 |
| cells rheumatoid | #1199 |
| antibodies mabs | #1200 |
| basic mechanisms | #1200 |
| susceptibility | #1200 |
| antibody | #1200 |
| somatically | #1201 |
| lung mice mice | #1204 |
| protein arginine | #1208 |
| identified loci | #1210 |
| h2k | #1211 |
| predisposition disease | #1212 |
| onset progression | #1212 |
| c5a | #1213 |
| rationales | #1214 |
| singlecell | #1214 |
| hdacs | #1217 |
| critical issues | #1218 |
| chronic inflammation | #1218 |
| igg subclass | #1220 |
| ilc2 | #1221 |
| mononuclear | #1223 |
| compared wt | #1223 |
| adaptive immune response | #1223 |
| subcellular fractionation | #1224 |
| adaptive immune responses | #1225 |
| tlymphocyte antigens | #1226 |
| chromosome 4 | #1227 |
| linkage analysis | #1229 |
| antimicrobial peptides amps | #1229 |
| analyse | #1230 |
| experimental models | #1231 |
| therapeutically | #1232 |
| subsets lymphocytes | #1233 |
| aps | #1233 |
| host defense | #1238 |
| immunological mechanisms | #1240 |
| human cd4 | #1241 |
| cell lymphocytes | #1244 |
| indel | #1247 |
| mouse | #1250 |
| immune inflammatory | #1251 |
| lining | #1252 |
| animal | #1253 |
| ltb | #1253 |
| dead cells | #1254 |
| animal doseresponse relationship | #1259 |
| mesenteric lymph nodes | #1263 |
| differentiation lymphocyte | #1263 |
| antigen presenting cells | #1264 |
| synovium | #1265 |
| pathogenic mechanisms | #1266 |
| adenine dinucleotide | #1269 |
| suppress | #1269 |
| rheumatoid arthritis patients | #1270 |
| suppressive function | #1270 |
| molecular pathogenesis | #1270 |
| synovial fluid | #1271 |
| rat mouse | #1273 |
| claudin4 | #1274 |
| eae model | #1274 |
| chromosomal regions | #1275 |
| rats mice | #1275 |
| inducer | #1279 |
| rattus norvegicus | #1282 |
| becn1 | #1282 |
| hla molecules | #1283 |
| staphylococcal | #1283 |
| c4a | #1283 |
| rodent models | #1284 |
| spreading | #1286 |
| joint destruction | #1287 |
| attacked | #1288 |
| disease response | #1290 |
| pathological processes | #1294 |
| immunochip | #1295 |
| suppressor cells | #1296 |
| serm | #1297 |
| day pregnancy | #1297 |
| peripheral cells | #1297 |
| production anti | #1299 |
| nadph oxidase activity | #1299 |
| publication animals antigens | #1300 |
| data protein | #1300 |
| restimulation | #1305 |
| model experimental | #1307 |
| hdac3 | #1307 |
| peptide library | #1309 |
| ali | #1310 |
| social isolation | #1310 |
| fab2 | #1312 |
| phagocytic cells | #1313 |
| generated | #1313 |
| introgressed | #1314 |
| permissive | #1315 |
| lymphoproliferation | #1315 |
| detailed characterization | #1316 |
| increased susceptibility | #1316 |
| immune | #1316 |
| protects | #1319 |
| estradiol treatment | #1320 |
| immunoglobulin isotypes | #1321 |
| hydrolyzes | #1321 |
| healthy human subjects | #1322 |
| intrathymic | #1322 |
| phagocytes | #1322 |
| submandibular | #1323 |
| collagen types | #1323 |
| aureus infections | #1325 |
| valuable tool | #1327 |
| acute phase proteins | #1327 |
| therapeutic antibodies | #1328 |
| dietary nitrate | #1329 |
| human igg | #1330 |
| receptor 2 | #1330 |
| immunological memory | #1332 |
| pockets | #1333 |
| thymectomy | #1335 |
| identically | #1335 |
| rats rats | #1336 |
| new therapies | #1336 |
| acute phase response | #1338 |
| induction phase | #1341 |
| cells mice | #1341 |
| adjuvants | #1344 |
| increasing evidence | #1348 |
| knockout mutation | #1349 |
| promiscuity | #1350 |
| galactosylceramides | #1356 |
| allergic contact | #1359 |
| elimination | #1361 |
| position | #1361 |
| alp | #1361 |
| regulatory genes | #1362 |
| believed | #1364 |
| disease activity score | #1364 |
| n44 | #1366 |
| hypersensitivity | #1367 |
| 590 | #1368 |
| bacterial arthritis | #1372 |
| ameliorates | #1374 |
| betad | #1375 |
| membrane glycoproteins | #1375 |
| trait | #1375 |
| shared | #1375 |
| rat spinal cord | #1379 |
| il1r | #1381 |
| immunogen | #1383 |
| abrogates | #1383 |
| surface cells | #1384 |
| exacerbation | #1388 |
| rats humans | #1388 |
| suffer | #1389 |
| variable region | #1389 |
| clinical signs | #1390 |
| regulatory treg | #1390 |
| cd2 | #1390 |
| squalene | #1392 |
| human patients | #1392 |
| feto | #1393 |
| phage display | #1393 |
| cd4cd8 | #1394 |
| effects rats | #1396 |
| inbred mice | #1397 |
| disease outcomes | #1397 |
| positional | #1399 |
| submandibular glands | #1400 |
| early patients | #1403 |
| joint disease | #1403 |
| mononuclear phagocytes | #1406 |
| linkage genetic | #1409 |
| disease phenotypes | #1412 |
| animals disease | #1413 |
| antigens humans | #1415 |
| enzymelinked immunosorbent | #1416 |
| activation neutrophils | #1417 |
| humans immune | #1417 |
| cytokine profile | #1424 |
| class switching | #1425 |
| bacterial infections | #1431 |
| genetic heterogeneity | #1436 |
| gene usage | #1438 |
| stages disease | #1439 |
| cells type | #1440 |
| peptide | #1441 |
| guillainbarré syndrome | #1451 |
| arthritis systemic | #1453 |
| inbred strains mice | #1454 |
| cell activation | #1458 |
| alpha1 | #1458 |
| monoclonal | #1460 |
| proinflammatory responses | #1461 |
| knockout rats | #1461 |
| expression genetic | #1462 |
| lupus | #1464 |
| salt concentrations | #1465 |
| ccr6 | #1467 |
| pfp | #1467 |
| opens | #1467 |
| cell origin | #1468 |
| inflammatory properties | #1469 |
| cells pregnancy | #1472 |
| activation status | #1473 |
| cartilage cell | #1474 |
| immune deficiency | #1474 |
| muscle muscle | #1476 |
| cells activated | #1478 |
| allelic variants | #1479 |
| allotype | #1480 |
| responses animals | #1482 |
| specific gene | #1482 |
| blisters | #1483 |
| markers genetic | #1483 |
| inflammatory diseases | #1486 |
| cells lung | #1486 |
| initiate | #1486 |
| genetic regulation | #1486 |
| stroke 95 | #1487 |
| hormone release | #1489 |
| host defence | #1489 |
| donated | #1490 |
| inbred rats | #1491 |
| mice day | #1491 |
| human cartilage | #1491 |
| humoral immune | #1497 |
| emphysematous | #1499 |
| myelin | #1499 |
| treatment inflammatory | #1504 |
| regulatory effects | #1504 |
| monocytes neutrophils | #1504 |
| specific monoclonal | #1505 |
| vivo vitro | #1505 |
| eluate | #1507 |
| joint arthritis | #1507 |
| mimicking | #1507 |
| fls | #1508 |
| mapped | #1509 |
| inflammatory cell | #1510 |
| hindlimbs | #1511 |
| chromosome 6 | #1512 |
| stimulates | #1515 |
| egfp | #1516 |
| induced ali | #1520 |
| human leukocyte antigen | #1524 |
| earlier studies | #1525 |
| lia | #1525 |
| genes dominant | #1528 |
| knockout mitochondria | #1530 |
| sex steroids | #1531 |
| streptococcus pyogenes | #1533 |
| glutamic acid | #1535 |
| malaise | #1536 |
| lysines | #1537 |
| downregulate | #1540 |
| net release | #1545 |
| protein rna | #1546 |
| production macrophages | #1547 |
| unexpectedly | #1547 |
| increased numbers | #1548 |
| acetylglucosaminidase | #1549 |
| chronic phase | #1554 |
| higher level | #1555 |
| mediated diseases | #1559 |
| intraperitoneally | #1560 |
| 4 humans | #1563 |
| neuroimmunomodulation | #1563 |
| copy variations | #1563 |
| activate | #1564 |
| intradermal | #1565 |
| vsg | #1566 |
| guerin | #1567 |
| matrix components | #1567 |
| mammalian embryo | #1568 |
| immunoglobulin humans | #1568 |
| formyl | #1569 |
| sufficient | #1573 |
| pineal | #1574 |
| cytotoxic lymphocyte | #1574 |
| independent | #1577 |
| cochran | #1577 |
| cathelicidin | #1578 |
| glycolipid | #1580 |
| collagens | #1585 |
| fab | #1592 |
| mac1 | #1593 |
| factor beta | #1597 |
| directed | #1597 |
| conserved | #1597 |
| defines | #1598 |
| cell mediated | #1600 |
| twins | #1600 |
| adoptive transfer | #1600 |
| f1 | #1600 |
| reactive nitrogen species | #1603 |
| autoantibodies biomarkers | #1604 |
| cell receptor | #1605 |
| estriol | #1607 |
| cells th17 | #1607 |
| helical | #1611 |
| stromal cells | #1615 |
| chondrocyte | #1616 |
| chronic inflammatory diseases | #1617 |
| immunity animals | #1617 |
| isosteric | #1619 |
| autoimmune diabetes | #1621 |
| c57bl 6 | #1622 |
| humans immunoglobulin | #1622 |
| anaphylatoxin | #1622 |
| differently | #1625 |
| unreactive | #1626 |
| antigen | #1626 |
| rat spinal | #1629 |
| iggs | #1630 |
| complement component | #1632 |
| c3b | #1635 |
| immunohistology | #1635 |
| lund | #1639 |
| collagen fibers | #1639 |
| type interferon | #1641 |
| mice increased | #1642 |
| p6 | #1644 |
| abrogated | #1644 |
| c4b | #1645 |
| aspartic acid | #1647 |
| intracellular ros | #1651 |
| sjl | #1652 |
| opsonization | #1653 |
| complement activation | #1657 |
| linked | #1658 |
| defence | #1658 |
| commonly | #1660 |
| complement receptors | #1660 |
| transporter type | #1661 |
| immune complexes | #1661 |
| staphylococcal enterotoxin | #1661 |
| enterotoxins | #1662 |
| mice knockout | #1664 |
| tcell receptors | #1665 |
| salt intake | #1668 |
| tumor vasculature | #1669 |
| coincided | #1670 |
| primary sjögren | #1671 |
| isopropylacrylamide | #1672 |
| pathogenic cells | #1673 |
| immunologic epitopes | #1673 |
| gamma production | #1678 |
| single nucleotide | #1683 |
| complement c5a | #1686 |
| cd206 | #1686 |
| cocktail | #1689 |
| auto | #1689 |
| igm antibodies | #1691 |
| method analysis | #1693 |
| agouti | #1694 |
| ido1 | #1694 |
| classical pathway | #1696 |
| transgenic mice | #1696 |
| severity | #1701 |
| animals autoantigens | #1704 |
| precede | #1704 |
| triple | #1704 |
| 5 months | #1704 |
| suppressors | #1706 |
| encoded | #1707 |
| disulfiram | #1711 |
| treg cells | #1711 |
| beta chains | #1712 |
| erosions | #1712 |
| mice neutrophils | #1714 |
| sjögrens syndrome | #1719 |
| ankylosis | #1719 |
| evoke | #1720 |
| pulmonary aspergillosis | #1721 |
| tolerance | #1721 |
| skewing | #1725 |
| oophorectomy | #1727 |
| showing | #1728 |
| myelin proteolipid | #1729 |
| mutant mice | #1729 |
| drug targets | #1732 |
| 369 | #1734 |
| immune responses | #1734 |
| analysis protein | #1734 |
| staphylococcal infections | #1736 |
| phagocytic | #1737 |
| sicca | #1737 |
| fmoc | #1739 |
| intranasally | #1740 |
| arthritis patients | #1742 |
| affinity binding | #1743 |
| 626 | #1744 |
| prophylactic treatment | #1744 |
| cd11 | #1745 |
| osteoclasts | #1746 |
| alternative pathway | #1748 |
| strain mice | #1748 |
| zap70 | #1748 |
| new loci | #1749 |
| responded | #1750 |
| neoplastic disease models | #1753 |
| peroxide | #1758 |
| infiltrating | #1762 |
| endoglycosidase | #1764 |
| inhibitory receptors | #1766 |
| dr2 | #1766 |
| higher frequency | #1770 |
| triggering | #1770 |
| multiple genes | #1770 |
| glycosylation | #1774 |
| peptide antigens | #1775 |
| operate | #1776 |
| blocking | #1781 |
| adoptively | #1782 |
| cnbr | #1783 |
| ll37 | #1784 |
| articular cell | #1784 |
| local administration | #1788 |
| immunohistological | #1789 |
| compartmentalized | #1791 |
| carbohydrates | #1792 |
| pathogenesis | #1793 |
| dogma | #1794 |
| render | #1794 |
| competed | #1797 |
| immune recognition | #1800 |
| disease pathogenesis | #1801 |
| polymorphism genetic | #1801 |
| rat models | #1802 |
| cd19 antigens | #1803 |
| rechallenge | #1803 |
| peyer | #1804 |
| obese diabetic | #1805 |
| aureus infection | #1808 |
| immunogenic | #1810 |
| predisposed | #1810 |
| complement pathway | #1811 |
| activated lymphocytes | #1811 |
| elucidation | #1811 |
| psoriatic | #1813 |
| recovery phase | #1814 |
| nonfunctional | #1817 |
| pregnancy rats | #1817 |
| il2r | #1818 |
| ossification | #1818 |
| promoting | #1818 |
| blymphocyte | #1819 |
| intravenously | #1819 |
| crossed | #1823 |
| katpase | #1824 |
| hydroxylated | #1825 |
| myelin sheath | #1825 |
| neurodegenerative diseases | #1827 |
| deplete | #1830 |
| female sex | #1833 |
| genetic susceptibility | #1836 |
| new treatments | #1839 |
| pathogenesis disease | #1841 |
| trif | #1843 |
| resolution inflammation | #1844 |
| clinical score | #1846 |
| subsequently | #1846 |
| inflammation macrophages | #1847 |
| estrogen | #1848 |
| cultured disease | #1849 |
| pyogenes | #1852 |
| specific immunity | #1854 |
| genetic variance | #1854 |
| cd8 lymphocytes | #1856 |
| macrophages neutrophils | #1856 |
| humoral | #1857 |
| rac2 | #1858 |
| barre | #1858 |
| cocktails | #1860 |
| haenszel | #1862 |
| secreting | #1863 |
| aggravation | #1864 |
| structural basis | #1864 |
| lacrimal apparatus | #1865 |
| rats groups | #1871 |
| silastic | #1871 |
| immunoadsorption | #1873 |
| inkt | #1874 |
| carries | #1875 |
| major | #1876 |
| subsequent development | #1879 |
| cartilages | #1879 |
| candidate | #1883 |
| antigen humans | #1890 |
| inflammation lung | #1892 |
| polyclonal | #1893 |
| bacterial clearance | #1894 |
| ovalbumin | #1897 |
| cyanogen | #1900 |
| striking | #1902 |
| tcr repertoire | #1903 |
| lymphatics | #1903 |
| complexity | #1905 |
| indicating | #1905 |
| proteins rats | #1907 |
| model rats | #1908 |
| mediated | #1910 |
| gammadelta | #1910 |
| enzyme linked | #1911 |
| cells neutrophils | #1912 |
| cell maturation | #1912 |
| interferon gamma | #1914 |
| erythematosus sle | #1916 |
| chromosome | #1916 |
| totally | #1918 |
| 6 hours | #1920 |
| cartilage tissue | #1923 |
| anti | #1924 |
| 721 | #1924 |
| gαq | #1926 |
| pronounced | #1927 |
| ears | #1929 |
| isoantigens | #1931 |
| bcell receptors | #1933 |
| expression cytokines | #1934 |
| animals lymphocytes | #1937 |
| trypanosoma brucei | #1937 |
| sialyltransferases | #1939 |
| mice receptors | #1940 |
| antigen tcell receptors | #1944 |
| type plasminogen | #1945 |
| predisposition | #1949 |
| prevented | #1950 |
| subclasses | #1950 |
| constituting | #1955 |
| cardiac allografts | #1956 |
| perforin | #1957 |
| snakes | #1957 |
| agp | #1959 |
| mmc | #1962 |
| pinocytosis | #1967 |
| edition | #1967 |
| iga igg | #1967 |
| levels serum | #1967 |
| fcγ receptor | #1969 |
| possibilities | #1969 |
| strong | #1971 |
| intravenous injection | #1972 |
| react | #1975 |
| mip | #1977 |
| stimulations | #1978 |
| carp | #1979 |
| synovial tissues | #1979 |
| ova | #1980 |
| inbred cba | #1980 |
| cd154 | #1982 |
| pregnant rats | #1983 |
| cell clone | #1985 |
| disease pathology | #1985 |
| milder | #1988 |
| spans | #1997 |
| mast cell | #1999 |
| cd18 | #2000 |
| transgenic rats | #2001 |
| microglia activation | #2002 |
| presenting cell | #2006 |
| heteroplasmy | #2007 |
| contact dermatitis | #2008 |
| rats effects | #2008 |
| reverted | #2008 |
| prototypic | #2011 |
| response infection | #2016 |
| abca1 | #2016 |
| barré syndrome | #2018 |
| knockout | #2020 |
| tissue inflammation | #2021 |
| immunoglobulin | #2023 |
| genes | #2025 |
| cell | #2027 |
| cytokine secretion | #2028 |
| mabs | #2028 |
| demyelination | #2030 |
| chord | #2031 |
| tetramers | #2032 |
| c5ar | #2033 |
| conformational epitopes | #2035 |
| beta gene | #2035 |
| mesenteric lymph | #2035 |
| 4 tlr4 | #2041 |
| factor mif | #2041 |
| mab | #2042 |
| diethyldithiocarbamate | #2043 |
| immunomodulatory properties | #2044 |
| sex chromosome | #2045 |
| cell immunity | #2047 |
| oestrogens | #2050 |
| hypergammaglobulinemia | #2050 |
| castration | #2053 |
| cell function | #2053 |
| species signal | #2053 |
| coinciding | #2055 |
| emphysema | #2056 |
| glycosylation humans | #2057 |
| increased frequency | #2058 |
| innate inflammation | #2058 |
| dramatically | #2059 |
| activation complement | #2061 |
| vitro vivo | #2061 |
| accompanied | #2067 |
| genetic differences | #2068 |
| dominant | #2070 |
| contributors | #2071 |
| hyaluronoglucosaminidase | #2072 |
| proteomics analysis | #2072 |
| mdsc | #2076 |
| mature cells | #2077 |
| polyradiculoneuropathy | #2077 |
| respiratory tract | #2079 |
| lysine residues | #2080 |
| antiphospholipid syndrome | #2081 |
| cell depletion | #2082 |
| mice pregnancy | #2083 |
| methotrexate mtx | #2094 |
| complement | #2094 |
| conditional deletion | #2095 |
| lysine | #2096 |
| addressed | #2097 |
| αβ | #2100 |
| bioreactor | #2100 |
| suggested | #2102 |
| led | #2103 |
| evokes | #2103 |
| antigens hla | #2104 |
| patients rheumatoid arthritis | #2105 |
| human chondrocytes | #2110 |
| nose | #2117 |
| lentiviral vectors | #2120 |
| glycan | #2122 |
| pulmonary inflammation | #2122 |
| immune functions | #2126 |
| pad4 | #2127 |
| oxidants | #2129 |
| total igg | #2130 |
| secondary receptors | #2133 |
| inducing | #2136 |
| occurring | #2139 |
| histopathological | #2140 |
| target tissues | #2141 |
| selective estrogen | #2141 |
| dissection | #2142 |
| plasminogen | #2143 |
| transduction lymphocytes | #2145 |
| extracellular calcium | #2146 |
| subphenotypes | #2146 |
| h2d | #2147 |
| bound | #2147 |
| circulating monocytes | #2149 |
| 129 strain mice | #2151 |
| immunohistochemical analysis | #2151 |
| reality | #2153 |
| clinical aspects | #2157 |
| periphery | #2161 |
| major histocompatibility complex | #2162 |
| rheumatoid biomarkers | #2165 |
| late stages | #2165 |
| moabs | #2165 |
| prone | #2169 |
| entire | #2174 |
| syringes | #2176 |
| mimics | #2177 |
| animal model | #2179 |
| immune regulation | #2180 |
| human leukocytes | #2181 |
| dynorphins | #2184 |
| psoriatic arthritis | #2184 |
| dnp | #2185 |
| native | #2188 |
| injury ali | #2200 |
| dss | #2203 |
| lps stimulation | #2204 |
| structural requirements | #2211 |
| molecular pathways | #2213 |
| confirming | #2214 |
| 12th | #2215 |
| therapeutic effects | #2216 |
| interleukin2 | #2216 |
| activation cells | #2217 |
| animal mice mice | #2217 |
| naïve | #2219 |
| regulates | #2220 |
| galactose | #2220 |
| suggesting | #2221 |
| wt mice | #2224 |
| immunoreactivity | #2225 |
| shrna | #2232 |
| mammalian | #2232 |
| neutralized | #2233 |
| governs | #2233 |
| presentation | #2234 |
| accelerates | #2236 |
| ctla4 | #2239 |
| reduced susceptibility | #2239 |
| autoimmune conditions | #2239 |
| lacked | #2240 |
| graft rejection | #2244 |
| cholera toxin | #2248 |
| inflammatory phenotype | #2248 |
| cell priming | #2252 |
| exacerbated | #2253 |
| monoclonal antibodies | #2254 |
| cell receptors | #2256 |
| tcell proliferation | #2261 |
| sjögren | #2263 |
| regulation immune | #2265 |
| involved pathogenesis | #2267 |
| hla | #2269 |
| progeny | #2274 |
| mph | #2274 |
| immunospot | #2278 |
| antigenic | #2279 |
| murine | #2279 |
| neutrophil apoptosis | #2280 |
| mice treatment | #2280 |
| lymph nodes | #2281 |
| dependent | #2284 |
| inflammatory | #2288 |
| immunizations | #2289 |
| homologous | #2292 |
| plasmatic | #2293 |
| determining | #2296 |
| histological evaluation | #2296 |
| modified proteins | #2296 |
| cba mice | #2297 |
| regulatory mechanisms | #2299 |
| knockout mice | #2300 |
| apocynin | #2302 |
| segregating | #2308 |
| infiltrating macrophages | #2309 |
| presentation antigens | #2310 |
| wounding | #2312 |
| genetic basis | #2315 |
| drastically | #2315 |
| il10 | #2317 |
| healthy donors | #2318 |
| barré | #2320 |
| hydroxylation | #2320 |
| inflammatory mechanisms | #2321 |
| throughput nucleotide | #2325 |
| sera | #2325 |
| p00002 | #2326 |
| antigens histocompatibility | #2328 |
| wild | #2329 |
| cells induced | #2331 |
| demyelinating disease | #2336 |
| n24 | #2338 |
| lewis | #2345 |
| gk | #2347 |
| receptor α | #2353 |
| reciprocal | #2353 |
| specific igg | #2358 |
| ethylenes | #2358 |
| illness stress | #2361 |
| monosaccharide | #2363 |
| hyaline | #2364 |
| biological agents | #2365 |
| sex hormone | #2366 |
| acrylamides | #2366 |
| lectins type | #2366 |
| degradative | #2367 |
| phosphoproteins | #2369 |
| wf | #2374 |
| eliminated | #2374 |
| immunogens | #2375 |
| peptides derived | #2375 |
| lymphotoxin | #2375 |
| treatment rheumatoid arthritis | #2376 |
| genetic selection | #2376 |
| amps | #2382 |
| cxcl1 | #2382 |
| antinociceptive | #2383 |
| nonalcoholic steatohepatitis | #2384 |
| mouse model | #2386 |
| contaminating | #2386 |
| sidechain | #2391 |
| phenotypes | #2391 |
| receptor transforming | #2392 |
| syngeneic | #2394 |
| knock | #2394 |
| septic arthritis | #2396 |
| systemic lupus erythematosus | #2397 |
| hla genes | #2398 |
| inflammatory reaction | #2400 |
| p38 mapk | #2400 |
| serum autoantibodies | #2408 |
| increased incidence | #2409 |
| mice models | #2411 |
| equina | #2413 |
| intraperitoneal injections | #2418 |
| genetic studies | #2420 |
| genetic receptors | #2420 |
| structure analysis | #2423 |
| realtime pcr | #2424 |
| mice expression | #2426 |
| tlr2 tlr4 | #2429 |
| lentivirus | #2430 |
| suggestive evidence | #2430 |
| acute phase | #2430 |
| unmodified | #2431 |
| collagen fibrils | #2432 |
| cytokines chemokines | #2432 |
| cko | #2432 |
| lymphocytes cd4 | #2432 |
| cells antigens | #2434 |
| agents arthritis | #2440 |
| early phases | #2440 |
| inflammatory activity | #2442 |
| mice multiple | #2446 |
| genetic predisposition | #2449 |
| receptors complement | #2450 |
| b6 | #2450 |
| 551 | #2451 |
| lipoxin | #2458 |
| inflammatory demyelinating | #2459 |
| animal disease models | #2463 |
| exemplified | #2466 |
| idiotype | #2468 |
| antibody responses | #2469 |
| strains | #2471 |
| administration intranasal | #2473 |
| animals cd4 | #2473 |
| additively | #2477 |
| axotomy | #2477 |
| translational modifications | #2477 |
| quantitative | #2480 |
| class | #2480 |
| regulatory | #2487 |
| animal experiments | #2492 |
| specific | #2493 |
| organ specific | #2497 |
| transforming growth factor | #2498 |
| negative feedback | #2501 |
| albeit | #2502 |
| alleviated | #2502 |
| cystatin | #2504 |
| mhc class genes | #2505 |
| multiparous | #2511 |
| transgenic microscopy | #2512 |
| bystander | #2515 |
| il17a | #2516 |
| ppd | #2518 |
| chemokines cytokines | #2519 |
| dichotomous | #2519 |
| contribute | #2522 |
| naturally | #2523 |
| treatment rheumatoid | #2524 |
| hyperostosis | #2525 |
| amiloride | #2526 |
| nod mice | #2527 |
| pathogenicity | #2534 |
| microsatellite markers | #2534 |
| infiltration | #2541 |
| resemblance | #2542 |
| undertaken | #2545 |
| postmenopausal osteoporosis | #2546 |
| proteolipid | #2552 |
| dapsone | #2560 |
| similarities | #2561 |
| igm iga | #2562 |
| plp | #2563 |
| kynurenine | #2563 |
| deprotection | #2564 |
| nox | #2566 |
| succeeded | #2567 |
| fine | #2573 |
| transferring | #2573 |
| passive | #2574 |
| dying cells | #2575 |
| rp patients | #2575 |
| tumor models | #2576 |
| quantitative traits | #2577 |
| incomplete | #2577 |
| complementarity | #2580 |
| peptides | #2585 |
| chick | #2589 |
| calgranulin | #2590 |
| peritoneal macrophages | #2591 |
| antibody levels | #2591 |
| misinterpretation | #2593 |
| interferon type | #2595 |
| sex hormones | #2597 |
| fibrinolysin | #2598 |
| antiinflammatory properties | #2603 |
| onset | #2603 |
| unlinked | #2605 |
| zymosan | #2610 |
| induction | #2611 |
| postulated | #2614 |
| exert | #2615 |
| antimicrobial peptides | #2618 |
| surprising | #2621 |
| interferon beta | #2623 |
| proteolipid protein | #2632 |
| ifn α | #2634 |
| single chain | #2639 |
| sialoglycoproteins | #2643 |
| plasmin | #2647 |
| unable | #2649 |
| asparagine | #2651 |
| tlr9 | #2653 |
| antigens | #2656 |
| disease genotype | #2658 |
| hla antigens | #2659 |
| antinuclear | #2663 |
| functional impact | #2663 |
| submandibular gland | #2663 |
| eluted | #2666 |
| osteonectin | #2667 |
| brucei | #2670 |
| invading | #2670 |
| n22 | #2670 |
| microliters | #2671 |
| biological pathways | #2673 |
| bordetella | #2680 |
| new therapeutic strategies | #2683 |
| ease | #2683 |
| leukocyte antigen | #2688 |
| th1 | #2690 |
| acd | #2696 |
| day treatment | #2697 |
| allelic | #2697 |
| igg3 | #2698 |
| genetic variations | #2698 |
| animal encephalomyelitis | #2702 |
| neutrophils macrophages | #2703 |
| gamma mice | #2711 |
| peptides protein | #2714 |
| γδ | #2716 |
| treatment mice | #2717 |
| rat model | #2718 |
| human complement | #2725 |
| patients anti | #2727 |
| polymorphic | #2729 |
| ifngamma | #2730 |
| biased | #2730 |
| lymphocyte subsets | #2730 |
| post partum | #2731 |
| lamina propria | #2735 |
| fumigatus | #2735 |
| serum anti | #2738 |
| fragment | #2743 |
| vav | #2743 |
| mice exposed | #2750 |
| leucocyte | #2754 |
| resemble | #2762 |
| bromocriptine | #2768 |
| transgenic mouse | #2772 |
| depleting | #2773 |
| human leukocyte | #2774 |
| tyrosine phosphatase | #2774 |
| cytolysis | #2777 |
| qtls | #2777 |
| strong evidence | #2777 |
| iga igm | #2780 |
| detectable | #2780 |
| enigmatic | #2780 |
| genetically | #2782 |
| finemapping | #2785 |
| explanation | #2785 |
| alcoholic steatohepatitis | #2786 |
| treated rats | #2786 |
| intraperitoneal | #2787 |
| tolerogenic | #2789 |
| bone cartilage | #2790 |
| sjogren syndrome | #2791 |
| current review | #2798 |
| inbred mrl | #2798 |
| animal encephalomyelitis autoimmune | #2799 |
| hk | #2801 |
| callithrix | #2804 |
| spleen | #2812 |
| 261 | #2813 |
| neuropathology | #2817 |
| genistein | #2819 |
| alpha | #2821 |
| lack | #2822 |
| activated macrophages | #2825 |
| hyaluronidase | #2830 |
| conventionally | #2831 |
| narrowed | #2832 |
| prl | #2835 |
| olive oil | #2838 |
| demyelinating diseases | #2841 |
| resistant | #2842 |
| hallmark | #2843 |
| glucose uptake | #2846 |
| beta receptor | #2847 |
| bind | #2848 |
| beta tgf | #2848 |
| demyelinating | #2852 |
| th1 response | #2852 |
| polymorphonuclear leukocytes | #2856 |
| phases | #2858 |
| dependent cell | #2859 |
| treg cell | #2859 |
| polymorphonuclear | #2864 |
| antibodies antinuclear | #2864 |
| interleukin receptors | #2864 |
| characterising | #2865 |
| splenocytes | #2865 |
| interleukin33 | #2869 |
| rats inbred strains | #2869 |
| cyanogen bromide | #2874 |
| disease characterized | #2875 |
| guillain | #2875 |
| cells cd8 | #2881 |
| periodontitis | #2882 |
| parvalbumin | #2884 |
| reveals | #2885 |
| clone cells | #2885 |
| exacerbate | #2888 |
| igg iga | #2891 |
| migration inhibitory | #2892 |
| costimulatory molecules | #2895 |
| tgfbeta | #2895 |
| dce | #2896 |
| innate immune responses | #2896 |
| antigens class humans | #2898 |
| dq | #2905 |
| antigen hla | #2907 |
| atp synthase | #2909 |
| enhancement | #2911 |
| linked immunosorbent | #2911 |
| studying | #2918 |
| shortly | #2920 |
| diseases disease | #2920 |
| allogenic | #2921 |
| ergometry | #2921 |
| vaccine development | #2925 |
| steadily | #2925 |
| type lectin | #2926 |
| obvious | #2927 |
| ifn γ | #2931 |
| autoimmune disorder | #2935 |
| dextran | #2939 |
| female flow | #2943 |
| injections | #2944 |
| expression macrophages | #2944 |
| ifn gamma | #2945 |
| proteins peptides | #2946 |
| cd68 | #2947 |
| patients antibodies | #2949 |
| interleukin4 | #2950 |
| cells immune | #2955 |
| eventually | #2956 |
| toll receptor | #2961 |
| cell infiltration | #2962 |
| expressions | #2963 |
| calcium ions | #2964 |
| qtl | #2965 |
| histocytochemistry | #2967 |
| suppressed | #2967 |
| hnrnp | #2980 |
| genetics | #2982 |
| ifn response | #2985 |
| cepacia | #2988 |
| antirheumatic agents | #2993 |
| elusive | #2994 |
| hdac | #2995 |
| thymus gland | #2997 |
| swedish | #2998 |
| respective | #3000 |
| lineage commitment | #3003 |
| indoleamine | #3009 |
| time points | #3009 |
| cells female | #3010 |
| innate | #3014 |
| therapeutic strategies | #3014 |
| illustrating | #3017 |
| anthrax | #3019 |
| interferon ifn | #3020 |
| wild type mice | #3026 |
| defensins | #3027 |
| vdr | #3031 |
| accelerating | #3033 |
| lung inflammation | #3033 |
| macrophage migration | #3036 |
| endo | #3039 |
| t‐cell | #3039 |
| synthetic peptides | #3040 |
| appearance | #3045 |
| quinoxalines | #3047 |
| cd8 | #3048 |
| immunomodulator | #3050 |
| model mice | #3051 |
| longterm treatment | #3052 |
| twin studies | #3053 |
| complex traits | #3055 |
| ppt | #3058 |
| interleukin23 | #3061 |
| profound | #3067 |
| sjögren syndrome | #3069 |
| prevailing | #3073 |
| salivary | #3076 |
| mediated immune | #3077 |
| role cell | #3078 |
| beta | #3080 |
| destruction | #3082 |
| irrespective | #3083 |
| model human | #3083 |
| gene expression profiling | #3086 |
| impairing | #3087 |
| nodes | #3091 |
| glutamic | #3092 |
| inhibitory factors | #3092 |
| parvalbumins | #3093 |
| inbred balb mice | #3098 |
| receptor 4 | #3098 |
| genetic deletion | #3100 |
| detailed description | #3101 |
| postpartum period | #3107 |
| germinal | #3108 |
| antirheumatic | #3109 |
| staphylococcus | #3114 |
| type wt | #3120 |
| neuronal cell | #3123 |
| effects treatment | #3124 |
| suspect | #3127 |
| igm igg | #3130 |
| specificity | #3131 |
| glycans | #3136 |
| monoclonal antibody | #3137 |
| receptors tlrs | #3142 |
| psoriasis | #3142 |
| logarithm | #3146 |
| cd4 cd8 | #3147 |
| preformed | #3151 |
| immune systems | #3152 |
| possibility | #3153 |
| cell activity | #3154 |
| molecule | #3155 |
| propria | #3155 |
| cba | #3164 |
| posttranslational modification | #3167 |
| sjogren | #3171 |
| massively | #3172 |
| accumulated | #3180 |
| cell specific | #3185 |
| precedes | #3185 |
| blockage | #3187 |
| dynorphin | #3191 |
| tissue specific | #3191 |
| pertussis toxin | #3192 |
| adult mice | #3193 |
| cells rats | #3193 |
| keratinocytes | #3194 |
| unravel | #3199 |
| reactivity | #3202 |
| helper | #3204 |
| modified | #3205 |
| ovx | #3208 |
| serum levels | #3210 |
| erbeta | #3211 |
| antiinflammatory | #3211 |
| nitroarginine | #3212 |
| phagosomes | #3212 |
| abs | #3216 |
| cells animals | #3224 |
| publication arthritis | #3224 |
| gpi | #3226 |
| chromosome 1 | #3237 |
| class iii | #3239 |
| clarified | #3242 |
| permitting | #3246 |
| collagenous | #3247 |
| macrophage | #3247 |
| lod score | #3252 |
| bacterial antibodies | #3254 |
| backbone | #3257 |
| nonalcoholic steatohepatitis nash | #3260 |
| female gonadal | #3263 |
| treated animals | #3264 |
| acrylic | #3265 |
| chronic inflammatory | #3267 |
| meps | #3270 |
| immunosorbent assay | #3272 |
| implicate | #3274 |
| inflammation interferon | #3278 |
| proteoglycans | #3278 |
| sch | #3280 |
| nephritis | #3283 |
| arthralgia | #3283 |
| gonadal steroid | #3284 |
| normal rats | #3287 |
| abundantly | #3289 |
| models genetic | #3298 |
| igg1 | #3298 |
| immunoglobulin heavy | #3303 |
| erythematosus | #3305 |
| proteins mice | #3309 |
| adaptations | #3309 |
| elicits | #3314 |
| characterise | #3314 |
| blastocyst | #3315 |
| nociception | #3316 |
| absence | #3318 |
| diseases autoimmune | #3321 |
| beta receptors | #3325 |
| publication animals | #3325 |
| mice protein | #3327 |
| anticardiolipin | #3328 |
| confirmed | #3329 |
| gc cells | #3331 |
| serologically | #3332 |
| suppression | #3338 |
| regional lymph nodes | #3341 |
| macromolecular | #3343 |
| clinical phenotypes | #3345 |
| cd62l | #3353 |
| influenced | #3355 |
| trypanosoma | #3358 |
| akr | #3371 |
| vitamin d3 | #3373 |
| editor | #3377 |
| antinuclear antibodies | #3382 |
| sle | #3384 |
| genetic polymorphisms | #3385 |
| ovariectomy | #3386 |
| mechanistic studies | #3395 |
| macroporous | #3395 |
| levels inflammatory | #3395 |
| explains | #3396 |
| mount | #3397 |
| tubercle | #3402 |
| somatic mutations | #3406 |
| receptors transforming | #3410 |
| haptens | #3413 |
| early phase | #3413 |
| positions | #3418 |
| nk cells | #3419 |
| erythematosus systemic | #3419 |
| neutrophil activation | #3421 |
| reacts | #3421 |
| penetrant | #3425 |
| reply | #3432 |
| proving | #3434 |
| receptor type | #3434 |
| dendritic cells | #3436 |
| serum igg | #3437 |
| alleles | #3440 |
| permitted | #3441 |
| cauda | #3443 |
| 4 months | #3444 |
| injection | #3445 |
| superoxide production | #3446 |
| protein tyrosine | #3447 |
| obscure | #3448 |
| humans immunization | #3448 |
| increased sensitivity | #3449 |
| antimicrobial peptide | #3451 |
| diffusely | #3459 |
| characterised | #3469 |
| h5n1 | #3470 |
| patients sle | #3470 |
| flow cytometry | #3476 |
| modifying | #3477 |
| multimers | #3491 |
| inflammatory mediators | #3491 |
| proteoglycan | #3496 |
| successes | #3497 |
| il21 | #3500 |
| ly | #3501 |
| elucidate | #3503 |
| developed | #3505 |
| classical | #3505 |
| protein processing | #3506 |
| salivary gland | #3507 |
| publication animals animals | #3509 |
| neutrophilic | #3510 |
| pathobiology | #3511 |
| pathological features | #3517 |
| specific cd4 | #3519 |
| globulins | #3526 |
| deoxyguanosine | #3528 |
| 267 | #3528 |
| phenotypically | #3529 |
| germline | #3529 |
| predispose | #3532 |
| micrometer | #3534 |
| lacrimal | #3534 |
| transglutaminases | #3535 |
| radiolabelled | #3539 |
| regulatory cells tregs | #3540 |
| cyclosporins | #3540 |
| mbq | #3541 |
| dominantly | #3548 |
| histological examination | #3554 |
| investigate | #3559 |
| infections staphylococcus | #3561 |
| mast cells | #3563 |
| cultured disease models | #3568 |
| socs1 | #3570 |
| humans interferon | #3571 |
| histological | #3574 |
| homogenate | #3576 |
| gamma | #3580 |
| interesting | #3580 |
| negative patients | #3583 |
| artificially | #3584 |
| role development | #3585 |
| cytolytic | #3589 |
| hindlimb | #3590 |
| il33 | #3593 |
| compared wild | #3597 |
| triggered | #3597 |
| usage | #3601 |
| immunohistochemical staining | #3608 |
| upregulation | #3612 |
| previous findings | #3617 |
| intranasal | #3619 |
| tcr | #3622 |
| cleave | #3624 |
| potential roles | #3624 |
| genetic association | #3629 |
| rp | #3633 |
| attenuate | #3633 |
| mapping chromosomes | #3634 |
| genetic | #3637 |
| valuable | #3637 |
| adhere | #3638 |
| today | #3645 |
| cultured culture media | #3651 |
| allele | #3655 |
| enhances | #3657 |
| gene deletion | #3657 |
| cd4 positive | #3659 |
| exerts | #3663 |
| tolllike receptor | #3665 |
| clinical severity | #3665 |
| luminol | #3667 |
| 95 association | #3671 |
| cd44 | #3678 |
| il23 | #3690 |
| tgf beta | #3691 |
| female genes | #3694 |
| fibronectins | #3697 |
| toll receptors | #3700 |
| igg igm | #3702 |
| heavy chain | #3705 |
| publication animals humans | #3708 |
| synovitis | #3708 |
| cyclohexanecarboxylic | #3709 |
| aggregated | #3717 |
| inbred nod mice | #3730 |
| systemic male | #3735 |
| sequence deletion | #3740 |
| dh | #3742 |
| 378 | #3746 |
| cells produce | #3750 |
| therapeutic benefit | #3752 |
| macrophage cell | #3753 |
| mediate | #3754 |
| contributing | #3754 |
| complement c4 | #3758 |
| immunochemistry | #3759 |
| biomedicine | #3763 |
| type 4 | #3763 |
| lymphocytes tumor | #3766 |
| epitope mapping | #3767 |
| identification | #3771 |
| partum | #3772 |
| mtdna | #3773 |
| d3 | #3775 |
| th17 | #3786 |
| jakob | #3786 |
| reduced expression | #3787 |
| diphtheria | #3803 |
| immunohistochemical | #3805 |
| hind | #3808 |
| skewed | #3820 |
| superoxide | #3822 |
| integrins | #3822 |
| ribonucleoprotein | #3823 |
| new opportunities | #3831 |
| models immunological | #3834 |
| encompassing | #3838 |
| mmp9 expression | #3839 |
| puerperal | #3839 |
| noncoding rna | #3840 |
| unclear | #3847 |
| amelioration | #3854 |
| il17 | #3858 |
| postulate | #3858 |
| identical | #3859 |
| housed | #3861 |
| genetic dna | #3867 |
| cells treg | #3873 |
| genetic promoter regions | #3880 |
| glycoside | #3887 |
| prominent | #3887 |
| kinase2 | #3887 |
| reacting | #3888 |
| dinucleotide | #3894 |
| decreased levels | #3896 |
| synoviocytes | #3900 |
| microsatellite repeats | #3903 |
| superoxides | #3904 |
| dominate | #3907 |
| recognition | #3912 |
| endogenous | #3918 |
| established | #3919 |
| animal studies | #3926 |
| rats messenger | #3931 |
| hladr | #3934 |
| immunophenotyping | #3941 |
| manifestations | #3942 |
| nerves | #3944 |
| toes | #3946 |
| neutrophils | #3947 |
| affect | #3947 |
| polymorphism | #3949 |
| gingivalis | #3957 |
| nets | #3958 |
| mechanisms involved | #3961 |
| involvement | #3973 |
| disrupted | #3975 |
| associate | #3975 |
| 297 | #3982 |
| adult arthritis | #3988 |
| stimulate | #3992 |
| heavy chains | #3992 |
| question | #3999 |
| ifn β | #3999 |
| broader | #4001 |
| patients osteoarthritis | #4009 |
| elevated levels | #4012 |
| sinuses | #4016 |
| chondrocytes | #4018 |
| superoxide dismutase | #4018 |
| individual patients | #4028 |
| ags | #4029 |
| inflammatory processes | #4033 |
| higher expression | #4034 |
| influences | #4034 |
| efficiently | #4050 |
| glycoproteins | #4054 |
| hla alleles | #4059 |
| expression cell | #4063 |
| conferred | #4065 |
| c1q | #4069 |
| fragments | #4072 |
| produce | #4072 |
| hinge | #4074 |
| eliciting | #4075 |
| stat4 | #4076 |
| requirement | #4076 |
| glycoprotein | #4077 |
| plethora | #4077 |
| contrast | #4085 |
| llc | #4089 |
| upregulated | #4090 |
| systemic lupus | #4092 |
| expression type | #4098 |
| fine mapping | #4102 |
| atpases | #4103 |
| leukocyte | #4105 |
| glands | #4107 |
| conferring | #4108 |
| neutrophil | #4113 |
| creutzfeldt | #4115 |
| current concepts | #4116 |
| gelatin | #4120 |
| absent | #4121 |
| therapy genetic | #4122 |
| sclerosis animals | #4124 |
| drives | #4126 |
| regulatory cells | #4126 |
| protect | #4131 |
| mycobacterial | #4133 |
| promoter polymorphism | #4137 |
| stat1 | #4144 |
| functionally | #4147 |
| articular cartilage | #4161 |
| lupus erythematosus | #4162 |
| hla dq | #4165 |
| motor neurons | #4166 |
| polygenic | #4169 |
| placenta pregnancy | #4173 |
| tumour necrosis factor | #4177 |
| stimulatory | #4178 |
| early pregnancy | #4180 |
| immunology | #4183 |
| effector | #4184 |
| systemic disease | #4187 |
| superoxide anion | #4191 |
| infiltrating lymphocytes | #4192 |
| spe | #4193 |
| monocyte | #4201 |
| breeders | #4203 |
| enterotoxin | #4206 |
| ici | #4207 |
| porphyromonas gingivalis | #4207 |
| beads | #4213 |
| antigens cd8 | #4214 |
| animal drug | #4222 |
| depletion | #4223 |
| cytometric analysis | #4224 |
| parathyroid | #4225 |
| long noncoding | #4227 |
| mutant | #4232 |
| inbred balb | #4239 |
| treated mice | #4242 |
| macrophage infiltration | #4244 |
| kidneys | #4244 |
| granulocytic | #4249 |
| chondrosarcoma | #4250 |
| continuously | #4250 |
| witnessed | #4252 |
| conjunction | #4256 |
| immunological | #4257 |
| immunity innate | #4258 |
| bout | #4260 |
| igh | #4262 |
| lymphoid | #4264 |
| cell repertoire | #4268 |
| denominator | #4270 |
| day1 | #4270 |
| complex | #4272 |
| suggestive | #4276 |
| dermatitis | #4285 |
| experimental mice | #4285 |
| clues | #4286 |
| gene targeting | #4290 |
| cd4 | #4291 |
| balb | #4292 |
| disease genetic | #4294 |
| repertoire | #4302 |
| molecular modeling | #4303 |
| provocation | #4303 |
| sciatic | #4307 |
| shares | #4307 |
| tuberculin | #4308 |
| positive cells | #4309 |
| functional role | #4310 |
| receptors interleukin2 | #4317 |
| cell populations | #4317 |
| suppressive effects | #4320 |
| hydroxy2deoxyguanosine | #4331 |
| pparγ | #4350 |
| new insight | #4353 |
| trypanosomiasis | #4358 |
| fungal infection | #4364 |
| glutamine | #4364 |
| peritonitis | #4365 |
| wildtype | #4370 |
| immunoassays | #4373 |
| swelling | #4375 |
| penetrance | #4381 |
| caused | #4381 |
| cell clones | #4396 |
| mucous | #4402 |
| disease chronic | #4402 |
| prevents | #4414 |
| restored | #4417 |
| joint | #4420 |
| modulating | #4426 |
| closer | #4434 |
| disturbed | #4434 |
| receptor beta | #4434 |
| buprenorphine | #4435 |
| model systems | #4443 |
| early | #4453 |
| acute chronic | #4454 |
| aspartic | #4458 |
| parathyroid glands | #4470 |
| confers | #4473 |
| inflammatory pain | #4477 |
| disease duration | #4480 |
| thymocytes | #4481 |
| calmette | #4488 |
| strains rats | #4489 |
| synthase type | #4490 |
| treg | #4493 |
| thickened | #4503 |
| neutralizing antibodies | #4503 |
| human cell | #4505 |
| genetic loci | #4510 |
| extensively | #4516 |
| colitis | #4526 |
| derived cells | #4532 |
| therapeutic implications | #4534 |
| immunotoxins | #4535 |
| beta cells | #4539 |
| cells th2 | #4541 |
| challenged | #4542 |
| lymphocytes cd8 | #4545 |
| 101 | #4546 |
| cytotoxic lymphocytes | #4547 |
| articular chondrocytes | #4553 |
| interleukin5 | #4558 |
| messenger rats rats | #4564 |
| beta cell | #4566 |
| homing | #4576 |
| extracellular ca2 | #4576 |
| hydrolases | #4577 |
| fasl | #4578 |
| cell separation | #4580 |
| proliferative | #4581 |
| neurosecretory | #4585 |
| immunologic | #4592 |
| production inflammatory | #4593 |
| suggests | #4596 |
| inbred shr rats | #4607 |
| modulatory | #4608 |
| interact | #4613 |
| ros levels | #4613 |
| igg antibody | #4613 |
| confer | #4616 |
| depleted | #4639 |
| conditioned medium | #4642 |
| environmental factors | #4643 |
| fashion | #4658 |
| positive selection | #4658 |
| porphyromonas | #4666 |
| visualized | #4667 |
| endorphins | #4669 |
| implicated | #4670 |
| determinant | #4675 |
| causing | #4678 |
| langerhans | #4681 |
| chains | #4681 |
| monocytes macrophages | #4683 |
| animals antigens | #4693 |
| 259 | #4696 |
| female rats | #4699 |
| lymph | #4707 |
| protecting | #4707 |
| inherited | #4709 |
| defined | #4710 |
| destabilization | #4716 |
| facs | #4718 |
| human studies | #4720 |
| orthomyxoviridae infections | #4725 |
| humans inflammation | #4729 |
| cell population | #4734 |
| positive patients | #4736 |
| α1 | #4739 |
| clone | #4741 |
| mediating | #4744 |
| factor 88 | #4750 |
| panel | #4753 |
| gout | #4757 |
| new drugs | #4764 |
| histopathology | #4767 |
| orchiectomy | #4773 |
| cellular localization | #4775 |
| e4 | #4776 |
| alveolar macrophages | #4776 |
| purified | #4778 |
| differing | #4793 |
| eralpha | #4798 |
| male membrane | #4800 |
| rodents | #4801 |
| osteoclastogenesis | #4809 |
| displaying | #4809 |
| hydrolyzed | #4815 |
| tumor antigens | #4816 |
| effector cells | #4819 |
| cd4 cd8 cells | #4821 |
| paw | #4821 |
| cytokines | #4821 |
| cholera | #4822 |
| distinct | #4831 |
| coincides | #4833 |
| litters | #4843 |
| stress rats | #4846 |
| tissue injury | #4847 |
| rats receptors | #4850 |
| interferon γ | #4852 |
| matrix ecm | #4852 |
| stemness | #4860 |
| articular | #4861 |
| venules | #4863 |
| infiltrate | #4868 |
| th17 cells | #4872 |
| tlr2 | #4880 |
| hpa axis | #4882 |
| ifn | #4885 |
| exocrine | #4888 |
| multifactorial | #4889 |
| 116 | #4891 |
| lod | #4892 |
| specific binding | #4893 |
| ige | #4896 |
| humoral immunity | #4897 |
| induced lung | #4899 |
| preimplantation | #4905 |
| essential roles | #4915 |
| discuss | #4916 |
| immunosorbent | #4917 |
| correlating | #4923 |
| interleukins | #4927 |
| deacetylases | #4928 |
| closely | #4932 |
| timepoints | #4940 |
| humans multiple | #4945 |
| deficiency | #4946 |
| naturally occurring | #4962 |
| disease process | #4962 |
| monitored | #4964 |
| elicit | #4966 |
| forelimb | #4967 |
| contradictory | #4975 |
| point mutation | #4976 |
| cell antigen | #4990 |
| understand | #4995 |
| male rats | #4998 |
| kupffer cells | #5001 |
| thymic | #5003 |
| eosinophilia | #5004 |
| innate immune | #5004 |
| modulates | #5011 |
| isotype | #5012 |
| wt | #5012 |
| upa | #5014 |
| opened | #5018 |
| sh3 | #5019 |
| granuloma | #5021 |
| gland | #5024 |
| expand | #5026 |
| enhancing | #5026 |
| vimentin | #5026 |
| poliomyelitis | #5041 |
| explaining | #5042 |
| il5 | #5044 |
| diamines | #5048 |
| heterozygous | #5049 |
| coculture techniques | #5051 |
| cd8 cells | #5055 |
| caveolin | #5065 |
| th1 cells | #5067 |
| linkage | #5067 |
| phospholipid | #5071 |
| arthritis juvenile | #5072 |
| sitedirected mutagenesis | #5076 |
| molecular basis | #5084 |
| cells blood | #5085 |
| bcg | #5086 |
| alum | #5087 |
| autologous | #5087 |
| olive | #5088 |
| new treatment | #5089 |
| multiple sclerosis | #5098 |
| master regulator | #5100 |
| osteopontin | #5109 |
| aged anti | #5110 |
| elispot | #5112 |
| occurs | #5112 |
| sulfasalazine | #5115 |
| isoantibodies | #5120 |
| dq antigens | #5134 |
| contributes | #5139 |
| lesser | #5145 |
| traditionally | #5148 |
| cytosolic | #5152 |
| epidermis | #5158 |
| connection | #5165 |
| cytokines female | #5170 |
| titrated | #5171 |
| preceded | #5175 |
| antigen receptor | #5178 |
| lymphocytes cytotoxic | #5179 |
| binding | #5185 |
| sex characteristics | #5186 |
| transfer | #5187 |
| polymorphism single | #5188 |
| phenotypic | #5191 |
| complement proteins | #5192 |
| molecular level | #5196 |
| ovariectomized | #5210 |
| popliteal | #5224 |
| ers | #5235 |
| serves | #5238 |
| beta2 | #5238 |
| chimeric | #5241 |
| immunosuppressive | #5246 |
| epidermal | #5250 |
| cognate | #5258 |
| mucus | #5258 |
| cd86 | #5261 |
| tested | #5262 |
| deleterious effects | #5266 |
| progenitors | #5270 |
| costimulation | #5275 |
| osteoclast | #5277 |
| detects | #5277 |
| erosion | #5278 |
| prolactin | #5280 |
| therapeutic intervention | #5280 |
| maternally | #5289 |
| gels | #5292 |
| leu | #5294 |
| plasmapheresis | #5298 |
| clinical findings | #5299 |
| key component | #5301 |
| neutralization | #5301 |
| drug humans | #5301 |
| amino | #5310 |
| staphylococcus aureus | #5312 |
| suggestion | #5312 |
| anhydrases | #5315 |
| manner | #5320 |
| c57bl 6j | #5320 |
| spontaneous | #5321 |
| lipopolysaccharides macrophages | #5345 |
| genetic mapping | #5348 |
| ketoglutarate | #5350 |
| opposing | #5352 |
| proinflammatory | #5365 |
| clathrin | #5369 |
| multiplexed | #5371 |
| glomerulonephritis | #5377 |
| modifies | #5379 |
| cultured human | #5386 |
| expansion | #5387 |
| il1α | #5391 |
| tolllike receptors | #5397 |
| oxidation reduction | #5398 |
| new strategies | #5401 |
| positive lymphocytes | #5402 |
| mice molecular | #5402 |
| tnf α | #5411 |
| antiinflammatory agents | #5417 |
| epigenetic mechanisms | #5417 |
| adversely | #5418 |
| fulvestrant | #5420 |
| activation | #5420 |
| dendritic | #5428 |
| compartments | #5429 |
| antigens surface | #5429 |
| signaling molecules | #5432 |
| mif | #5457 |
| cell culture | #5458 |
| wide spectrum | #5473 |
| sideeffects | #5478 |
| multitude | #5482 |
| located | #5499 |
| immunoglobulins | #5500 |
| reproduced | #5507 |
| histological analysis | #5507 |
| lactating | #5515 |
| cytotoxic | #5519 |
| cytokines humans | #5525 |
| balb mice | #5542 |
| therapeutic | #5547 |
| thymus | #5551 |
| immunosuppressive agents | #5559 |
| sexual dimorphism | #5560 |
| pv | #5560 |
| nociceptive | #5565 |
| redox | #5572 |
| cell expansion | #5578 |
| acute lung | #5583 |
| t1d | #5585 |
| percentage | #5588 |
| allergic reactions | #5592 |
| typed | #5596 |
| lipopolysaccharide lps | #5598 |
| potently | #5600 |
| acute lung injury | #5603 |
| oxidase activity | #5613 |
| control animals | #5614 |
| structural homology | #5616 |
| sequence amino | #5621 |
| synthases | #5633 |
| biotinylation | #5642 |
| bead | #5645 |
| pemphigus | #5649 |
| urgent | #5650 |
| type ifn | #5655 |
| proliferative responses | #5658 |
| abolished | #5660 |
| explants | #5660 |
| regarded | #5663 |
| 198 | #5671 |
| directing | #5676 |
| lung mice | #5677 |
| heterotrimeric | #5684 |
| antioxidant defense | #5685 |
| numbers | #5685 |
| aetiology | #5687 |
| triggers | #5689 |
| keratins | #5695 |
| progression disease | #5697 |
| cytokine expression | #5697 |
| skeletal muscle | #5698 |
| experimental animals | #5700 |
| immune mediated | #5710 |
| avenues | #5715 |
| effective treatments | #5735 |
| altogether | #5737 |
| variable | #5759 |
| integrases | #5760 |
| hfd | #5762 |
| ecm | #5776 |
| mechanisms | #5794 |
| mast | #5802 |
| linking | #5808 |
| frozen | #5808 |
| b16 | #5808 |
| inflammatory disorders | #5809 |
| diabetes t1d | #5814 |
| allergic | #5820 |
| splenic | #5829 |
| bal | #5830 |
| hampered | #5832 |
| toxoid | #5835 |
| earliest | #5837 |
| key regulators | #5844 |
| gabapentin | #5847 |
| type receptors | #5850 |
| large proportion | #5851 |
| proteinases | #5862 |
| cfa | #5868 |
| stronger | #5871 |
| disease genotype humans | #5872 |
| hyaluronan receptors | #5875 |
| deleted | #5875 |
| vitro experiments | #5880 |
| microtomography | #5882 |
| single cells | #5896 |
| evidence role | #5898 |
| modulation | #5900 |
| ace2 | #5917 |
| standardization | #5918 |
| abp | #5919 |
| synthetic | #5920 |
| low doses | #5925 |
| bronchoalveolar lavage fluid | #5925 |
| ics | #5932 |
| identifying | #5941 |
| subclass | #5941 |
| depend | #5947 |
| genomic regions | #5947 |
| explain | #5951 |
| interfere | #5953 |
| biobank | #5960 |
| cytokine production | #5962 |
| expression humans | #5965 |
| nerve regeneration | #5966 |
| factor 1 | #5968 |
| avidin | #5970 |
| foxp3 | #5975 |
| costimulatory | #5977 |
| clarify | #5980 |
| symptom onset | #5983 |
| denaturation | #5986 |
| inability | #5988 |
| knee joint | #5990 |
| eosinophils | #5991 |
| cell subset | #6000 |
| immunity | #6010 |
| glyburide | #6010 |
| 88 | #6014 |
| tetanus | #6019 |
| stress induced | #6022 |
| consisting | #6023 |
| fluorescent dyes | #6044 |
| cnvs | #6045 |
| stimulated | #6056 |
| nih | #6065 |
| igm | #6073 |
| cleared | #6074 |
| tumor infiltrating | #6074 |
| laminin | #6075 |
| genetic therapy | #6077 |
| relapsing remitting | #6083 |
| sle patients | #6089 |
| responsible | #6091 |
| undertook | #6097 |
| messengers | #6100 |
| cages | #6103 |
| stat6 | #6105 |
| ligated | #6107 |
| bone diseases | #6115 |
| uncoupling | #6115 |
| telomeric | #6122 |
| infection mice | #6127 |
| unique | #6140 |
| replacing | #6149 |
| plasma cells | #6150 |
| lowers | #6156 |
| inguinal | #6166 |
| susceptibility gene | #6171 |
| responses | #6171 |
| prophylactic | #6183 |
| genomewide association studies | #6193 |
| instances | #6210 |
| cell functions | #6210 |
| models human | #6217 |
| interferon | #6220 |
| translation | #6222 |
| humans lupus | #6235 |
| characterized | #6236 |
| progesterone | #6253 |
| introduction | #6260 |
| cell type | #6265 |
| exclusively | #6269 |
| protective | #6270 |
| microarray | #6272 |
| serum concentration | #6278 |
| sexes | #6280 |
| immune cell | #6285 |
| myelomonocytic | #6286 |
| histone | #6287 |
| biological evaluation | #6290 |
| difficult | #6298 |
| dermis | #6313 |
| sheath | #6316 |
| monolithic | #6318 |
| allowed | #6320 |
| minor | #6320 |
| tracheal | #6322 |
| estrus | #6336 |
| immunomodulatory | #6337 |
| lymphocyte count | #6339 |
| localize | #6347 |
| tumor immune | #6348 |
| remitting | #6355 |
| borrelia burgdorferi | #6355 |
| cell biology | #6355 |
| microsatellite | #6356 |
| virgin | #6356 |
| signs | #6360 |
| tears | #6363 |
| tryptic | #6370 |
| pertussis | #6372 |
| unresolved | #6378 |
| ros generation | #6379 |
| cells cell | #6381 |
| metalloproteinase | #6392 |
| human subjects | #6394 |
| nicotinamide | #6408 |
| registers | #6410 |
| prodromal | #6450 |
| gonadal | #6451 |
| neuropathological | #6454 |
| models molecular | #6455 |
| peritoneum | #6460 |
| express | #6470 |
| biologic | #6473 |
| transgenes | #6474 |
| c4 | #6475 |
| immunity mucosal | #6476 |
| inoculation | #6477 |
| genetic variants | #6477 |
| severe | #6501 |
| gene function | #6502 |
| demonstrates | #6508 |
| organ specificity | #6511 |
| cell numbers | #6513 |
| stages | #6515 |
| nitrite | #6523 |
| synergy | #6523 |
| chronic | #6523 |
| share | #6539 |
| played | #6540 |
| proteins animals | #6559 |
| apc | #6559 |
| antibody titers | #6572 |
| cytotoxicity immunologic | #6575 |
| pace | #6583 |
| proteases | #6588 |
| rheumatic | #6588 |
| expression genes | #6603 |
| toll | #6603 |
| stain | #6604 |
| major source | #6614 |
| translocating | #6615 |
| parturition | #6635 |
| hpa | #6636 |
| whitney | #6639 |
| solid phase | #6644 |
| affinity | #6645 |
| regulation | #6650 |
| parenchyma | #6650 |
| presently | #6651 |
| sclerosis | #6655 |
| memory cell | #6657 |
| cystine | #6658 |
| cells cd4 | #6665 |
| subfamily | #6672 |
| melatonin | #6683 |
| animals antioxidants | #6683 |
| current understanding | #6687 |
| burgdorferi | #6696 |
| macrophages alveolar | #6701 |
| long noncoding rnas | #6715 |
| histone deacetylases | #6742 |
| normal levels | #6747 |
| pups | #6747 |
| estrogens | #6749 |
| demonstration | #6755 |
| relevant | #6761 |
| comparative genomics | #6768 |
| elastase | #6774 |
| cd8 positive | #6776 |
| helpful | #6782 |
| interleukin18 | #6782 |
| cytometric | #6804 |
| demonstrate | #6812 |
| study role | #6813 |
| glucose transport | #6814 |
| crystal structure | #6819 |
| induced acute | #6825 |
| intra articular | #6825 |
| eosinophil | #6829 |
| cd19 | #6829 |
| cterminal | #6829 |
| conflicting | #6830 |
| lname | #6833 |
| antilymphocyte | #6836 |
| molecules | #6840 |
| case control | #6852 |
| aspergillosis | #6852 |
| lymphoid tissues | #6854 |
| participates | #6855 |
| periodontal disease | #6855 |
| vascular endothelium | #6862 |
| sciatic nerve | #6863 |
| alter | #6865 |
| bioreactors | #6867 |
| activating | #6871 |
| facial nerve | #6873 |
| cell communication | #6882 |
| tool | #6883 |
| cytokine release | #6887 |
| lethality | #6889 |
| inflammatory responses | #6893 |
| lung injury | #6900 |
| ankle joint | #6907 |
| harboring | #6908 |
| gastritis | #6915 |
| tumour necrosis | #6921 |
| recessive | #6922 |
| acetaldehyde | #6925 |
| induced pulmonary | #6931 |
| alternative | #6934 |
| microarray analysis | #6937 |
| cyclic | #6951 |
| inflammatory response | #6953 |
| sulfones | #6960 |
| player | #6974 |
| likewise | #6976 |
| exacerbations | #6984 |
| cdr | #6993 |
| equally | #7001 |
| rac1 | #7013 |
| biological function | #7014 |
| mapping | #7016 |
| translational | #7020 |
| degrade | #7020 |
| mimic | #7025 |
| fewer | #7033 |
| assay elisa | #7033 |
| suppressing | #7047 |
| th1 th2 | #7048 |
| histology | #7056 |
| nucleotide | #7060 |
| genome wide | #7063 |
| target cells | #7063 |
| heterogeneous | #7071 |
| aureus | #7072 |
| subjected | #7072 |
| immune cells | #7075 |
| serine proteases | #7082 |
| proportion | #7083 |
| reduced | #7086 |
| glomeruli | #7088 |
| finally | #7092 |
| atherosclerotic lesions | #7094 |
| orthomyxoviridae | #7108 |
| lyme disease | #7115 |
| thp1 cells | #7121 |
| apoptotic cells | #7124 |
| dividing | #7134 |
| mounted | #7137 |
| autophagy | #7144 |
| extracellular | #7153 |
| immunity cellular | #7161 |
| genetic markers | #7162 |
| messenger rats | #7166 |
| cascades | #7175 |
| synteny | #7188 |
| moiety | #7194 |
| promoted | #7198 |
| higher incidence | #7202 |
| lymphoid tissue | #7205 |
| bovine serum albumin | #7219 |
| dependency | #7223 |
| amino acid | #7225 |
| relevance | #7233 |
| mtx | #7237 |
| recognised | #7238 |
| polysaccharides | #7242 |
| sirt1 | #7251 |
| participate | #7253 |
| prevalent | #7262 |
| immuno | #7265 |
| role pathogenesis | #7272 |
| breeding | #7286 |
| inheritance | #7292 |
| rolling | #7300 |
| prime | #7313 |
| dissecting | #7326 |
| avidity | #7332 |
| expressed genes | #7334 |
| adhesins | #7335 |
| inflammasome | #7342 |
| potential targets | #7343 |
| secreted | #7347 |
| disease specific | #7350 |
| uncontrolled | #7353 |
| metalloendopeptidases | #7355 |
| microglobulin | #7363 |
| adulthood | #7369 |
| transduction animals | #7370 |
| oxide nitric | #7377 |
| array | #7387 |
| analyses | #7391 |
| nervous | #7406 |
| transglutaminase | #7410 |
| chemokines | #7411 |
| interleukin6 | #7411 |
| proven | #7418 |
| supernatants | #7428 |
| genotyping | #7446 |
| immunocytochemistry | #7453 |
| fusion protein | #7456 |
| cells peripheral | #7461 |
| β2 | #7467 |
| airways | #7489 |
| adjuvant | #7493 |
| inhibitory factor | #7500 |
| cytotoxic cells | #7518 |
| disease incidence | #7535 |
| anchor | #7536 |
| eliminate | #7540 |
| early disease | #7541 |
| il1 beta | #7545 |
| lesser extent | #7547 |
| interleukin1beta | #7549 |
| necrotic | #7550 |
| activity relationship | #7553 |
| responder | #7562 |
| elevations | #7589 |
| interacting | #7594 |
| micrograms | #7596 |
| hydrocarbon | #7610 |
| appeared | #7610 |
| arginine | #7621 |
| evident | #7628 |
| cytometry | #7630 |
| unexplained | #7632 |
| allogeneic | #7640 |
| peripheral nervous | #7645 |
| sustain | #7654 |
| receptors immunologic | #7659 |
| graft survival | #7661 |
| component | #7661 |
| murine model | #7665 |
| considerable | #7704 |
| histone deacetylase | #7707 |
| placental | #7712 |
| differentially expressed | #7721 |
| chromosomes | #7722 |
| activators | #7728 |
| motifs | #7730 |
| critical roles | #7731 |
| bacterial toxins | #7735 |
| diagnostics | #7735 |
| initiation | #7745 |
| 325 | #7749 |
| rodent | #7751 |
| chain | #7753 |
| granulocyte | #7754 |
| leukocytes mononuclear | #7766 |
| candidate genes | #7769 |
| mer | #7772 |
| activates | #7772 |
| 37°c | #7773 |
| manuscript | #7780 |
| resolving | #7797 |
| carbonic | #7798 |
| cells tregs | #7800 |
| cell surface receptors | #7807 |
| diet fat | #7810 |
| tgf beta1 | #7831 |
| lipopolysaccharides | #7836 |
| patients levels | #7843 |
| strain | #7844 |
| cells pbmcs | #7853 |
| sirtuin | #7854 |
| retinoid | #7862 |
| interleukin1 | #7866 |
| ifnγ | #7872 |
| gene therapy | #7878 |
| amenable | #7895 |
| analyze | #7897 |
| illness | #7901 |
| lymphopenia | #7909 |
| 2nd | #7917 |
| th2 | #7918 |
| fact | #7925 |
| mann | #7929 |
| myocarditis | #7932 |
| discoveries | #7955 |
| cellular immune | #7957 |
| immunodiffusion | #7959 |
| transform infrared | #7960 |
| positive | #7982 |
| nitrites | #7983 |
| candidate gene | #7987 |
| scoring | #7989 |
| tregs | #7991 |
| direct effects | #7991 |
| unknown | #7993 |
| immune function | #7994 |
| oxidative | #7996 |
| fertilized | #8002 |
| identifies | #8007 |
| haplotypes humans | #8011 |
| polymorphisms | #8012 |
| psa | #8015 |
| essential | #8017 |
| hydroxy | #8030 |
| capacity | #8031 |
| raised | #8040 |
| lncrna | #8047 |
| macroscopic | #8049 |
| myeloid differentiation | #8054 |
| respiratory distress | #8063 |
| address | #8064 |
| drive | #8066 |
| evaluation preclinical | #8067 |
| factor signal | #8077 |
| ascertained | #8077 |
| spanning | #8085 |
| hypophyseal | #8087 |
| tetramer | #8088 |
| appearing | #8088 |
| clinical evaluation | #8089 |
| suboptimal | #8101 |
| physiological | #8105 |
| prolongation | #8108 |
| homozygosity | #8108 |
| considerably | #8109 |
| intronic | #8113 |
| prerequisite | #8120 |
| reasons | #8130 |
| nash | #8133 |
| bovine | #8133 |
| latest | #8134 |
| definition | #8141 |
| macrophages peritoneal | #8141 |
| dying | #8148 |
| trachea | #8156 |
| peripheral nerve | #8160 |
| relapses | #8166 |
| conditioned | #8167 |
| elevated | #8167 |
| harbor | #8170 |
| characterize | #8170 |
| bacterial infection | #8176 |
| expression | #8180 |
| member | #8181 |
| induced inflammation | #8186 |
| rescue | #8192 |
| sacrificed | #8197 |
| cassette | #8198 |
| analysing | #8209 |
| underlying | #8214 |
| preferential | #8216 |
| genetic associations | #8225 |
| sulphate | #8225 |
| defective | #8238 |
| ors | #8241 |
| marginal zone | #8244 |
| foster | #8245 |
| wide | #8261 |
| cultured cytokines | #8268 |
| ppar | #8274 |
| fibrinogen | #8275 |
| bone resorption | #8290 |
| clinical manifestations | #8294 |
| disease genome | #8295 |
| differ | #8295 |
| subcutaneous injection | #8300 |
| streptococcal | #8302 |
| oxygen | #8304 |
| combined treatment | #8309 |
| monoester | #8310 |
| remodeling | #8311 |
| aspergillus fumigatus | #8316 |
| peptide1 | #8316 |
| 11 | #8316 |
| genetically modified | #8320 |
| tlr | #8339 |
| cov2 infection | #8349 |
| vh | #8363 |
| boronic | #8363 |
| frequency | #8364 |
| parietal | #8367 |
| firstly | #8379 |
| fibrils | #8388 |
| migrate | #8391 |
| expressed | #8400 |
| poly | #8401 |
| residue | #8401 |
| p001 | #8404 |
| cd11b | #8408 |
| unaffected | #8411 |
| hydrophilicity | #8420 |
| advancement | #8424 |
| notion | #8424 |
| macrophage activation | #8429 |
| highlights | #8433 |
| defense | #8436 |
| viable | #8460 |
| 14 | #8468 |
| lamina | #8472 |
| manifestation | #8482 |
| protein conformation | #8485 |
| damaging | #8500 |
| promotes | #8502 |
| booster | #8512 |
| inflammatory process | #8516 |
| involves | #8520 |
| cells express | #8525 |
| mildly | #8527 |
| drug development | #8539 |
| phenotype | #8539 |
| burkholderia | #8540 |
| forkhead transcription | #8544 |
| human neutrophils | #8545 |
| estradiol | #8546 |
| copy | #8554 |
| tubule | #8558 |
| adaptive | #8568 |
| inflammatory cytokines | #8576 |
| responsive | #8580 |
| cellular functions | #8582 |
| marginal | #8600 |
| productive | #8609 |
| region | #8618 |
| stress reactive | #8622 |
| chickens | #8638 |
| xanthine | #8641 |
| positivity | #8659 |
| uncovered | #8689 |
| inducers | #8705 |
| outline | #8708 |
| experimental mice mice | #8716 |
| vigorous | #8717 |
| constitutive expression | #8717 |
| ccaat | #8720 |
| staphylococci | #8725 |
| regulatory cell | #8734 |
| cytokine | #8750 |
| recovered | #8751 |
| resorption | #8757 |
| rejection | #8759 |
| larynx | #8761 |
| subset | #8775 |
| chemokine receptor | #8777 |
| impaired | #8781 |
| highlight | #8782 |
| promoter | #8789 |
| cells human | #8790 |
| 4 weeks | #8792 |
| homozygous | #8792 |
| generate | #8799 |
| fungal infections | #8807 |
| human serum | #8808 |
| occasionally | #8808 |
| parotid | #8809 |
| chemically | #8809 |
| generates | #8811 |
| female male | #8812 |
| cytokine levels | #8825 |
| correlated | #8830 |
| kupffer | #8836 |
| cell phenotype | #8866 |
| pathway | #8867 |
| precisely | #8877 |
| bovis | #8882 |
| pathways | #8883 |
| unidentified | #8885 |
| frequencies | #8890 |
| deletion | #8893 |
| key regulator | #8903 |
| endopeptidases | #8922 |
| flow cytometric | #8932 |
| strengthen | #8941 |
| hypothalamo | #8941 |
| and or | #8942 |
| staining | #8944 |
| chemiluminescence | #8945 |
| modulate | #8948 |
| pge2 | #8966 |
| pitfalls | #8967 |
| subpopulation | #8967 |
| attack | #8975 |
| neonatal | #8981 |
| gene | #8983 |
| endosomal | #8987 |
| 129 | #8990 |
| vasculature | #9008 |
| rna long | #9017 |
| adrenocorticotropic | #9019 |
| chemoattractant | #9019 |
| discriminate | #9043 |
| thp1 | #9068 |
| leading | #9074 |
| positioned | #9075 |
| specific role | #9081 |
| glut4 | #9084 |
| hl60 | #9115 |
| cd4 cell | #9129 |
| differentially | #9131 |
| human | #9131 |
| cell surface | #9135 |
| pad | #9136 |
| ongoing | #9160 |
| reconstitution | #9166 |
| negative | #9175 |
| causative | #9182 |
| preincubation | #9186 |
| secrete | #9196 |
| tnf | #9198 |
| lethal | #9205 |
| serologic | #9213 |
| respiratory syndrome | #9222 |
| started | #9233 |
| innate immunity | #9233 |
| sequence | #9238 |
| cells isolated | #9241 |
| glomerulus | #9242 |
| immortalized | #9244 |
| severely | #9250 |
| offer | #9255 |
| orphan | #9255 |
| millions | #9268 |
| ubiquitous | #9272 |
| matrix | #9273 |
| killer | #9278 |
| crystal structures | #9313 |
| clear | #9315 |
| smoking status | #9329 |
| sdspage | #9335 |
| copolymers | #9346 |
| carbohydrate | #9368 |
| neutralizing | #9381 |
| immunoblot | #9395 |
| sweden | #9420 |
| functionality | #9425 |
| cysteine | #9458 |
| ifnα | #9459 |
| lacks | #9460 |
| treatment strategies | #9463 |
| immunomodulation | #9473 |
| luminescent | #9474 |
| molecular | #9484 |
| endotoxins | #9487 |
| tlr4 | #9501 |
| immobilized | #9505 |
| hormonal | #9519 |
| immunofluorescence | #9519 |
| cyclosporin | #9519 |
| sensitized | #9523 |
| detrimental | #9524 |
| heritable | #9530 |
| preexisting | #9543 |
| neuroinflammation | #9558 |
| factor beta1 | #9560 |
| interferon regulatory | #9572 |
| regulated | #9576 |
| culture techniques | #9577 |
| analogous | #9593 |
| entering | #9608 |
| affinities | #9614 |
| steroid hormones | #9615 |
| pretreated | #9624 |
| vaccinated | #9638 |
| gestation | #9639 |
| mammalian cells | #9643 |
| attached | #9647 |
| genetic models | #9655 |
| basement membrane | #9657 |
| key | #9658 |
| vehicle | #9670 |
| cell adhesion | #9678 |
| dramatic | #9694 |
| slight | #9694 |
| accessible | #9708 |
| snp | #9709 |
| azathioprine | #9721 |
| ear | #9723 |
| environment interaction | #9730 |
| humanized | #9753 |
| livers | #9753 |
| maintenance | #9756 |
| metabolic syndrome mets | #9758 |
| functional analysis | #9772 |
| blocked | #9776 |
| cleavage | #9781 |
| microscopic | #9784 |
| adhesion cell | #9784 |
| nasal | #9786 |
| plasminogen activator | #9788 |
| structure activity | #9789 |
| lowered | #9804 |
| infectious | #9804 |
| sterile | #9810 |
| driven | #9836 |
| fibronectin | #9846 |
| delineation | #9856 |
| rheumatology | #9870 |
| phage | #9872 |
| memory cells | #9874 |
| nonhuman primates | #9876 |
| pathogens | #9902 |
| serological | #9907 |
| coculture | #9927 |
| interleukin8 | #9936 |
| healthy control | #9938 |
| reactions | #9953 |
| monkeys | #9973 |
| anticipated | #9993 |
| nucleic acids | #10007 |
| flare | #10014 |
| inflammatory cytokine | #10023 |
| genotype | #10053 |
| serum | #10061 |
| leukocytes | #10067 |
| administered | #10070 |
| differentiation factor | #10076 |
| inflammation male | #10091 |
| generating | #10093 |
| surface receptors | #10102 |
| fibrin | #10105 |
| virulence factors | #10110 |
| cells patients | #10110 |
| activated | #10122 |
| ccl4 | #10125 |
| il1beta | #10131 |
| edge | #10132 |
| new strategy | #10136 |
| host cells | #10139 |
| mitogens | #10140 |
| cell signaling | #10143 |
| kappa | #10143 |
| th2 cells | #10147 |
| retroviridae | #10157 |
| postmenopausal | #10172 |
| traps | #10177 |
| hydrogen peroxide | #10184 |
| placenta | #10185 |
| named | #10188 |
| tlrs | #10207 |
| delta | #10218 |
| summarize | #10236 |
| day | #10244 |
| molecular biology | #10259 |
| rats spraguedawley receptors | #10277 |
| arg | #10279 |
| reproducible | #10283 |
| animals anti | #10304 |
| germ | #10305 |
| gene environment | #10307 |
| tendency | #10317 |
| scid | #10324 |
| lectins | #10329 |
| dismutase | #10332 |
| avian influenza | #10343 |
| reductive | #10347 |
| complete | #10365 |
| mediators | #10378 |
| nterminal | #10392 |
| partially | #10400 |
| lasting | #10406 |
| promote | #10424 |
| determine | #10429 |
| cterminus | #10432 |
| refined | #10437 |
| kill | #10441 |
| cattle | #10446 |
| assays | #10447 |
| indirectly | #10460 |
| mediates | #10474 |
| thioredoxin | #10475 |
| occur | #10477 |
| motif | #10479 |
| redundant | #10502 |
| receptor binding | #10504 |
| developing | #10513 |
| behavior animal | #10515 |
| promoter regions | #10545 |
| phosphate | #10548 |
| produced | #10552 |
| exception | #10554 |
| dysregulated | #10557 |
| critical | #10564 |
| influence | #10568 |
| understood | #10572 |
| converting enzyme | #10584 |
| progressive | #10597 |
| rise | #10608 |
| female | #10609 |
| shortened | #10612 |
| small molecule | #10616 |
| nf kappa | #10617 |
| extracellular matrix | #10620 |
| paralysis | #10632 |
| primers | #10636 |
| collectively | #10637 |
| underlie | #10642 |
| testosterone | #10659 |
| macrophage colony | #10664 |
| selective inhibitor | #10667 |
| aged osteoarthritis | #10675 |
| summary | #10684 |
| repeats | #10685 |
| pbs | #10702 |
| respond | #10705 |
| cerebrospinal fluid | #10708 |
| 17 | #10713 |
| disruption | #10729 |
| issue | #10762 |
| conformation | #10767 |
| il18 | #10770 |
| generation | #10781 |
| cleaved | #10800 |
| 103 | #10811 |
| conditional | #10821 |
| capture | #10822 |
| operated | #10824 |
| seropositive | #10826 |
| cellular mechanisms | #10838 |
| belonging | #10857 |
| saline | #10857 |
| restraint | #10864 |
| phosphatase | #10866 |
| immunoblotting | #10872 |
| factor1 | #10880 |
| base | #10885 |
| connective tissue | #10896 |
| phagocytosis | #10904 |
| multifunctional | #10904 |
| ineffective | #10909 |
| avoid | #10909 |
| luciferase | #10915 |
| bronchoalveolar | #10916 |
| promise | #10920 |
| secondary | #10926 |
| pivotal | #10926 |
| mulatta | #10929 |
| mannose | #10934 |
| persisted | #10939 |
| concluded | #10955 |
| methotrexate | #10967 |
| myeloid cells | #10978 |
| airway inflammation | #10982 |
| degrading | #10983 |
| subcutaneously | #10984 |
| immunoassay | #10984 |
| characterization | #10986 |
| governing | #10998 |
| septic | #11000 |
| ethanol | #11000 |
| tnfα | #11003 |
| mpo | #11010 |
| cell subsets | #11012 |
| originally | #11016 |
| 263 | #11027 |
| immunohistochemistry | #11028 |
| occurrence | #11030 |
| scid mice | #11030 |
| messenger | #11037 |
| hyper | #11040 |
| optical imaging | #11045 |
| skin | #11056 |
| establish | #11066 |
| calcitriol | #11067 |
| tumor progression | #11088 |
| paternal | #11094 |
| add | #11096 |
| freezing | #11102 |
| systemic | #11112 |
| infection animals | #11117 |
| focusing | #11144 |
| genetic polymorphism | #11161 |
| innate immune response | #11167 |
| male | #11167 |
| osteoarthritis | #11176 |
| subsequent | #11177 |
| receptors | #11177 |
| influx | #11177 |
| affinity chromatography | #11186 |
| genes involved | #11187 |
| ankylosing spondylitis | #11197 |
| article | #11201 |
| directly | #11208 |
| bsa | #11210 |
| limited | #11223 |
| sorting | #11229 |
| elicited | #11230 |
| interleukin10 | #11232 |
| disulfides | #11233 |
| contributed | #11248 |
| peptidase | #11251 |
| human blood | #11281 |
| ability | #11284 |
| extensive | #11297 |
| humans influenza | #11314 |
| genotyped | #11318 |
| compared controls | #11322 |
| depends | #11323 |
| oxidant | #11344 |
| caution | #11347 |
| addressing | #11351 |
| tissue damage | #11352 |
| correlate | #11354 |
| extra | #11356 |
| histopathologic | #11376 |
| neuroglia | #11384 |
| modifications | #11385 |
| experimental evidence | #11409 |
| increased expression | #11410 |
| pharmacology | #11413 |
| oxidative phosphorylation | #11428 |
| eosinophilic | #11432 |
| interleukin12 | #11437 |
| quantified | #11438 |
| receptor | #11445 |
| hla class | #11447 |
| cell death | #11460 |
| enhance | #11461 |
| reduces | #11466 |
| governed | #11476 |
| initiating | #11479 |
| contrasting | #11480 |
| melanoma cells | #11488 |
| compared healthy | #11489 |
| cd8 cell | #11498 |
| ankle | #11508 |
| serine | #11525 |
| cytosol | #11542 |
| recipient | #11546 |
| ca2 | #11559 |
| therapeutic interventions | #11561 |
| mets | #11566 |
| jurkat | #11569 |
| backgrounds | #11570 |
| inflammatory effects | #11595 |
| culture medium | #11599 |
| differential expression | #11606 |
| alteration | #11627 |
| frequently | #11627 |
| chicken | #11649 |
| swiss | #11652 |
| enhanced | #11661 |
| exerted | #11663 |
| immunologic memory | #11672 |
| transforming growth | #11678 |
| relief | #11691 |
| synergism | #11703 |
| controls | #11730 |
| psychotic | #11730 |
| toxin | #11735 |
| aiming | #11737 |
| innovative | #11751 |
| amyotrophic | #11769 |
| cell lineage | #11773 |
| constitutes | #11774 |
| inoculated | #11781 |
| commentary | #11785 |
| multiple | #11805 |
| selective | #11814 |
| display | #11817 |
| moderately | #11819 |
| altered | #11829 |
| insufficient | #11830 |
| sequence homology | #11840 |
| 9 | #11857 |
| graft | #11866 |
| analogues | #11871 |
| forkhead | #11888 |
| stained | #11890 |
| enzyme | #11942 |
| augmentation | #11943 |
| classic | #11944 |
| supplied | #11946 |
| gastrointestinal tract | #11958 |
| animals bone | #11966 |
| reveal | #11966 |
| maternal fetal | #11968 |
| adherent | #11980 |
| stress response | #11991 |
| contribution | #11998 |
| tgf | #12005 |
| biomarker | #12016 |
| antiserum | #12017 |
| cricetulus | #12021 |
| deacetylase | #12050 |
| encoding | #12051 |
| plasma cell | #12059 |
| aethiops | #12067 |
| propose | #12072 |
| fat diet | #12104 |
| immunologic factors | #12106 |
| protection | #12107 |
| downstream | #12107 |
| il2 | #12111 |
| tyrosine | #12113 |
| lung | #12116 |
| effectively | #12118 |
| replaced | #12144 |
| induced cell | #12147 |
| bromide | #12152 |
| humans | #12155 |
| switched | #12181 |
| quiescent | #12181 |
| genetic vectors | #12203 |
| oligodeoxyribonucleotides | #12204 |
| myd88 | #12222 |
| histologic | #12222 |
| lectin | #12223 |
| therapeutics | #12230 |
| mesenteric | #12231 |
| toxic | #12231 |
| represents | #12233 |
| receptors estrogen | #12236 |
| corticosterone | #12242 |
| noncoding | #12244 |
| diabetic mice | #12257 |
| fibroblasts humans | #12268 |
| recombinant | #12270 |
| splice | #12271 |
| involving | #12273 |
| fluorescent antibody | #12276 |
| mineral | #12297 |
| tnf alpha | #12300 |
| streptococcus | #12310 |
| harmful | #12319 |
| depending | #12361 |
| acid | #12363 |
| leukocyte count | #12369 |
| syndromes | #12371 |
| tradeoff | #12389 |
| interplay | #12412 |
| origin | #12416 |
| clonal | #12420 |
| microfilament | #12423 |
| reversed | #12439 |
| publication adaptor proteins | #12462 |
| weaker | #12464 |
| protein expression | #12503 |
| pain | #12532 |
| hydrochloride | #12535 |
| drug design | #12567 |
| functional | #12573 |
| suppressor | #12596 |
| rats treated | #12596 |
| binding site | #12597 |
| monomeric | #12605 |
| cells natural | #12637 |
| medullary | #12637 |
| explained | #12643 |
| macaca | #12645 |
| notably | #12664 |
| fetuses | #12665 |
| chronic diseases | #12665 |
| cdnas | #12679 |
| adenine | #12679 |
| 6 weeks | #12681 |
| p38 mitogen | #12681 |
| investigation | #12697 |
| instance | #12709 |
| alveolar | #12729 |
| persistent | #12729 |
| receptor alpha | #12743 |
| modulators | #12770 |
| interactions | #12785 |
| aimed | #12791 |
| nature | #12795 |
| influencing | #12800 |
| diminished | #12804 |
| initiated | #12813 |
| tibia | #12813 |
| sole | #12814 |
| metalloproteinases | #12819 |
| thought | #12823 |
| twin | #12854 |
| isolated | #12871 |
| solely | #12882 |
| disadvantages | #12886 |
| sulfhydryl | #12921 |
| sustained | #12922 |
| assay | #12926 |
| breakdown | #12984 |
| cell division | #13004 |
| embryonic development | #13020 |
| damage | #13056 |
| removing | #13067 |
| tryptophan | #13079 |
| tightly | #13087 |
| crystallography | #13101 |
| hyaluronic | #13102 |
| enabling | #13133 |
| time pcr | #13141 |
| publications | #13143 |
| receptors cell | #13145 |
| stereoisomerism | #13158 |
| distress syndrome | #13175 |
| ancestral | #13179 |
| retained | #13203 |
| valine | #13205 |
| division | #13213 |
| suffering | #13215 |
| single nucleotide polymorphisms | #13234 |
| opportunity | #13243 |
| opportunities | #13258 |
| 1 protein | #13270 |
| chemotaxis | #13279 |
| modulator | #13283 |
| lavage fluid | #13293 |
| transgene | #13297 |
| ascending | #13302 |
| regulators | #13320 |
| elucidated | #13323 |
| purity | #13330 |
| bronchoalveolar lavage | #13334 |
| nk | #13353 |
| fisher | #13357 |
| inhibitory effects | #13362 |
| lymphoproliferative | #13372 |
| amyotrophic lateral | #13377 |
| facilitating | #13380 |
| overexpressed | #13383 |
| scattered | #13389 |
| borrelia | #13393 |
| intact | #13410 |
| independently | #13433 |
| thiol | #13434 |
| fibroblast | #13447 |
| oocytes | #13463 |
| embryos | #13465 |
| marrow derived | #13484 |
| spraguedawley receptors | #13488 |
| overcome | #13489 |
| endopeptidase | #13500 |
| aspect | #13523 |
| lateral sclerosis | #13577 |
| tail | #13589 |
| selectively | #13591 |
| lipopolysaccharide | #13598 |
| elisa | #13612 |
| heritability | #13616 |
| vertebrates | #13627 |
| renal disease | #13634 |
| cure | #13674 |
| peripheral | #13689 |
| reproductive | #13755 |
| clones | #13757 |
| requires | #13783 |
| profiling gene | #13808 |
| lavage | #13811 |
| exon | #13822 |
| arising | #13831 |
| secretory | #13835 |
| techniques | #13873 |
| 6 | #13879 |
| killer cells | #13891 |
| exposed | #13917 |
| cloned | #13927 |
| iga | #13936 |
| hepatocytes | #13938 |
| tolerant | #13992 |
| lncrnas | #14002 |
| anti inflammatory | #14010 |
| killed | #14033 |
| selectin | #14034 |
| sensitization | #14035 |
| environmental | #14057 |
| insertion | #14063 |
| recombinant proteins | #14070 |
| neighboring | #14098 |
| reflects | #14102 |
| great | #14120 |
| preclinical | #14123 |
| highlighting | #14145 |
| preventing | #14148 |
| healthy individuals | #14159 |
| administration | #14164 |
| vaccination | #14176 |
| potent | #14183 |
| retroviral | #14208 |
| multigene | #14246 |
| advances | #14275 |
| amino acids | #14298 |
| ester | #14310 |
| oxidative stress | #14315 |
| cord | #14319 |
| incidence | #14322 |
| impairs | #14323 |
| domain | #14325 |
| psychosis | #14326 |
| bovine serum | #14329 |
| p38 | #14329 |
| isolation | #14334 |
| differentiation | #14342 |
| multiprotein | #14366 |
| mineral density | #14406 |
| #14414 | |
| differentiation cells | #14414 |
| resolve | #14420 |
| colony stimulating | #14421 |
| consistently | #14448 |
| kinases animals | #14452 |
| paracrine | #14452 |
| adenoviridae | #14472 |
| chlorocebus | #14481 |
| marrow transplantation | #14485 |
| targeted | #14490 |
| pathology | #14492 |
| il1 | #14500 |
| integrative | #14510 |
| cells vitro | #14537 |
| monocytes | #14540 |
| bone density | #14589 |
| infectious diseases | #14593 |
| biomedical | #14605 |
| nitrate | #14616 |
| nf kappab | #14627 |
| recombinant human | #14632 |
| divergent | #14638 |
| pathological | #14640 |
| enzyme activation | #14658 |
| lupus nephritis | #14661 |
| smoking | #14673 |
| transforming | #14675 |
| gfp | #14681 |
| inborn | #14696 |
| hand | #14698 |
| green fluorescent | #14703 |
| scarce | #14718 |
| substances | #14724 |
| risk developing | #14724 |
| nitrates | #14728 |
| oxide synthase | #14731 |
| p005 | #14732 |
| particulate | #14751 |
| oxidoreductases | #14753 |
| protein binding | #14757 |
| blood vessels | #14759 |
| human cells | #14768 |
| interferon alpha | #14780 |
| il1β | #14800 |
| degenerative | #14815 |
| proteinase | #14817 |
| originating | #14824 |
| vitro | #14829 |
| overlapping | #14835 |
| biocompatible | #14851 |
| prostaglandins | #14881 |
| controlled | #14895 |
| interaction | #14916 |
| chronically | #14923 |
| genomic dna | #14929 |
| potential therapeutic | #14939 |
| colleagues | #14950 |
| plays | #15011 |
| cross | #15041 |
| implications | #15063 |
| escape | #15078 |
| granule | #15079 |
| receptor gene | #15089 |
| phosphoric | #15090 |
| converting | #15126 |
| acute respiratory | #15173 |
| spinal cord | #15185 |
| seroepidemiologic | #15205 |
| bmd | #15213 |
| proliferation cells | #15219 |
| covalently | #15234 |
| preferentially | #15252 |
| adhesion | #15299 |
| fetus | #15300 |
| processed | #15329 |
| allografts | #15337 |
| synthase | #15339 |
| bone mineral density | #15340 |
| accelerate | #15346 |
| neurodegenerative | #15377 |
| pretreatment | #15379 |
| blood mononuclear | #15414 |
| interleukin6 il6 | #15440 |
| comparative | #15474 |
| selected | #15486 |
| antigens bacterial | #15511 |
| cells dcs | #15513 |
| locally | #15521 |
| transcriptase polymerase | #15530 |
| influenza human | #15537 |
| basis | #15540 |
| hormone | #15542 |
| central nervous | #15566 |
| estrogen receptor | #15572 |
| transduction | #15579 |
| vaccines | #15623 |
| responsiveness | #15647 |
| rna interference | #15649 |
| binds | #15651 |
| accelerator | #15673 |
| limitation | #15675 |
| pyruvate | #15682 |
| sequenced | #15696 |
| conformational | #15701 |
| cd28 | #15708 |
| connective | #15748 |
| gastric | #15775 |
| single | #15789 |
| fluorescent | #15793 |
| bone loss | #15832 |
| induced expression | #15835 |
| protein structure | #15849 |
| spinal | #15861 |
| vasculitis | #15884 |
| treating | #15887 |
| kappab | #15894 |
| gcsf | #15908 |
| competitive | #15910 |
| positron emission | #15913 |
| downregulation | #15914 |
| systemic inflammation | #15944 |
| methylated | #15945 |
| neurodegeneration | #15945 |
| involve | #15980 |
| ap1 | #15985 |
| plasmon resonance | #15986 |
| reflected | #15993 |
| chromatographic | #16019 |
| cnv | #16065 |
| oligonucleotide array | #16092 |
| 106 | #16097 |
| responding | #16105 |
| pluripotent | #16135 |
| bone mineral | #16141 |
| undetectable | #16148 |
| skeletal | #16151 |
| neurons | #16154 |
| tissue distribution | #16155 |
| disequilibrium | #16156 |
| beta1 | #16172 |
| exhibited | #16189 |
| response treatment | #16236 |
| grafted | #16238 |
| array sequence | #16239 |
| glandular | #16252 |
| functional studies | #16273 |
| responders | #16278 |
| new class | #16282 |
| subunit | #16293 |
| required | #16309 |
| animals base | #16310 |
| subclinical | #16311 |
| linkage disequilibrium | #16342 |
| receptor signaling | #16351 |
| difference | #16367 |
| remarkably | #16382 |
| molecular structure | #16391 |
| form | #16409 |
| signalling | #16414 |
| molecular mechanism | #16419 |
| publication antibodies | #16433 |
| cd40 | #16468 |
| shr | #16471 |
| capable | #16496 |
| grouped | #16512 |
| subcutaneous | #16522 |
| fibroblasts | #16525 |
| revealing | #16544 |
| targeting | #16552 |
| node | #16585 |
| respiratory | #16585 |
| organs | #16586 |
| tumor cells | #16600 |
| antibodies bacterial | #16603 |
| subunits | #16626 |
| profiling | #16651 |
| necrosis | #16655 |
| negatively | #16709 |
| establishing | #16709 |
| uric | #16743 |
| irradiated | #16757 |
| nick | #16765 |
| intramolecular | #16795 |
| deeper | #16801 |
| instrumental | #16812 |
| detected | #16851 |
| immunoreactive | #16859 |
| clinically | #16859 |
| serve | #16878 |
| inhibitory | #16881 |
| documented | #16904 |
| greatly | #16907 |
| colony | #16928 |
| turn | #16941 |
| immunosuppression | #16942 |
| mmps | #16957 |
| inhibition | #16959 |
| receptor 1 | #16964 |
| additionally | #16970 |
| humans hydrogen | #16982 |
| structurally | #16985 |
| prior | #16994 |
| additional | #17005 |
| binding protein | #17006 |
| recombinant fusion | #17013 |
| sulfate | #17069 |
| b7 | #17077 |
| count | #17083 |
| il12 | #17096 |
| sex factors | #17111 |
| consist | #17113 |
| minimal | #17116 |
| alpha subunit | #17119 |
| lysosomal | #17126 |
| unexpected | #17137 |
| tissue | #17148 |
| pluripotent stem | #17151 |
| receptors tumor | #17172 |
| csf | #17185 |
| activator | #17202 |
| lymph node | #17208 |
| underlying mechanisms | #17217 |
| stimulation | #17249 |
| starting | #17298 |
| peritoneal | #17299 |
| cell proliferation | #17318 |
| fluid | #17330 |
| propensity | #17345 |
| generations | #17377 |
| humans immunity | #17410 |
| constitute | #17425 |
| demonstrated | #17444 |
| membrane | #17466 |
| muscle skeletal | #17479 |
| allowing | #17505 |
| types | #17505 |
| transcriptase | #17515 |
| fibrous | #17515 |
| type iii | #17546 |
| localization | #17547 |
| constitutive | #17559 |
| cytometry humans | #17570 |
| discovery | #17583 |
| treatments | #17596 |
| peripheral blood | #17615 |
| variation | #17616 |
| packed | #17678 |
| differed | #17683 |
| expanded | #17687 |
| proved | #17691 |
| plasmon | #17698 |
| longitudinally | #17713 |
| pbmcs | #17728 |
| stimulating factor | #17743 |
| somatic | #17805 |
| inflammatory bowel disease | #17815 |
| dcs | #17827 |
| relating | #17861 |
| alpha tnf | #17880 |
| neuroendocrine | #17920 |
| oligonucleotide | #17954 |
| homology | #17962 |
| surface plasmon | #17971 |
| pregnancy | #17985 |
| chromosomal | #17994 |
| post | #17998 |
| inhibit | #18002 |
| labelled | #18004 |
| damaged | #18064 |
| osmolar | #18107 |
| 2 4 | #18130 |
| creating | #18142 |
| cytoplasm | #18155 |
| released | #18157 |
| trigger | #18161 |
| corticosteroids | #18164 |
| species | #18168 |
| endocrine | #18192 |
| vertebrate | #18206 |
| labeled | #18208 |
| subcellular | #18231 |
| rna messenger | #18235 |
| protein serine | #18279 |
| limiting | #18281 |
| reverse transcriptase | #18325 |
| evidenced | #18329 |
| truncated | #18336 |
| net | #18345 |
| avian | #18345 |
| males | #18375 |
| critically | #18389 |
| assumed | #18433 |
| modulated | #18444 |
| rats wistar | #18448 |
| pathogen | #18464 |
| immunogenicity | #18486 |
| acids | #18490 |
| reaching | #18494 |
| nonparametric | #18512 |
| constitutively | #18518 |
| processing | #18609 |
| hyaluronan | #18609 |
| sulfonamides | #18643 |
| investigating | #18651 |
| 15 | #18656 |
| 22 | #18658 |
| verify | #18669 |
| signal transduction | #18682 |
| agents steroidal | #18685 |
| remaining | #18721 |
| aim | #18788 |
| cerebrospinal | #18788 |
| created | #18803 |
| cultured | #18823 |
| balanced | #18823 |
| carry | #18829 |
| pathophysiological | #18830 |
| production | #18927 |
| nerve | #18943 |
| nested | #18957 |
| nfκb | #18987 |
| failed | #18988 |
| sequence analysis | #19002 |
| specific antigen | #19050 |
| observations | #19062 |
| provided | #19067 |
| bone marrow | #19084 |
| lungs | #19111 |
| stimulating | #19136 |
| protein | #19164 |
| bearing | #19167 |
| publication administration | #19185 |
| gained | #19200 |
| mitochondrial | #19260 |
| symptoms | #19288 |
| lost | #19298 |
| majority | #19304 |
| intra | #19311 |
| interacts | #19344 |
| hormones | #19441 |
| fatal | #19464 |
| interferons | #19489 |
| analyzing | #19515 |
| exogenous | #19526 |
| cytoskeletal | #19553 |
| adrenal | #19553 |
| rapidly | #19574 |
| inducible | #19616 |
| etiology | #19652 |
| environment | #19668 |
| implanted | #19680 |
| lps | #19681 |
| mice scid | #19683 |
| vesicular | #19701 |
| lineage | #19719 |
| markers | #19789 |
| histologically | #19817 |
| offers | #19826 |
| cutaneous | #19834 |
| precise | #19836 |
| pharmacological | #19854 |
| fetal | #19862 |
| shifted | #19875 |
| newly | #19892 |
| supporting | #19915 |
| vitro techniques | #19945 |
| yielded | #19948 |
| 8 | #19978 |
| 28 | #19979 |
| cns | #19979 |
| response relationship | #20014 |
| transient | #20038 |
| modify | #20055 |
| designated | #20056 |
| reverse | #20057 |
| casecontrol study | #20088 |
| mutagenesis | #20118 |
| illustrated | #20126 |
| downregulated | #20133 |
| ultimately | #20202 |
| κb | #20256 |
| 1 diabetes | #20263 |
| hypothalamic | #20285 |
| primary | #20303 |
| entered | #20310 |
| nitric | #20316 |
| gene expression | #20364 |
| markedly | #20453 |
| genotype humans | #20460 |
| mature | #20491 |
| microglia | #20561 |
| circulating | #20574 |
| overexpressing | #20593 |
| human pair | #20604 |
| polyacrylamide | #20612 |
| marrow | #20651 |
| defining | #20660 |
| pregnant | #20665 |
| equal | #20678 |
| resting | #20729 |
| injured | #20739 |
| mild | #20819 |
| local | #20825 |
| discovered | #20835 |
| cricetinae | #20839 |
| reduction | #20847 |
| illustrate | #20874 |
| lactic | #20908 |
| hypothesized | #20913 |
| tended | #20919 |
| 10 | #20952 |
| successful | #20952 |
| cell derived | #20955 |
| aberrant | #20961 |
| animals biomarkers | #21033 |
| 2 | #21085 |
| attractive | #21228 |
| acute | #21279 |
| produces | #21297 |
| transfected | #21316 |
| marked | #21340 |
| decreased | #21383 |
| maternal | #21389 |
| emerged | #21445 |
| survived | #21524 |
| confirms | #21558 |
| membrane proteins | #21585 |
| forming | #21593 |
| preserved | #21732 |
| contained | #21802 |
| previous | #21805 |
| 16 | #21813 |
| doses | #21835 |
| immunodeficiency | #21852 |
| electrophoresis | #21867 |
| mellitus type | #21871 |
| natural killer | #21877 |
| cell count | #21898 |
| prolonged | #21903 |
| heavy | #21965 |
| increasing | #21979 |
| polymeric | #22042 |
| gradually | #22067 |
| glial | #22202 |
| selecting | #22242 |
| extremely | #22248 |
| 4 | #22274 |
| opportunistic | #22307 |
| accepted | #22356 |
| emission tomography | #22395 |
| enable | #22402 |
| humans models | #22445 |
| initially | #22458 |
| microscopy confocal | #22466 |
| physiologic | #22470 |
| appears | #22488 |
| releasing | #22497 |
| suitable | #22522 |
| humans immunosuppressive | #22529 |
| confirm | #22553 |
| chemokine | #22558 |
| metabolic | #22585 |
| actins | #22597 |
| loss | #22611 |
| nf | #22756 |
| reactive protein | #22834 |
| utilizing | #22899 |
| transformed | #22917 |
| progression female | #22918 |
| detailed | #23005 |
| natural | #23089 |
| cell types | #23132 |
| sex | #23234 |
| null | #23277 |
| untranslated | #23305 |
| signaling | #23324 |
| syndrome | #23335 |
| bone | #23397 |
| necrosis factor | #23407 |
| rich | #23430 |
| cells tumor | #23467 |
| nucleic | #23501 |
| continued | #23663 |
| cellular | #23667 |
| expression gene | #23728 |
| attenuated | #23757 |
| mitogen | #23814 |
| serine threonine | #23835 |
| examine | #23864 |
| fusion proteins | #23968 |
| organ | #23990 |
| remained | #23998 |
| prevent | #24026 |
| confined | #24245 |
| oxidized | #24325 |
| called | #24330 |
| discussed | #24334 |
| genomic | #24394 |
| covering | #24485 |
| embryonic | #24490 |
| interleukin | #24583 |
| varying | #24640 |
| weeks | #24698 |
| mechanistic | #24796 |
| putative | #24897 |
| sarcoidosis | #24963 |
| detect | #24963 |
| remains | #25082 |
| controversial | #25175 |
| implies | #25192 |
| stromal | #25269 |
| type 1 diabetes | #25410 |
| enriched | #25470 |
| relation | #25543 |
| attributed | #25618 |
| 7 | #25632 |
| proteins | #25644 |
| tumor necrosis | #25683 |
| dysregulation | #25711 |
| cytoplasmic | #25732 |
| inflammatory agents | #25735 |
| energetic | #25813 |
| healthy | #25887 |
| representing | #25917 |
| challenging | #25976 |
| threonine | #25988 |
| mechanisms underlying | #26094 |
| signal | #26163 |
| tnfalpha | #26432 |
| frequent | #26487 |
| individuals | #26568 |
| antibodies viral | #26579 |
| growth factor | #26602 |
| validated | #26686 |
| lower | #26708 |
| treat | #26713 |
| 3 | #26751 |
| tolerated | #26780 |
| pathophysiology | #26782 |
| explored | #26850 |
| tumor necrosis factor | #26925 |
| comparable | #26955 |
| normal | #27016 |
| define | #27055 |
| exist | #27121 |
| presented | #27123 |
| consists | #27152 |
| intracellular | #27233 |
| invariant | #27331 |
| animals cells | #27339 |
| adaptor proteins | #27447 |
| chromosomes human | #27524 |
| associations | #27560 |
| kda | #27648 |
| tract | #27680 |
| possess | #27765 |
| exclude | #27824 |
| cell tumor | #27826 |
| attributable | #28018 |
| proteins humans | #28150 |
| heterozygote | #28266 |
| treated | #28436 |
| observe | #28472 |
| remain | #28560 |
| regulation humans | #28667 |
| threonine kinases | #28809 |
| hypothesis | #28819 |
| require | #28838 |
| examined | #29041 |
| infection | #29082 |
| 5 | #29247 |
| animals apoptosis | #29491 |
| intracellular signaling | #29517 |
| easily | #29557 |
| effective | #29656 |
| 005 | #29706 |
| fully | #29936 |
| exhibit | #29947 |
| gtp binding | #29997 |
| intravenous | #30185 |
| cell movement | #30520 |
| oxide | #30546 |
| reached | #30655 |
| active | #30908 |
| versus | #30963 |
| 1 | #31228 |
| cell differentiation | #31374 |
| vary | #31548 |
| blotting western | #31843 |
| free | #32409 |
| expression regulation | #32516 |
| needed | #32543 |
| objectives | #32805 |
| generally | #33368 |
| inhibited | #33394 |
| clinical | #33439 |
| sought | #34008 |
| reduce | #34128 |
| biological | #34247 |
| reflect | #34701 |
| separately | #34818 |
| agents | #34868 |
| assess | #34935 |
| polymerase | #35201 |
| nuclear | #35715 |
| polymerase chain | #36180 |
| formed | #36819 |
| chain reaction | #36949 |
| 001 | #36954 |
| measured | #42007 |
Jalankan laporan | |
Prominent publications by Rikard Holmdahl
KOL-Index: 15284
The purpose of the study was to map the dominant T cell epitope of the CB11 sequence of CII in RTlu haplotype rats and to determine if, when used as a synthetic peptide, it would induce tolerance to protect against CIA. A dominant epitope corresponding to residues 184-198 included in the sequence of the CB11 fragment of bovine CII was identified in proliferation assay using peptides in an epitope scanning system using synthetic peptides of 15 amino acids, overlapping by 12 amino acids. ...
| Dikenal sebagai Mucosal Tolerance | Synthetic Peptide | Cell Epitope | Cia Cii | Collagen‐induced Arthritis |
KOL-Index: 14658
An antibody response to defined epitopes located on the triple helical portion of type II collagen (CII) is associated with the development of collagen-induced arthritis (CIA) and rheumatoid arthritis (RA). Monoclonal antibodies to epitopes associated with arthritis, but not antibodies specific for epitopes not associated with arthritis, induce arthritis in mice, the so-called collagen antibody induced arthritis (CAIA) model. We have selected monoclonal IgG antibodies specific for four ...
| Dikenal sebagai Collagen Antibody | Induced Arthritis | Monoclonal Antibodies | Mice Inbred | Specific Epitopes |
KOL-Index: 13984
The Aq major histocompatibility complex (MHC) class II molecule is associated with susceptibility to murine collagen-induced arthritis (CIA), whereas the closely related H-2Ap molecule is not. To understand the molecular basis for this difference, we have analyzed the ability of H-2Aq and H-2Ap molecules (referred to as Aq and Ap) to bind and present collagen type II (CII)-derived glycosylated and non-glycosylated peptides. T cell clones specific for the immunodominant CII 256-270 ...
| Dikenal sebagai Collagen‐induced Arthritis | Transgenic Models | Aq Molecule | Structural Basis | C3h Mice |
KOL-Index: 13727
BACKGROUND: Autoantibodies to cyclic citrullinated peptides (anti-CCP) are present in most patients with rheumatoid arthritis (RA), and associate with HLA-DRB1 shared epitope (SE) alleles.
OBJECTIVE: To investigate reactivities of anti-CCP to various citrullinated proteins/peptides, which represent potential autoantigens in RA, and to examine the relationship between such antibodies, and their association with genetic variants within HLA-DRB1 SE alleles.
METHODS: Serum samples from 291 ...
| Dikenal sebagai Citrullinated Antigens | Rheumatoid Arthritis | Drb1 Alleles | Ccp Patients | Antibody Reactivities |
Localization of a critical restriction site on the I-A beta chain that determines susceptibility to collagen-induced arthritis in mice
[ PUBLICATION ]
Type II collagen-induced arthritis (CIA) in mice is an autoimmune experimental model for rheumatoid arthritis. Susceptibility to CIA is associated with certain major histocompatibility complex class II haplotypes. The two very closely related haplotypes H-2q and H-2p differ in susceptibility to CIA. Only mice of H-2q (DBA/1, B10G strains) but not mice of H-2p-expressing strains (like strain B10P) develop CIA and an autoimmune response to type II collagen (CII) after immunization with ...
| Dikenal sebagai Mice Cia | Beta Chain | Rheumatoid Arthritis | H2q Haplotype | Type Collagen Cii |
KOL-Index: 13513
INTRODUCTION: It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent ...
| Dikenal sebagai Citrullinated Peptides | Onset Symptoms | Development Rheumatoid Arthritis | Combination Acpa | Hlase Smoking |
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients
[ PUBLICATION ]
OBJECTIVE: High titers of specific anti-citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well-defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their ...
| Dikenal sebagai Citrullinated Antigens | Synovial Fluid | Rheumatoid Arthritis Patients | Type Collagen | Antibodies Acpas |
Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats
[ PUBLICATION ]
INTRODUCTION: Toll-like receptors (TLRs) are involved in both innate and adaptive immune responses and are likely to play a complex role in the pathogenesis of human rheumatoid arthritis (RA) and experimental arthritis. The objective of this study was to identify the key TLR in pristane-induced arthritis (PIA), a rat model for RA, and to clarify its roles in the initiation and maintenance of arthritis.
METHODS: Arthritis in DA rats was induced by pristane and the severity was evaluated ...
| Dikenal sebagai Induced Arthritis | Tlr3 Expression | Rats Pristane | Receptor 3 | Inbred Strains Severity |
KOL-Index: 12776
Multiple sclerosis (MS) is a complex chronic neurologic disease with a suspected autoimmune pathogenesis1,2. Although there is evidence that the development of MS is determined by both environmental influences and genes, these factors are largely undefined3,4, except for major histocompatibility (MHC) genes. Linkage analyses and association studies have shown that susceptibility to MS is associated with genes in the human histocompatibility leukocyte antigens (HLA) class II region, but ...
| Dikenal sebagai Multiple Sclerosis | Transgenic Mice | Hla Dr2 | Humanized Model | Spontaneous Disease |
KOL-Index: 12721
Polymorphism of the major histocompatibility complex (MHC) influences susceptibility to experimental autoimmune encephalomyelitis (EAE) induced by myelin basic protein (MBP) in rats. Current concepts relate such influences to the capacity of class II molecules to present relevant peptides to autoreactive T cells. We have here analyzed the MHC influence on the immune response and the development of EAE after immunization with the immunodominant peptide MBP-63-88. Analysis of MHC-congenic ...
| Dikenal sebagai Myelin Basic Protein | Experimental Autoimmune | Major Histocompatibility | Rats Eae | Immune Response |
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
[ PUBLICATION ]
OBJECTIVE: The presence of antibodies against cyclic citrullinated peptides has been demonstrated to precede the onset of symptoms of rheumatoid arthritis (RA) by several years. The aim of this study was to analyze antibodies against 10 citrullinated autoantigen-derived peptides for reactivity before the onset of RA symptoms.
METHODS: A case-control study was conducted within the Medical Biobank of Northern Sweden. The study was performed in 409 individuals, 386 of whom donated 717 blood ...
| Dikenal sebagai Citrullinated Peptides | Rheumatoid Arthritis | Onset Symptoms | Antibodies Cep1 | Type Collagen |
KOL-Index: 12510
Antibodies against type II collagen (anti-CII) are arthritogenic and have a crucial role in the initiation of collagen-induced arthritis. Here, we have determined the dependence of T and B cells in collagen-antibody-induced arthritis (CAIA) during different phases of arthritis. Mice deficient for B and/or T cells were susceptible to the CAIA, showing that the antibodies induce arthritis even in the absence of an adaptive immune system. To determine whether CII-reactive T cells could have ...
| Dikenal sebagai Collagen Type | Arthritis Mice | Antigen Tcell | Antibodies Cii | Adaptive Immune |
KOL-Index: 12427
The nonobese diabetic (NOD) mouse spontaneously develops autoimmune-mediated diseases such as diabetes and Sjögren's syndrome. To investigate whether NOD genes also promote autoimmune-mediated arthritis we established a NOD strain with an MHC class II fragment containing the A(q) class II gene predisposing for collagen induced arthritis (NOD.Q). However, this mouse was resistant to arthritis in contrast to other A(q) expressing strains such as B10.Q and DBA/1. To determine the major ...
| Dikenal sebagai Genetic Control | Complement Factor | Induced Arthritis | Locus Chromosome | Mice Inbred |
Orang -orang kunci untuk Rheumatoid Arthritis
Top Kols di dunia
Pilih frasa pencarian rheumatoid arthritis , rheumatoid arthritis patients , rheumatoid arthritis treatment , rheumatoid arthritis risk , rheumatoid arthritis study
Rikard Holmdahl:Dampak ahli
Konsep yang manaRikard Holmdahlmemiliki pengaruh langsung:Rheumatoid arthritis, Induced arthritis, Experimental arthritis, Collagen type, Type collagen, Animal models, Reactive oxygen species, Autoimmune diseases.
Rikard Holmdahl:Dampak Kol
Konsep yang terkait dengan karya penulis lain yang manafor which Rikard Holmdahl memiliki pengaruh:Rheumatoid arthritis, Multiple sclerosis, Autoimmune diseases, Oxidative stress, Animal models, Reactive oxygen species, Nadph oxidase.
Tools
Apakah ini profil Anda? Klaim profil Anda Salin URL Sematkan tautan ke profil Anda |